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CHAPTER - I   
INTRODUCTION, AIMS AND OBJECTIVES 
  Introduction: 
My doctor is 
A good doctor 
He made me no 
Iller than I was  
 Willem Hussem (The Netherlands) 1900-1974  
Transalation: Peter Raven 
As once quoted by Hippocrates, “Primum non nocere” - in the first place do no 
harm is often cited as one of the foundation stones of a sound medical care1.  
Mankind has always desired for survival of the fittest and the modern medicine, 
medicine health care facilities and its novel interventions have made it possible to a 
varied extent. While one of the most essential pillars of a responsible medical care is 
that of an accurate and proper prescription, there remains quite a lot of lacunae and 
ambiguity in this area  according to various studies2,3,4. 
 Prescription order being an important therapeutic transaction between physician 
and patient, it brings into focus the diagnostic acumen and therapeutic 
proficiency of the physician with instructions for palliation or restoration of the 
patient’s health. The most carefully conceived prescription order may become 
therapeutically useless, however, unless it communicates clearly with the 
pharmacist and adequately instructs the patient on how to take the prescribed 
medication5.  A drug prescription is often the end point of a patient’s visit to a 
medical practitioner, as an instruction from the prescriber to a dispenser, it ought to 
be considered a medico-legal document that should be written legibly, accurately 
and completely6.  
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Basic prescription writing skills is a prerequisite for a proper prescription to avoid 
prescription errors, as it is suppose to teach and train a budding doctor on how to 
write a prescription, something that he would do for decades to come. Prescribing 
physicians as well as those involved in the execution of the prescription hold a legal 
responsibility for prescription. 
Although the prescription format may very slightly from one country to another, 
most countries agree on the core elements that should be included in prescription 
order. These are - prescriber’s name, address, telephone number and signature, 
patient’s name, address, age, weight (important at the extremes of age), prescription 
date, drug name (preferably generic), formulation, strength, dose, frequency of 
administration, quantity prescribed, reasons for prescribing and instructions for use. 
A good quality prescription is an extremely important factor for minimizing errors in 
the dispensing of medication and physicians should adhere to the guidelines for 
prescription writing for the benefit of the patient7. A proper documentation of the 
prescribing practice allows the identification of acceptable and non-acceptable 
prescribing habits. Such information is needed to set up continuous systems to 
ensure good prescribing habits and to maintain an efficient health care system. 
Health professionals may also utilize these informations to develop guidelines for a 
cost effective prescribing in their local areas. As the complexities of medication 
management pose a significant safety risk for the patients. Each of the phases of the 
medication process, namely prescribing, dispensing, administering and monitoring, 
provide opportunities for confusion or error. Medication errors are defined as a 
failure/s in the treatment process that leads to or has the potential to lead to harm to 
the patient frequently occur at the drug ordering or prescribing stage8. There are two 
major types of medication errors i.e. prescription errors which encompass those 
related to the act of prescription writing and that of prescribing faults which 
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encompass irrational prescribing, inappropriate prescribing, underprescribing and 
ineffective prescribing arising from erroneous medical judgement or decisions 
concerning treatment or treatment monitoring9,10. Such errors can occur both in 
general practice and hospital, although they are rarely fatal they can affect patients 
safety and quality of health care 3,11.   
Prescription errors as defined by Dean et al using the Delphi technique is defined as 
a clinically meaningful prescribing error which occurs when there is an 
unintentional significant reduction in the probability of treatment being timely and 
effective or increase in the risk of harm when compared with generally accepted 
practice12.  
 
Figure-1 illustrates the relationships between medication errors, prescribing errors, 
adverse drug events (ADEs), potential adverse drug events (potential ADEs) and 
adverse drug reactions.  
 
Therefore prescription errors are a common cause of adverse events or medication 
errors and may be largely preventable13. Although prescribing errors occur in a 
range between 0.56% and 9.9% of all prescriptions14.  These error rates are 
dependent on the definitions and various study methods used for prescribing errors. 
All such errors in turn are a major component of medical errors, which are an 
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important factor that influences the quality of patient care. According to Barach et 
al., nearly 100,000 individuals per year in the US die of preventable medical 
errors15.  
 Learning about how to prescribe and prescribing skills appears to fall between two 
pillars: (i) it is not taught at medical school and (ii) it is assumed to be in place by 
the doctors of first employment. The question remains when do doctors actually 
receive training for effective prescription writing practices.  There are other cultural 
factors as well which contribute to how a prescription activity is perceived among 
doctors. Cultural differences particularly when it involves questioning authority 
have led to the inability of junior doctors and nurses to question the decisions of 
seniors, especially that of senior doctors16. A critical outcome of such phenomenon 
can lead to pharmacists being seen as a line of defense against errors, or actually 
inhabiting that role of deciding about medication dose and frequency. 
Prescribing being one of common tasks in daily general practice, there seems 
abundant evidence of continuous poor prescribing in the world e.g. evidence of poor 
prescribing in UK17.  While poor prescribing is not an uncommon practice in India 
also18. In India, conventional or traditional methods of prescribing on a prescription 
i.e. hand written on a prescription blank are still prevalent. Physicians as well as 
pharmacists, however, should be exposed to alternative means of prescription e.g. 
prescription forms, electronically transmitted prescriptions, fax simile prescriptions, 
telephonic order etc. and in fact most of the doctors are willing for a shift from 
traditional methods. Development of the ability to write and dispense a complete 
and unambiguous prescription(s) consistently is an essential, yet often neglected, 
part of a medical care training process. Unfortunately the prescriptions written by 
qualified physicians suffer from serious deficiencies and are not properly written. 
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Prescriptions containing errors communicate incompletely or inadequately to the 
pharmacist and may have various detrimental consequences. There seems to be an 
urgent need for physician education on appropriate prescription writing and 
furthermore re-inclusion of tutorials on prescription writing in final clinical year and 
internship of medical students. Administrative monitoring of the prescription habits 
of physicians is needed both to improve the health care process and to maintain the 
improvement. This study is an effort directed to find out the errors in prescription 
writing and interventions to improve upon such error prone practices of prescription 
writing.  
Given the current scenario or scale of prescription errors, a need was felt concerning 
lacunae’s in the field of prescription writing.  This study serves as an important 
reminder   to the practicing consultants to write proper accurate prescriptions and to 
avoid prescription errors. Since writing of prescriptions is an important aspect of 
medical practice, there is need for physicians and the consultants in various 
respective areas to focus on the importance of proper prescription writing orders. By 
examining the various aspects of prescription writing that can cause errors and by 
modifying prescribing habits, accordingly, the physician can improve the chance 
that the patient will receive the correct prescription, whether in a hospital or in an  
outpatient setting. By being alert to common problems that can occur with 
medication orders and communicating with the patients, physician, pharmacists and 
other health care professional one can assist in reducing prescription errors thereby 
decreasing the number of medication errors.  
 Aims of the Study:  
1. To find out the pattern or rate of prescription errors.  
2.  To find out whether prescription writing abides with the W.H.O. standards of 
prescription writing. 
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3. To assess the causes of prescription writing errors in Anand district.   
 Objectives of the Study:   
1. To reemphasize on the importance of error free prescription writing in 
clinicians and health care providers. 
2. To increase awareness about the problems caused by errors in prescription 
writing and ways to minimize the same. 
3. To devise novel interventions for the practicing clinicians to prevent 
prescription errors. 
Errors will always occur in any system, but it is essential to identify causes and 
attempts to minimize risk. Although it is difficult to quantify precisely the extent of 
prescription errors, they are frequent and often avoidable representing a major threat 
to patient safety. Prescribers should be informed and made aware of errors that have 
been made in their environment and the conclusions of the analysis. Error reporting 
systems have been widely used both internally as well as externally in various health 
care institutions19.  
Hippocrates himself, in the first volume of his Epidemics, put all events better in 
context i.e. when dealing with the diseases has two precepts in the mind: to procure 
benefit and not to harm “One must not become overly obsessed by the safety issues, 
but it is a necessary element in good medical care.  
So the main objective of the present study is to emphasize on the skills of 
prescription writing and thus create an awareness amongst the existing and future 
clinicians on ways and means to minimize prescriptions errors.  
 
CHAPTER – II 
 
REVIEW OF 
LITERATURE 
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CHAPTER - II   
REVIEW OF LITERATURE 
2.1  Prescription:  
2.1.1 What is a medical prescription? 
A prescription order is an important therapeutic transaction between the physician 
and the patient. It brings into focus the diagnostic acumen and therapeutic 
proficiency of the physician with instructions for the palliation and or restoration of 
the patients health. The most carefully conceived prescription order may become 
therapeutically useless, however, unless it communicates clearly with the 
pharmacists and adequately instructs the patient on how to take prescribed 
medications5. Thus a prescription is a health care program implemented by a 
physician or other medical practitioner in the form of instructions that govern the 
plan of care for an individual patient. Proficiency at writing a prescription accurately 
and speedily requires practice. Prescription writing has changed in modern medicine 
as a result of several developments. Most of the preparations today are compounded 
by pharmaceutical companies and the pharmacists current role in most cases is 
dispensing. The practice of writing long complex prescription orders containing 
many active ingredients, adjuvants, correctives and elegant vehicles has been 
abandoned in favor of single drugs and mixtures of drugs compounded by 
pharmaceutical companies. Even when combinations of several active ingredients 
are desirable, pharmaceutical companies often provide suitable combinations. A 
properly written prescription provides a primer on proper approach to medication 
prescribing and order process, to prevent medication misadventures and a resource 
for practitioners in effectively providing pharmaceutical care for their patients. 
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Prescription is an instruction from a prescriber to a dispenser. The prescriber is not 
always a doctor but can also be a paramedical worker, such as medical assistant, a 
midwife or a nurse. The dispenser is not always a pharmacist, but can be a pharmacy 
technician, an assistant or a nurse. Every country has its own standards for the 
minimum information required for a prescription, and its own laws and regulations 
to define which drugs require a prescription and who is entitled to write it. 
Commonly the term prescription is used to mean an order to take certain 
medications. Prescription orders should be written legibly while prescriptions have a 
legal implication as they may indicate that the prescriber takes the responsibility for 
the clinical care of the patient and in particular for monitoring efficacy and safety. 
However, as medications have increasingly become prepackaged manufactured 
products and medical practices have become more complex, the scope of meaning of 
the term prescription has also broadened to also include clinical assessments, 
laboratory task and imaging studies relevant to optimizing the safety or efficacy of 
the treatment.  
 The word ‘prescription’ comes from the Latin ‘Pre’ and ‘Scribo’, means literally 
‘written before’ i.e. that which is ‘written before’ the application of the treatment. In 
its broadest sense, it includes any instructions for the benefit of the patient20.  
2.2  Prescription Writing:  
2.2.1 Historical review of origin of drugs and prescription  
 Knowledge of ancient prescriptions can be found in both Chinese21 and Egyptian 
writing22. The ancients started their prescriptions with an appeal to God for success, 
the use of the symbol Rx established centuries ago is rooted in ancient alchemical 
practice having an obscure origin has been carried down to the present times. ‘Rx’ 
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may be derived from the Egyptian “Eye of Horus” symbol denoting, health or may 
be a symbolic appeal by physicians to the god Jupiter for a prescription’s success. 
More commonly, Rx is said to be an abbreviation for the Latin word recipere, 
meaning “take” or “take thou” as a direction to a pharmacist, preceding the 
physician’s “recipe” for preparing a medication. What is clear is the origin of the 
abbreviation “Sig” for the “Latin “Signatura”, used on the prescription to mark the 
directions for administration of the medication. Many ancient prescriptions were 
noted for their multiple ingredients and complexity of preparation. The importance 
of the prescription and the need for complete understanding and accuracy made it 
imperative that a universal and a standard language be employed. Thus Latin was 
continued until approximately a generation ago. Latin is no longer the international 
language of medicine, but a number of commonly used abbreviations are derived 
from old Latin usage.  
The prescriptions and the treatment of disease have, with the progress of time, has 
gone through many evolutions. Treatment beginning occurred among our   ancestors 
as songs, dances and various enchantations, it was learnt early that certain agents, if 
associated with the other efforts to drive out evil spirits, tend to produce the desired 
effect, and medicine soon became a partner to religious effort. 
Before the days of the priestcraft, the wise man or woman of the tribe whose 
knowledge of the healing properties of the plants had been gathered through 
experience or handed down by word of mouth was called upon to attend to the sick 
or the wounded and prepare the remedy. It was in preparation of the medicinal 
materials that the art of the apothecary was originated. The art of apothecary has 
always been associated with mystery, and its practitioners were believed to have 
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connection with the world of spirits and thus performed as intermediaries between 
the seen and the unseen.  
The concept of prescriptions dates back to the beginning of history, so long there 
were medications, a writing system to record directions for preparation and usage, 
there were prescriptions.  Thus the history of prescription writing is almost as old as 
the history of man. Among the most ancient inscriptions, now being deciphered are 
found formulae for preparing medicines. Some of these show that even at the 
remotest times there was some knowledge of Materia Medica, that this knowledge 
was employed by some physicians in writing instructions (prescription) for the 
preparation of remedies, and there is reason to suppose that these instructions were 
executed by others (pharmacists).  
Numerous ancient tablets, scrolls and other relics as early as 3000 BC have been 
uncovered and deciphered by archaeological scholars to the delight of historians of 
both medicine and pharmacy. One of them being the Sumerian clay tablet from the 
third millennium BC on which are believed to be the world’s oldest written 
prescriptions. Among them are a preparation of a seed of carpenter plant, gum resin 
of markhazi and thyme, all pulverized and dissolved in beer and a combination of 
powdered roots of Moon Plant and white Pear tree also dissolved in roots23.  
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Historical Aspects24: 
1.       Before the Dawn of History: 
 
 
From beginnings as remote and simple as these came the proud profession of 
Pharmacy. Its development parallels that of man. Ancient man learned from
instinct, from observation of birds and beasts. Cool water, a leaf, dirt, or mud was
his first soothing application. By trial, he learned which served him best.
Eventually, he applied his knowledge for the benefit of others. Though the
cavemen's methods were crude, many of today's medicines spring from sources as
simple and elementary as those which were within reach of early men.  
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2.         Pharmacy in Ancient Babylonia: 
 
 
Babylon, jewel of ancient Mesopotamia, often called the cradle of civilization,
provides the earliest known record of practice of the art of the apothecary.
Practitioners of healing of this era (about 2600 B.C.) were priest, pharmacist and
physician, all in one. Medical texts on clay tablets record first the symptoms of
illness, the prescription and directions for compounding, then an invocation to the
gods. Ancient Babylonian methods find counterpart in today's modern
pharmaceutical, medical, and spiritual care of the sick. 
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3.        Pharmacy in Ancient China: 
 
 
 
 
Chinese Pharmacy, according to legend, stems from Shen Nung (about 2000 B.C.),
emperor who sought out and investigated the medicinal value of several hundred
herbs. He reputed to have tested many of them on himself, and to have written the 
first Pen T-Sao, or native herbal, recording 365 drugs. Still worshiped by native
Chinese drug guilds as their patron god, Shen Nung conceivably examined many
herbs, barks, and roots brought in from the fields, swamps, and woods that are still 
recognized in Pharmacy today. In the background is the "Pa Kua," a mathematical
design symbolizing creation and life. Medicinal plants include podophyllum,
rhubarb, ginseng, stramonium, cinnamon bark, and, in the boy's hand, ma huang or 
Ephedra. 
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4.         Days of the Papyrus Eberus: 
 
 
 
Though Egyptian medicine dates from about 2900 B.C., best known and most
important pharmaceutical record is the "Papyrus Ebers" (1500 B.C.), a collection of
800 prescriptions, mentioning 700 drugs. Pharmacy in ancient Egypt was conducted
by two or more echelons: gatherers and preparers of drugs and "chiefs of
fabrication" or head pharmacists.  
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5.        Theophrastus - Father of Botany:  
 
 
Theophrastus (about 300 B.C.), among the greatest early Greek philosophers and 
natural scientists, is called the "father of botany". His observations and writings
dealing with the medical qualities and peculiarities of herbs are unusually accurate,
even in the light of present knowledge. He lectured to groups of students who 
walked about with him, learning of nature by observing her treasurers at firsthand. In
his hands he holds a branch of belladonna. Behind him are pomegranate blooms,
senna, and manuscript scrolls. Slabs of ivory, coated with colored beeswax, served 
the students as "slates." Writing was cut into the surface with a stylus. 
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6.        The Royal Toxicologist - Mithridates VI: 
 
 
Mithridates VI, King of Pontus (about 100 B.C.), though he battled Rome for a
lifetime, found time to make not only the art of poisoning, but also the art of
preventing and counteracting poisoning, subjects of intensive study. Unhesitatingly
he used himself as well as his prisoners as "guinea pigs" on which to test poisons and
antidotes. Behind him are rhizotomists, offering fresh, flowering aconite, ginger, and
gentian. At lower right is a crater - a two-piece forerunner of the champagne bucket. 
His famed formula of alleged panantidotal powers, "Mithridatum," was popular for
over a thousand years. 
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7.         Terra Sigillata - an early "Trademarked" Drug: 
 
Man learned early of the prestigious advantage of trademarks as a means of
identification of source and of gaining customers' confidence. One of the first
therapeutic agents to bear such a mark was Terra Sigillata (Sealed Earth), a clay 
tablet originating on the Mediterranean island of Lemnos before 500 B.C. One day
each year clay was dug from a pit on a Lemnian hillside in the presence of
governmental and religious dignitaries. Washed, refined, rolled to a mass of proper 
thickness, the clay was formed into pastilles and impressed with an official seal by
priestesses, then sun-dried. The tablets were then widely distributed commercially. 
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8.        Dioscorides - a Scientist Looks at Drugs: 
 
 
In the evolution of all successful and enduring systems of knowledge there comes a
time when the observations of many men, or the intensive studies of one, transcend
from the level of trade or vocation to that of a science. Pedanios Dioscorides (first
century A.D.), contributed mightily to such a transition in Pharmacy. In order to
study materia medica, Dioscorides accompanied the Roman armies throughout the
known world. He recorded what he observed, promulgated excellent rules for
collection of drugs, their storage and use. His texts were considered basic science as
late as the sixteenth century. 
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9.         Galen - Experimenter in Drug Compounding: 
 
Of the men of ancient times whose names are known and revered among both the
professions of Pharmacy and Medicine, Galen, undoubtedly, is the foremost. Galen
(130-200 A.D.) practiced and taught both Pharmacy and Medicine in Rome; his
principles of preparing and compounding medicines ruled in the Western world for
1,500 years; and his name still is associated with that class of pharmaceuticals 
compounded by mechanical means - galenicals. He was the originator of the formula 
for a cold cream, essentially similar to that known today. Many procedures Galen
originated have their counterparts in today's modern compounding laboratories. 
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10.      Damian and Cosmas - Pharmacy's Patron Saints: 
 
 
Twinship of the health professions, Pharmacy and Medicine, is nowhere more
strikingly portrayed than by Damian, the apothecary and Cosmas, the physician.
Twin brothers of Arabian descent, and devout Christians, they offered the solace of
religion as well as the benefit of their knowledge to the sick who visited them. Their
twin careers were cut short in the year 303 by martyrdom. For centuries their tomb
in the Syrian city of Cyprus was a shrine. Churches were built in their honor in
Rome and other cities. After canonization, they became the patron saints of
Pharmacy and Medicine, and many miracles were attributed to them. 
 
  
 
21
11.      Monastic Pharmacy: 
 
 
During the middle ages remnants of the Western knowledge of Pharmacy and 
Medicines were preserved in the monasteries (fifth to twelfth centuries). These 
scientists are known to have been taught in the cloisters as early as the seventh 
century. Manuscripts from many islands were translated or copied for monastery 
libraries. The monks gathered herbs and simples in the field, or raised them in their 
own herb gardens. These they prepared according to the art of the apothecary for the 
benefit of the sick and injured. Gardens such as these still may be found in 
monasteries in many countries. 
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12.       The First Apothecary Shops: 
 
 
The Arabs separated the arts of apothecary and physician, establishing in Bagdad 
late in the eighth century the first privately owned drug stores. They preserved much 
of the Greco-Roman wisdom, added to it, developing with the aid of their natural 
resources syrups, confections, conserves, distilled waters and alcoholic liquids. The 
apothecary is examining logs of sandalwood offered by a traveling merchant, while 
children indulge their taste for sweets with stalks of sugar cane.  
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13.       Avicenna - the "Persian Galen": 
 
 
Among the brilliant contributors to the sciences of Pharmacy and Medicine during
the Arabian era was one genius who seems to stand for his time - the Persian, Ibn 
Sina (about 980-1037 A.D.), called Avicenna by the Western world. Pharmacist,
poet, physician, philosopher and diplomat, Avicenna was an intellectual giant, a
favorite of Persian princes and rulers. He wrote in Arabic, often while secluded in 
the home of an apothecary friend. His pharmaceutical teachings were accepted as
authority in the West until the 17th century; and still are dominant influences in the
Orient. 
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14.       Separation of Pharmacy and Medicine: 
 
 
 
 
 
 
In European countries exposed to Arabian influence, public pharmacies began to 
appear in the 17th century. However, it was not until about 1240 A.D. that, in Sicily 
and Southern Italy, Pharmacy was separated from Medicine. Frederick II of 
Hohenstaufen, who was Emperor of Germany as well as King of Sicily, was a living 
link between Oriental and Occidental worlds. At his palace in Palermo, he presented 
subject pharmacists with the first European edict completely separating their 
responsibilities from those of Medicine, and prescribing regulations for their 
professional practice. 
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15.       The first Official Pharmacopoeia: 
 
The idea of a pharmacopoeia with official status, to be followed by all apothecaries, 
originated in Florence. The Nuovo Receptario, originally written in Italian, was 
published and became the legal standard for the city-state in 1498. It was the result 
of collaboration of the Guild of Apothecaries and the Medical Society - one of the 
earliest manifestations of constructive interprofessional relations. The professional 
groups received official advice and guidance from the powerful Dominican monk, 
Savonarola, (seated foreground) who, at the time, was the political leader in 
Florence. 
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16.       The Society of Apothecaries of London: 
 
Trade in drugs and spices were lucrative in the middle ages. In the British Isles, it 
was monopolized by the Guild of Grocers, which had jurisdiction over the 
apothecaries. After years of effort, the apothecaries found allies among court 
physicians. King James I, flanked by two "Beefeaters" wore heavily padded attire 
because of fear of stabbing. Upon persuasion by the philosopher-politician, Francis 
Bacon, the King granted a charter in 1617 which formed a separate company known 
as the "Master, Wardens and Society of the Art and Mystery of the Apothecaries of 
the City of London" over vigorous protests of the grocers. This was the first 
organization of pharmacists in the Anglo-Saxon world. 
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17.        Louis Hébert, Apothecary to New France (Canada): 
 
Young Parisian Apothecary Louis Hébert answered the call of the New World in 
1605, when he helped de Monts and Champlain build New France's first settlement, 
the Habitation at Port Royal (Nova Scotia, Canada). Hébert looked after the health 
of the pioneers, cultivated native drug plants, and supervised the gardens. At the 
waterfront, he examined specimens of drug plants offered by Micmac Indians. 
These included Arum, (Jack-in-the-Pulpit), Eupatorium (Boneset), Verbascum 
(Mullein) and Hydrastis (Golden Seal). When the Habitation was destroyed by the 
English in 1613, he returned to his Parisian apothecary shop. The lure of Canada 
was strong, however, and in 1617, he and the family returned with Champlain to 
Quebec, where Hébert's "green thumb" gained him lasting fame as the first 
successful farmer in what is now Canada. 
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18.       The Governor who healed the Sick: 
 
Many Europeans "of quality and wealth, particularly those who were non-
conformists in religion" were attracted to the possibilities of the American Colonies. 
From Britain came John Winthrop, first Governor of Massachusetts Bay Colony and 
founder of Boston. Governor Winthrop, unable to induce professionals to the 
Colony, sought advice from English apothecaries and physicians, and added to his 
small store of imported drugs those derived from plants native to New England. In 
his home (about 1640), he made available as best he could the ‘art and myslay’ of 
the apothecary for his citizens. 
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19.       The Marshall Apothecary: 
 
Christopher Marshall, an Irish immigrant, established his apothecary shop in 
Philadelphia in 1729. During 96 years, this pioneer pharmaceutical enterprise 
became a leading retail store, nucleus of large-scale chemical manufacturing; a 
"practical" training school for pharmacists; an important supply depot during the 
Revolution; and finally, it was managed by granddaughter Elizabeth, America's first 
woman pharmacist. Christopher earned the title of "The fighting Quaker" during the 
Revolution; his sons, Charles and Christopher, Jr. (shown as youths with their father, 
about 1754) earned individual fame and carried on his fine traditions. 
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20.       The First Hospital in Colonial America: 
 
Colonial America's first hospital (Pennsylvania) was established in Philadelphia in 
1751; the first Hospital Pharmacy began operations there in 1752, temporarily set up 
in the Kinsey house, which served until the first hospital building was completed. 
The ingenuity of Benjamin Franklin was helpful in both. First Hospital Pharmacist 
was Jonathan Roberts; but it was his successor, John Morgan, whose practice as a 
hospital pharmacist (1755-56), and whose impact upon Pharmacy and Medicine 
influenced changes that were to become of importance to the development of 
professional pharmacy in North America. First as pharmacist, later as physician, he 
advocated prescription writing and championed independent practice of two 
professions. 
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21.       Scheele - Greatest of the Pharmacists-Chemists: 
 
During his few short years, Carl Wilhelm Scheele gave to the world discoveries that 
have brought its people incalculable advantages. Yet he never forgot that he was, 
first of all, a pharmacist. Encouraged by enlightened preceptors, all of his 
discoveries were made in the Swedish pharmacists in which he worked, as 
apprentice, as clerk, and finally as owner, in Köping. He began in a corner of the 
stock room of Unicorn Apothecary in Gothenburg. With rare genius, he made 
thousands of experiments, discovered oxygen, chlorine, prussic acid, tartaric acid, 
tungsten, molybdenum, glycerin, nitroglycerin, and countless other organic 
compounds that enter into today's daily life, industry, health, and comfort. 
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22.       Craigie - America's first Apothecary General: 
 
First man to hold the rank of a commissioned pharmaceutical officer in an American 
army was the Bostonian apothecary, Andrew Craigie. First appointed commissary of 
medical stores by Massachusetts' Committee of Safety, April 30, 1775, he was 
present at the Battle of Bunker Hill, June 17, 1775, and probably assisted in taking 
care of the sick and wounded there in a makeshift station back of the lines. When 
Congress reorganized the Medical Department of the Army in 1777, Craigie became 
the first Apothecary General. His duties included procurement, storage, manufacture, 
and distribution of the Army's drug requirements. He also developed an early 
wholesaling and manufacturing business. 
 
  
 
33
23.       Sertürner - First of the Alkaloid Chemists: 
 
Swedish pharmacist Scheele paved the way for isolating organic plant acids; but it 
remained for a young German apothecary, Friedrich Wilhelm Adam Sertürner, to 
give the world opium's chief narcotic principle, morphine and to recognize and 
prove the importance of a new class of organic substances: alkaloids. His first 
announcements challenged, Sertürner in 1816 conducted a new series of bold, 
startling experiments in his apothecary shop in Einbeck, including a series of 
physiologic tests on himself and three young friends.  
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24.       Caventou, Pelletier and Quinine: 
 
Taking their cue from Sertürner's alkaloidal experiments, two French pharmacists, 
Messrs. Pierre-Joseph Pelletier and Joseph-Bienaimé Caventou, isolated emetine 
from ipecacuanha in 1817; strychnine and brucine from nux vomica in 1818 then, in 
their laboratory in the back of a Parisian apothecary shop, they tackled the problem 
that had baffled scientists for decades - wrestling  with the secrets of the Peruvian 
barks that were so useful against malaria. In 1820 Caventou and Pelletier announced 
the methods for separation of quinine and cinchonine from the cinchona barks 
prepared pure salts, had them tested clinically, and set up manufacturing facilities. 
Many other discoveries came from their pharmacy-laboratory high honors were 
accorded them. 
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25.       American Pharmacy Builds and its Foundations: 
 
Faced with two major threats deterioration of the practice of pharmacy, and a 
discriminatory classification by the University of Pennsylvania medical faculty, the 
pharmacists of Philadelphia held a tempestuous protest meeting in Carpenters' Hall, 
February 23, 1821. At a second meeting, March 13, the pharmacists voted formation 
of: an association, which became The Philadelphia College of Pharmacy, a school of 
pharmacy and a self-policing board.  
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26.       The Shakers and Medicinal Herbs: 
 
First U.S. industry in medicinal herbs was carried on by the United Society of 
Believers in Christ's Second Appearing, commonly known as the Shakers. Begun 
about 1820, and commercially important by 1830, the medicinal herb industry grew, 
hit its peak in the 1860's, then waned at the close of the century. The Shakers 
gathered or cultivated some 200 varieties dried, chopped, and pressed them into 
"bricks" wrapped, labeled, and sold them to pharmacists and physicians world-wide. 
Tons of solid and fluid extracts also were produced. The Shaker label was 
recognized for reliability and quality for more than a century. 
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27.       The American Pharmaceutical Association: 
 
Need for better intercommunication among pharmacists; standards for education and 
apprenticeship; and quality control of imported drugs, led to calling of a convention 
of representative pharmacists in the Hall of the Philadelphia College of Pharmacy, 
October 6 to 8, 1852. Under leadership of its first President, Daniel B. Smith, and 
first Secretary, William Procter, Jr., the twenty delegates launched The American 
Pharmaceutical Association, mapped its objectives; and opened membership to "All 
pharmaceutists and druggists" of good character who subscribed to its Constitution 
and to its Code of Ethics. The Association continues to serve Pharmacy today. 
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28.       European and American Pharmacy Meet: 
 
Over the years, no real discord has existed between representatives of European and 
American Pharmacy so far as ethical and scientific aims are concerned. But when 
the groups met for the first time, at the Second International Congress of Pharmacy 
in Paris, France, August 21 to 24, 1867, there was a great divergence of opinion on 
the subject of compulsory limitation of pharmacies. William Procter, Jr., leading the 
delegates of The American Pharmaceutical Association, told the international body 
that "Public opinion is in America a forceful agent of reform," and that, in his 
country, "there is not the slightest obstacle toward a multiplication of drug stores “ 
& this declaration vividly documented the American Way of Pharmacy. 
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29.       The Father of American Pharmacy: 
 
Rarely has a titular distinction been so deserved. William Procter, Jr., graduated 
from The Philadelphia College of Pharmacy in 1837 operated a retail pharmacy 
served the College as Professor of Pharmacy for 20 years was a leader in founding 
The American Pharmaceutical Association served that organization as its first 
secretary; later, as its president; served 30 years on the U.S.P. Revision Committee; 
was for 22 years Editor of the American Journal of Pharmacy. In 1869, though 
retired, Procter continued to edit the Journal in a small publication office located 
besides the College's Tenth Street building. 
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30.        A Revolution in Pharmaceutical Education: 
 
When Dr. Albert B. Prescott launched the pharmacy course at the University of 
Michigan in 1868, critical attention was aroused because he abandoned the 
traditional requirement of pre graduation apprenticeship. At the 1871 convention of 
the American Pharmaceutical Association, he was denied credentials and ostracized. 
However, the Michigan course pioneered other major changes: laboratory pharmacy, 
a definite curriculum that included basic sciences, and a program that demanded 
students' full-time attention. During the next thirty years, Dr. Prescott had the 
satisfaction of seeing his once revolutionary innovations generally adopted by 
pharmaceutical faculties. 
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31.       The Pharmacopoeia Comes of Age: 
 
 
 
 
 
 
 
 
 
 
The first "United States Pharmacopoeia" (1820) was the work of the medical 
profession. It was the first book of drug standards from a professional source to have 
achieved a nation's acceptance. In 1877, the "U.S.P." was in danger of dissolution 
due to the lack of interest of the medical profession. Dr. Edward R. Squibb, 
manufacturing pharmacist as well as physician, took the problem to The American 
Pharmaceutical Association convention. Pharmacists formed a "Committee on 
Revision" whose chairman was the hospital pharmacist Charles Rice, assisted by 
pharmacist-educator Joseph P. Remington, and by Dr. Squibb, their indefatigable 
collaborator.  
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32.       The Standardization of Pharmaceuticals: 
 
Despite the professional skill and integrity of 19th-century pharmacists, seldom did 
two preparations of vegetable drugs have the same strength, even though prepared 
by identical processes. Plant drugs varied widely in active alkaloidal and glucosidal 
content. The first answer to this problem came when Parke, Davis and Company 
introduced standardized "Liquor Ergotae Purificatus" in 1879. Dr. Albert Brown 
Lyons, as the firm's Chief Chemist, further developed methods of alkaloidal assay. 
Messrs. Parke and Davis recognized the value of his work, and in 1883, announced a 
list of twenty standardized "normal liquids." Parke-Davis also pioneered in 
developing pharmacologic and physiologic standards for pharmaceuticals. 
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33.       Wresting the Jungle's Secrets: 
 
Expeditions in search of new medicinal plants probably are as old as Pharmacy. 
Scientific adventurers, such as Henry Hurd Rusby (1855-1940), opened vast new 
horizons for the advancement of Pharmacy and Medicine, late in the nineteenth 
century. Sent by Parke, Davis and Company in 1884 to Peru for supplies of coca 
leaves, Dr. Rusby crossed the Andes and journeyed down the Amazon to the 
Atlantic amid incredible hardships. He returned with 45,000 botanical specimens. 
Among them were many new drug plants, including cocillana bark, pharmaceutical 
preparations of which are still important to Medicine. Dr. Rusby later became Dean 
of the College of Pharmacy of Columbia University. 
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34.        Stanislas Limousin - Pharmacal Inventor: 
 
One of those men singularly gifted in combining scientific knowledge with technical 
skill and with inventive genius was the French retail pharmacist, Stanislas Limousin 
(1831-1887). Among the many devices which he introduced to Pharmacy and 
Medicine were the medicine dropper; the system of coloring poisons (such as 
corrosive sublimate) and wafer cachets (which found favor prior to mass production 
of the gelatin capsule). His greatest contributions, however, were the development 
and perfection of apparatus for the inhalation and therapeutic administration of 
oxygen; and invention of glass ampoules that could be sealed and sterilized for 
preservation of solutions for hypodermic use. 
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35.       The Era of Biologicals: 
 
When, in 1894, Behring and Roux announced the effectiveness of diphtheria 
antitoxin, pharmaceutical scientists both in Europe and in the United States rushed 
to put the new discovery into production. Parke, Davis and Company was among the 
pioneers. The serum became available in 1895, and lives of thousands of children 
were saved. Inoculation of horses with diphtheria toxin was the first step of many in 
producing antitoxin. In 1903, Parke-Davis received U.S. Biological License No. 1. 
New, improved biological products have continued to become available, climaxed in 
1955 by poliomyelitis vaccine. 
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36.       The Development of Chemotherapy: 
 
One of the successful researchers in the development of new chemical compounds 
specifically created to fight disease-causing organisms in the body was the French 
pharmacist, Ernest Francois Auguste Fourneau (1872-1949), who for 30 years 
headed chemical laboratories in the world-renowned Institute Pasteur, in Paris. His 
early work with bismuth and arsenic compounds advanced the treatment of syphilis. 
He broke the German secret of a specific for sleeping sickness paved the way for the 
life-saving sulfonamide compounds; and from his laboratories came the first group 
of chemicals having recognized antihistaminic properties. His work led other 
investigators to broad fields of chemotherapeutic research. 
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37.       Pharmaceutical Research: 
 
Research in some form has gone hand in hand with the development of Pharmacy 
through the ages. However, it was the chemical synthesis of antipyrine in 1883 that 
gave impetus and inspiration for intensive search for therapeutically useful 
compounds. Begun by the Germans, who dominate the field until World War I, the 
lead in pharmaceutical research passed thereafter to the United States. Research in 
Pharmacy came into its own in the late 1930's and early 1940's has grown steadily 
since, supported by pharmaceutical manufactures, universities and government. 
Today it used techniques and trained personnel from every branch of science in the 
unending search for new life-saving drug products. 
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38.       Pharmaceutical Manufacturing Comes of Age: 
 
Pharmaceutical manufacturing as an industry apart from retail Pharmacy had its 
beginnings about 1600; really got under way in the middle 1700's. It developed first 
in Germany, then in England and in France. In America, it was the child of wars - 
born in the Revolution grew rapidly during and following the Civil War became 
independent of Europe during World War I, came of age during and following 
World War II. Utilizing latest technical advances from every branch of science, 
manufacturing pharmacy economically develops and produces the latest and greatest 
in drugs in immense quantities, so that everywhere physicians may prescribe them 
and pharmacists dispense them for the benefit of all mankind. 
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39.       The Era of Antibiotics: 
 
Antibiotics are not new. Their actions probably were first observed by Pasteur in 
1877. However, the second quarter of the 20th century marked the flowering of the 
antibiotic era - a new and dramatic departure in the production of disease-fighting 
drugs. Fleming's discovery of penicillin in 1929 went undeveloped and Florey and 
Chain studied it in 1940. Under pressure of World War II, the pharmaceutical 
manufacturers rapidly adapted mass production methods to penicillin have reduced 
costs to 1/1000th the original. Antibiotic discoveries came rapidly in the '40's. 
Intensive research continues to find antibiotics that will conquer more of men's 
microbial enemies. 
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40.       Pharmacy Today and Tomorrow: 
 
Pharmacy, with its heritage of 50 centuries of service to mankind, has come to be 
recognized as of the great professions. Like Medicine, it has come through many 
revolutions, has learned many things, had to discard many of its older ways. 
Pharmacists are among the community's finest educated people. When today's retail 
pharmacist fills a prescription written by a physician, he provides a professional 
service incorporating the benefits of the work of pharmacists in all branches of the 
profession - education, research, development, standards, production, and 
distribution. Pharmacy's professional stature will continue to grow in the future as 
this great heritage and tradition of service is passed on from preceptor to apprentice, 
from teacher to student, from father to son. 
As already stated prescriptions being one of the most important therapeutic 
transactions between physician and the patient. The art of prescription writing is an 
ancient inheritance, its origin is lost in antiquity, but its importance through the 
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centuries has made it, one of the most significant written communications of the 
human race.   
To avoid undesirable and or serious adverse effects on the patient, both the 
physician and the pharmacist must render the highest professional service. Accurate 
diagnosis, proper selection of medications, dosage form and route of administration, 
proper size and timing of dose, precise dispensing, accurate labeling and correct 
packaging all must be provided.  
2.2.2 General aspects of practical prescription writing:  
One of the primary communication links between the prescriber, pharmacist and 
patient is a complete safe and accurate prescription. Completion of all essential 
elements of a prescription will assure that it is accurately interpreted and is not 
subject to alteration6.  
Although perceived as a mundane component of the work of most clinicians, the 
process of good prescribing requires significant skills and care which should be 
undertaken with due thought and consideration. Good prescribing involves the 
recommendations of the correct dose and formulation of an appropriate drug, 
accompanied by clear instructions regarding, when how and for how long the drug is 
taken. A prescription should be a written clinical information about the patient and 
the symptoms and ideally following solicitations of the patient preferences and 
discussion of alternative treatment strategies. Prescriptions are handwritten on 
preprinted prescription form that are assembled into pads or alternatively printed 
onto similar forms using a computer printer. Preprinted on the form is the text that  
identifies the document as prescription, the name , address of the prescribing  
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provider and any other legal requirement such as registration number or e.g. DEA 
(Drug enforcement Administration) number in United States. Unique for each 
prescription is the name of the patient. Literally the word, recipe means simply take 
or take thou and when a medical practitioner writes a prescription beginning with  
Rx, he or she is completing the command. This was probably originally directed at 
the pharmacist who needed to take a certain amount of each ingredient to compound 
the medicine rather than at the patient who must take the medicine in the sense of 
consuming it. The word prescription can be decomposed into ‘pre’ and ‘script’ and 
literally means to write, before a drug can be prepared. Modern prescriptions are 
actually ‘extemporaneous prescriptions from the Latin extempore i.e. extempore = 
composed, performed or uttered on the spur of the moment. Thus extemporaneous 
means the prescription is written on the spot for a specific ailment. This is 
distinguished from a nonextemporaneous prescription which is a generic recipe for a 
general ailment.  
Modern prescriptions evolved with the separation of role of the pharmacists from 
that of physicians. Predating the modern legal definition prescriptions traditionally 
were  composed of 4 parts  “ a superscription”, an  “inscription”, subscription and 
signature and even today the prescription consist of the superscription, the 
inscription, the subscription  the  signa, the name and signature of the prescribe, all 
contained in a single form. 
A complete, safe and an accurate prescription writing is one of the primary 
communications links between the prescriber, pharmacist and patient. This in turn  
is an efficient resource for practitioners in effectively providing pharmaceutical care 
for their patients.  
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Superscription: 
The superscription includes the Date of the prescription and the patient information 
(for identification) name, age, address, weight of the patient, with the treatment 
symbol Rx. The symbol Rx separates the superscription from the inscription 
section.  In this arrangement of prescription the Rx symbol for recipe, is an 
exhortation to the pharmacist by medical practitioner, that I want the patient to have 
the following medication, or it means in other words, take the following 
components and compound this medication for the patient.  
Where Rx came from?  
 
 
 
The Eye of Horus    The Rx symbol share similar elements    The symbol for Jupiter
  
The symbol Rx is derived from the major lines in the symbol of the Eye of Horus. 
Horus was an Egyptian God. Horus’s eye also called the Wadjet Eye, became a 
symbol for health. The Egyptians considered it a symbol of good and restored health. 
The symbol was passed along through the ages. As William Osler wrote in 1910, “In 
a cursive form it is found in mediaeval translations of the works of Ptolemy the 
astrologer, as the sign of the planet Jupiter. As such it was placed upon horoscopes 
and upon formula containing drugs made for administration to the body, so that the 
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harmful properties of these drugs might be removed under the influence of the lucky 
plant.” There is another theory of Rx’s origin. In that version, Rx is an abbreviation 
for the Latin word recipere, which means “take” or “take thou”. Long ago, this 
would not have been a direction to a patient but to a pharmacist, preceding the 
physician’s “recipe” for preparing a medication. That may be, but the shape of the 
symbol is a strong argument in favour or the Eye and Horus as its origin. If you look 
closely at the major lines of the eye of Horus, you can see the elements of the 
symbol Rx. 
Inscription:  
The body of the prescription or inscription contains the name and strength of the 
drug to be dispensed, or the amount of each ingredient to be compounded. Earlier in 
ancient times the inscription section was further composed of one or more of the 
following:  
 A basic or chief ingredient intended to cure. 
 An adjuvant to assist its actions. 
 A corrective or a corrigent to prevent or lessen the undesired effect and 
decrease the disagreeable odour of ingredients.  
 A vehicle or a excipient to make suitable for administration and which is  
pleasant to the patient.  
In writing inscription following points should be observed:  
a) Each ingredient should be written on a separate line.  
b) Always begin each line with capital letter.  
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c) The name of active ingredients should be written first, and solids should come 
before that of liquid.  
d) While writing the names of preparations of drugs use correct, english names of 
abbreviated Latin names, preferably the former, as have been recommended by 
the pharmacopeias as that can lead to confusion e.g. BID in Latin is two times 
a day rather than before dinner as thought by the patient.  
e) The quantity of each drug ordered should follow the name of each ingredient 
and while writing the doses it is desirable be that the prescriber follows metric 
system.   
Subscription:  
The subscription is the instruction to the pharmacist usually consisting of a short 
sentence such as - make a solution, mix and place into 30 capsules, or dispense 30 
tablets. The subscription section contains dispensing directions to Pharmacists.  - i.e. 
compounding instruction or quantities to be dispensed.  
Signature: 
The signature section contains directions to the patient such as’ Take one 
teaspoonfull 3 times a day before meals’ and is often abbreviated as sig or signa. It 
is also helpful to include the indication for one medication, for example for ulcers. 
Wherever possible instructions of general nature such as take as directed should be 
avoided since the patient may misunderstand or forget oral directions given by the 
physician. In addition to these basic parts of a prescription it should have the 
patients name and also signature of the prescribing medical practitioner. This is 
written either in English or in vernacular language. The prescribers name or initial 
and the date are written at the bottom. Some state laws require that if substitution is 
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to be prohibited, the physician must actually write Dispense as written or a similar 
phrase. In case of addiction producing drugs like narcotic analgesics e.g. morphine 
and pethidine, barbiturates and certain poisonous drugs, the registration number of 
the prescriber should also be written at the bottom and address of the patient at the 
top.  
Although every country has its own standards for prescriptions, there are many 
practical issues for prescribing doctors to master, one of them which is very 
important is concerned with the writing of Prescriptions. There are four common 
types of prescriptions namely:  
 Prescription in general practice. 
 Hospital prescriptions for in patients.  
 Hospital prescriptions for a non-hospital pharmacy.  
 Private prescriptions.  
In all cases certain principles should be followed. A prescription should be a precise, 
accurate, clear and readable set of instruction/s. The instructions should be sufficient 
for a pharmacist to provide a patient with both the correct drug and the instructions 
on how to take it and also for the nurse to administer a drug accurately in hospital.  
Construction of the Prescription Order: 
Since traditions, a prescription order follows a definite pattern that facilitates its 
interpretation. While only one prescription should be written on an order blank all 
prescriptions should be written in ink, this practice is compulsory for schedule II 
drugs under the controlled substances act of 1970 as erasures on a prescription easily 
can lead to dispensing errors or diversion of controlled substances Prescription pad 
blanks normally are imprinted with a heading that gives the name of the physician 
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and the address and phone number of the practice site. Following issues in 
prescription writing are a cause of major concern. The figure below shows elements 
required for prescription writing5.  
 
A sample of an ideal prescription.  
The prescription must be carefully prepared to identify the patient and the 
medication to be dispensed, as well as the manner in which the drug is to be 
administered. Accuracy and legibility are essential. Use of abbreviations, 
particularly Latin, is discouraged, as it leads to dispensing errors. Inclusion of the 
purpose of the medication in the subscription (e.g. ‘for control of blood pressure’) 
can prevent errors in dispensing. For example, the use of losartan for the treatment 
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of hypertension may require 100 mg/day (1.4 mg/kg per day), whereas treatment of 
congestive heart failure with this angiotensin II-receptor antagonist should not 
generally exceed 50 mg/day. Including the purpose of the prescription can also assist 
patients in organizing and understanding their medications. Including the patient’s 
weight on the prescription can be useful in avoiding dosing errors, particularly when 
drugs are administered to children. 
When using institutional blanks that do not bear the physicians information, the 
physician should always print his or her name and phone number on the face of the 
prescription to clearly identify the prescriber and facilitate communication with 
other health care professionals if question arises. As stated earlier according to 
United States law requires that the prescription for controlled substances include the 
name address and the Drug Reinforcement Agency (DEA) registration number of 
the physician. The medicolegal significance of mentioning registration number of 
the qualified medical practitioner cannot be overemphasized besides being a legal 
requirement to be fulfilled by doctors as well as registered medical practioners by 
the director General of health23.  This again indicated a need for Pharmacy and 
medical educators to further emphasize the importance of writing complete 
prescriptions and also calls for implementation of educational and monitoring 
Programmes to bring more awareness to all concerned so as to reduce the rate of non 
compliance in prescription writing and hence minimizing chances of Prescription 
errors. Moreover according to information regarding Medical council registration 
number, doctors are required to quote their registration number on all medical 
prescriptions, reports and all other documentation and records, whether in paper or 
electronic format relating to their medical practice thus prescribing doctor should 
put his rubber stamp bearing his full name, qualification and registration number.  
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Date:  
Date of the prescription order is an important piece of the patients medical records, 
and it can assist the pharmacist in recognizing the potential problems. For example, 
when an opioid is prescribed for pain due to an injury, and the prescription is 
presented to the pharmacist 2 weeks after the issuance, the drug may no longer be 
indicated. Compliance behavior also can be estimated using the dates when a 
prescription is filled or refilled .In many countries the validity of a prescription has 
no time limit, but in some countries pharmacists do not give out drugs on 
prescriptions older than three to six months.    
Name, Address and Age of the Patient:  
Name, address, age of patient, this information is necessary to expedite the handling 
of the prescriptions order and to avoid possible confusion with medications intended 
for someone else. The patients name and address are needed in order to assure that 
the correct medication goes to the correct patient and also for the identification and 
record keeping purposes. For medications whose dosage involves calculations a 
patient’s pertinent factors such as weight, age, body surface area also should be 
listed. Prescribers often commit errors in dosage calculations that can be prevented25. 
When prescribing a drug whose dosage involves a calculation based on body weight 
or surface area it is a good practice to include both the calculated dose and the 
dosage formula used such as 240 mg every 8 hourly (40 mg/kg per day) to allow 
another health care professional to double check the prescribed dose, e.g. medication 
orders in hospitals and clinical settings such as those of antibiotics or antiepileptic 
medications that are sometimes difficult to adequately dose. It is essential for the 
pharmacist to verify the patients name and age, otherwise it is impossible to monitor 
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the prescribed dose. The pharmacist should place the name of patient on the bottle or 
the container exactly as the doctor   has written it. Prescription orders, for schedule II 
drugs are required to contain the full name and address of the patient. Moreover 
name, initials and hospital’s case number is important in hospital. If there are   two 
patients of the same name in the ward, this should be clearly stated, to avoid 
confusion and error.  
Drug name, strength and inert additives:  
The body of prescription order contains the name, strength or dose of the desired 
drug. The name of the drug should preferably be given in block capitals. Moreover it 
is strongly recommended to use the generic (non proprietary) name because it 
facilitates education and information as the drugs have different kinds of brand 
names.  
Chemical name, official name and brand name:  
 The chemical names are those whose form generally follows the rules issued 
by the International Union of Pure and Applied Chemistry (IUPAC). 
 The approved (official or generic) name, is usually the international non 
proprietary name, recommended by WHO, but may be some locally approved 
name (e.g. British approved name or United States adopted name). 
 The proprietary name (Brand name or Trade name) given to it by a 
pharmaceutical manufacturer for example:  
Chemical name:  -6 [amino (4-hydroxy phenyl) acetyl 1- amine] -3, 3 dimethyl 
-7 one-4- thia – 1 azabicyclo [3.2.0] heptane 2- carboxylic acid.  
Official name: Amoxicillin  
Proprietary names: Amorail, Almodan, Amox, Rimonallin, Mox.  
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There remains a lot of controversy regarding prescribing by proprietary or approved 
name. If a prescriber writes the drug by non- proprietary name, it means that he/she 
is not expressing an opinion about a particular brand, of drug which may be 
unnecessary for the patient. It also enables the pharmacist to maintain a more limited 
stock of drugs or dispense the cheapest drugs. However if there is a particular reason 
to prescribe that brand or a special brand the trade name can be added. Some 
countries allow generic substitution by pharmacist and require the addition, ‘Do not 
substitute’ or ‘dispense as written’ if that brand and none other than that brand is to 
be dispensed.  Prescribing by proprietary name can lead to missing, and forgetting 
the ingredients in a particular combination or a formulation, moreover if a doctor 
prescribes a drug by specific brand which is unavailable at the pharmacy store, it can  
result in  delay of  treatment.  
However if a doctor makes effort to prescribe where ever possible by approved 
name, particularly from the start of his career, he will generally find it just as easy as 
prescribing by proprietary name or else it is best to use the nonproprietary name 
followed by the name of manufacturer in parenthesis especially in cases where a 
specific manufacturer product has distinct advantages or if a physician wishes to 
prevent a change of product on subsequent refills, such a practice limits confusion of 
look alike names or sound alike names. So one should encourage to prescribe by 
non-proprietary name. 
 Look alike and sound alike drug names are responsible for approximately 25% of 
medication errors reported to USP MERP26. Even the drug whose name seems more 
distinct easily can be confused when handwriting styles and cognitive mechanisms 
such as confirmation bias become contributing factors27. Procedures exist for a 
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drug’s generic or brand name to be changed if it repeatedly causes errors or is found 
to be particularly dangerous, but many errors can occur before the change is 
instituted by the United States Food and Drug e.g. in 1990, the trade name for 
omeprazole in the United states under the FDA (United States Adopted Name 
(USAN) Council was changed from LOSEC to PRILOSEC because of the possible 
confusion of LOSEC with LASIX. In 2000, Amrione was renamed Inamrione in an 
effort to prevent further (sometimes fatal mix ups with amiodarone, although errors 
between the two had been reported for a number of years. It also has been proposed 
that the USAN of amiodarone be changed to camiodarone28 although this change 
has not yet been approved. The risk of look alike and sound alike errors can be 
minimized by printing the drug name and writing a complete prescription, order that 
includes the drug’s strength, specific direction, and indication for use, as this 
additional information often can help differentiate between products. Including the 
drug’s indication is particularly useful, as similar name rarely exist within the same 
therapeutic category. Oral orders generally are discouraged, but their safety can be 
increased by speaking slowly, spelling out problematic words and numbers, and 
having the order repeated back. For drugs having a look alike or sound alike 
alternate, it can be helpful to indicate both the brand and generic names. Some of the 
examples of sound alike drug names in Indian markets are cited below:  
 
Brand name Generic drug Clinical use Manufacture 
Tab. Aldactone 
Inj.Aldarone 
Spironolactone 
Amiodarone 
Diuretic 
Anti-arrhythmic 
RPG life 
Alidac 
Inj. Amicom 
Inj. Amicor 
Amikacin 
Amrinone 
Anti microbial 
Congestive heart 
failure  
Comed 
Samarth pharma 
 
Bactroban 
cream 
Mupirocin (2%)  
Ciclpirox oleamine 
Topical anti- 
microbial 
Glaxo smithklie 
Hoexhst marion 
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Batrafan Topical anit- fungal rouseel  
Brand name Generic drug Clinical use Manufacture 
Tab. Cadolac  Katorolac   NSAID Cadila Pharma 
Tab Carloc Carvedilol Non selective beta 
blocker 
Cipla 
Tab Combutol Ethambutol Antitubercular Lupin 
Tab Carbatol Carbamazepine Antiepileptic Torrent 
Tab Daonil Gilbenclamide Sulphonylurea Aventis 
Tab Depsonil Imipramine Tricyclic 
antidepressant 
SPPL 
Tab Dilantin  Phenytoin A nticonvulsant Parke davis 
Tab Dilcontin Diltiazem Antihypertensive Modimundipharma 
Tab Epitril Clonazepam Anticonvulsant Novartis 
Tab Enalapril Enalapril Antihypertensive Intas 
Tab Facital Mefloquin Antimalarial Zydus cadila 
Tab Farlutal Medroxypro-
gesterone acetate 
Progesterone Pharmacia 
andUpjohn 
CapMoclox Amoxacillin 
+Cloxacillin 
Antimicrobial Kopran 
Cap Macox Rifampicin Antileprosy Macleods 
CAP Neurontin Gabapentin Anticonvulsant Parke davis 
Tab Nitrocontin Glceryltrinitrate Antianginal Modi mundi pharma 
Tab Opam Pioglitazone Antidiabetic Wockhardt 
CapOpaz Omeprazole Proton Pump 
Inhibitor 
Aglowmed 
Inj Oframax Ceftriaxone Antimicrobial Ranbaxy 
 Inj Okavax Live attenuated 
vaccine of varicella 
zoster 
Vaccine Aventis Pasteur 
Tab Rapilin Repaglinide Antidiabietic Azetac 
 
Instructions about dose/strength are also an extremely important part of prescription 
order writing. The strength of the drug indicates how many milligrams each tablet, 
suppository or milliliter of fluid should contain. Internationally accepted 
abbreviations should be used gm for gram, ml for milliliter. It is preferable to avoid 
decimals and wherever necessary write words in full to avoid misunderstandings 
and errors e.g. Write levothyroxin 50 micrograms, not 0.50 milligrams or 50 mg. 
Badly handwritten, prescriptions can lead to errors, and it is the legal duty of the 
doctor to write legibly and clearly. Strength and its inert additives of each drug 
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should be placed together after drug in one line. If the number of drugs is more, in 
same prescription order, the name and the amount of each drug are placed together 
on a line directly under the preceding one. 
The number of days for which medication is contemplated, the number of dose per 
day, and the size of each dose determines the bulk of prescription.  A major factor 
that should be a determinant of the quantity of the drug dispensed is the mental state 
of the patient and the potential toxicity of the drug. If a patient is depressed or 
potentially suicidal he may take it all at one time, so do not prescribe the total 
quantities of drug to such patients. Instead of this, a convenient rule of thumb is to 
prescribe only enough medication for 7-14 days unless the patient will be taking the 
drug for an extended period of time. 
In prescription for controlled drugs or those with a potential for abuse, it is safer to 
write the strength and total amount in words, to prevent tampering. Instruction for 
use must be clear and the maximum daily dose mentioned. Storage of unused 
portions of a prescription and sharing of prescriptions with others who were not 
intended to receive them should be discouraged. Frequency of administration should 
be clearly indicated e.g. Atenolol 10 mg once daily, Amoxicillin 250 mg three times 
a day, etc. Simpler the instruction the better for the patient or the recipient e.g. 
regarding dosage interval mentioning 6 hourly or 8 hourly, is preferable rather than 
three times a day. 
Use of abbreviations: 
It is recommended to practice use of standard abbreviations. Abbreviations are 
known to lead to dispensing errors29. Once daily dosing at the bed-time (qhs) may 
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be misinterpreted as (qhr) for every hour. The use of slash mark(/) to separate names 
and the dosages can result in incorrect  drug or dose being dispensed, the slash mark 
may be interpreted as  a  letter or a number. When medications are measured in units 
or international units the abbreviation U or IU must NOT be used, as it leads to 
errors such as misinterpretation of U as 0 or four or IU as 10 or 14.The word unit 
should be written as such. There are many examples of confusion in interpretation of 
a physician order30. The critical message is that practitioners should write out 
treatment fully in English if errors are to be avoided. 
 Areas of particular concern in preparation of medication orders in both institutional 
and outpatient settings can be summarized as follows:  
 Quantities of 1 gram or more should be written in grams e.g. write 2 g.   
 Quantities less than 1 gram but more than 1 milligram should be written in 
milligrams e.g. write 100 mg not 0.1 g. 
 Quantities less than 1 milligram should be written in micrograms or nanogram 
as appropriate. Do not abbreviate microgram or nanogram e.g. write 100 
micrograms not 0.1 mg or 100 g or 100 mcg.  
 If a decimal point cannot be avoided for values under 1, write a zero before it 
e.g. write 0.5 ml, not 5 ml.   
 Use ml for milliliters.   
 For liquid medicines given orally, dose should be stated specifically as either 5 
ml or 10 ml, special spoons or calibrated caps are given to the patient for 
measurement of the required dose31.  
 Many abbreviations are derived from Latin phrases31 e.g. ad lib (at pleasure), ac 
(before meals), pc (after meals), bid (twice a day), hs (at bed time), qid (four times a 
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day), stat (immediately), tid (three times a day), qh (every hour), Q4h (every 4 
hours), Tab (tablet), gtt (drops), prn (as and when needed). However, all 
abbreviations carry an increased risk for confusion and misinterpretation and should 
be used cautiously32.  
Route:  
Route and method of administration should be clearly indicated e.g. oral, sublingual, 
intravenous, intramuscular, subcutaneous unless the route is obvious e.g. 
Beclomethasone inhaler two puffs every four hourly. The use of syringe pumps is 
increasing and this special form of drug administration needs good communication, 
between nurse, doctor and the patient. Education at all levels of health care is 
required to avoid prescription error.  
Directions to the Pharmacist:  
In the prescription orders for a single drug this usually consists of  “dispense 10 
tablets, dispense ‘200 ml’, dispense with oral syringes, while for 2 or more drugs, 
following phrases can be used ‘mix’, ‘make a solution’ etc.  
Directions for the Patient:   
Directions for the patient should always be written in English or vernacular language 
as Latin language serves no useful purpose. Directions as already mentioned, should 
focus on the amount of drug, frequency and time of dose. Other factors like dilution, 
route of administration, demonstration of device intended for use, instructions like 
take oral medication in upright position with a glass full of water, shake the liquid 
medication before use, apply lotions by not rubbing, liniment application by rubbing 
should be instructed to the patients in vernacular language, beforehand to avoid 
  
 
67
possible errors. The first word of the directions to the patient should only serve as a 
reminder of the correct route of administration e.g. directions for a preparation for 
internal use should start with the word take, for an ointment or lotion the word 
‘apply’, for suppositories the word ‘insert’ and for drops ‘to be placed’ in 
conjunctiva sac, external auditory canal or nostril. The directions to the patient 
should also be employed as a reminder of the intended purpose of the prescription, 
by including such phrases as for relief of pain, for relief of headache, or to relieve it. 
However directions that would be embarrassing to the patient if placed on the 
prescription order or label should be given in private.  
Refill Information:  
Under the Durham - Humphrey Amendment to Food, Drug and Cosmetic Act 
prescription orders for drugs that bear the caution legend Federal law prohibits 
dispensing without the prescription may not be refilled without the consent of the 
prescriber. Under the Drug Abuse Control Amendments i.e. prescription orders for 
Schedule III and Schedule IV drugs cannot be refilled for more than 5 times, and the 
prescription order is invalid 6 months from the date of issue. These restrictions are 
intended to control the overuse and abuse of such prescription medications. 
Physicians should make it a practice to indicate the number of refills on each 
original prescription order, irrespective of whether it is for controlled substance. 
This may be indicated by instruction to refill a number of times or not to refill. 
Statements such as refill ad lib are never appropriate. Such information need not be 
written on narcotic prescription orders for Schedule II substances, since by law these 
cannot be refilled. The Comprehensive Drug Abuse Prevention and Control Act, 
commonly referred to as the Controlled Substances Act is designed to control the 
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distribution of all depressant and stimulant drugs e.g. opioids, barbiturates, and 
Amphetamines and other drugs with abuse potential. This act requires the 
pharmacist to keep records of the receipt and the disposition of all controlled 
substances. The records must be maintained for a period of at least 2 years and be 
available for inspection by an authorized person. Prescription orders for controlled 
substances in Schedule II must be type written or written in ink and signed by the 
practitioner and such prescription orders cannot be refilled. The physician must 
write a new prescription if the administration of the drug is to be continued. 
Prescription orders for the drugs covered under Schedule III or IV may be issued 
either orally or in writing by a practitioner and may be refilled.  
Physicians should do all they can do to prevent abuse of prescription orders. It is a 
good practice to write out the number of refills desired during a specific time period 
on each and every prescription order. Arabic numerals may be easily altered and, if 
not indicated instructions may be easily forged. Furthermore when an authorization 
for refill is not given on the prescription order, it cannot be refilled without personal 
authorization by the prescriber.  
Controlled Substance:   
Schedule I (examples: heroin, methylene dioxymethamphetamine, lysergic acid 
diethylamide, mescaline, and all salts and isomers).  
1. High potential for abuse.  
2. No accepted medical use in the United States or lacks accepted safety for use 
in treatment in the United States. May be used for research purposes by 
properly registered individuals.  
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Schedule II (examples: morphine, oxycodone, fentanyl, meperidine, 
dextroamphetamine, cocaine, amobarbital). 
1. High potential for abuse.  
2. Has a currently accepted medical use in the United States. 
3. Abuse of substance may lead to server psychological or physical dependence. 
Schedule III (examples: anabolic steroids, nalorphine, ketamine, certain schedule II 
substances in suppositories, mixtures or limited amounts per dosage unit). 
1. Abuse potential less than substance in Schedule I or Schedule II.  
2. Has a currently accepted medical use in the United States.  
3. Abuse of substance may lead to moderate or low physical or psychological 
dependence relative to substance in Schedule III.   
Schedule IV (example: alprazolam, phenobarbital, meprobamate, modafinil). 
1. Abuse potential less than substance in Schedule III. 
2. Has a currently accepted medical use in the United States.  
3. Abuse of substance may lead to moderate or low physical or psychological 
dependence relative to substance in Schedule III.   
Schedule V (examples: buprenorphine, products containing a low does of an opioid 
plus a non narcotic ingredient such as codeine and guaifenesin cough syrup or 
diphenoxylate and atropine tablets). 
1. Low potential for abuse relative to Schedule IV. 
2. Has a currently accepted medical use in the United States. 
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3. Some Schedule V products may be sold in limited amounts without a 
prescription at the discretion of the pharmacist; however, if a physician wishes 
a patient to receive one of these products, it is preferable to provide a 
prescription. 
Prescribers Initials or Signature: 
The prescription order is completed by the practitioner signing the bottom of the 
blank, with the appropriate professional degree following the signature.  
Handwriting and Legibility of a Prescription: 
 Doctors are legally obliged to write clearly, as emphasized in one of the court of 
appeal ruling for example in one of the cases wherein a doctor had not written a 
clear prescription for Amoxil tablets (Amoxicillin). The court indicated that a doctor 
owed a duty of care to a patient to write a prescription clearly and with sufficient 
legibility to allow for possible mistakes by a busy pharmacist. The court concluded 
that the word Amoxil on the prescription could have been read as Daonil. It found 
that the doctor had been in breach of his duty to write clearly and had been 
negligent. The court concluded that the doctor’s negligence had contributed to the 
negligence of the pharmacist, although the greater proportion of the responsibility 
(75%) lay with the pharmacist. On appeal the doctor argued that the word on the 
prescription standing on its own could reasonably have been read incorrectly but that 
various other aspects of prescription should have alerted the pharmacist. That the 
strength prescribed was appropriate for Amoxil but not for Daonil, the prescription 
was for Amoxil to be taken three times a day while Daonil is usually taken once a 
day, the prescription was for only seven days’ treatment, which was unlikely for 
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Daonil. All of these factors should have raised doubts in the mind of the pharmacist 
and as a result he should have contacted the doctor. This argument was rejected in 
the court of appeal. The implications of this ruling are that doctors are under a legal 
duty of care to write clearly that is with sufficient legibility. When illegible 
handwriting results in a breach of that duty, causing personal injury, then the courts 
will be prepared to punish the careless by awarding sufficient damages.   
In 1999, there was another court case involving a prescription that featured poor 
handwriting resulted in judgments against the physician who did not write clearly 
and the pharmacist who misread the prescription and did not call to question the 
dosage. The intended medication was ISORDIL (Isosorbide dinitrate), but 
PLENDIL (felodipine) was dispensed instead. The patient suffered a myocardial 
infraction and died several days later. The importance of preparing clear and legible 
prescription cannot be overstated. Poor penmanship will compound the likelihood 
that there will be harmful errors resulting form an already dangerous system of 
employing numerous overlapping and similar abbreviations, look alike and sound 
alike drug names, and archaic measurement and numeral systems33,34. In a study of 
physicians handwriting, it is stated that misinterpreted prescription have been cited 
as the second most frequent and costly type of malpractice claim35. Despite the 
widespread nature of this problem there are solutions, the easiest of which is to print 
orders care. Preprinted order forms are used in many inpatient setting and to lesser 
extent for outpatient although useful, these forms must be developed with great care 
or else their design may contribute to medical errors36. At the same time, 
prescriptions, when handwritten, are quite notorious for being illegible37.  
Conventions for avoiding ambiguity: 
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A perfectly legible prescription for the ideal drug therapy can injure a patient if its 
intent is not clear. An in patient order written as “Cyclphosphamide 4 g/m2 days 1-
4” or “ Cyclophosphamide 1 g/m2 each day for 4 days” could prove fatal the highly 
publicized death of a health care reporter in 1994 was the result of this type of 
misunderstanding38. Over the years, prescribers have developed many conventions 
for prescription-writing, with the goal of avoiding ambiguities or misinterpretation39. 
 Omissions or contractions for the sake of expediency often are culprits behind 
misleading orders. Many types of medication errors can be attributed to some 
ambiguity in the prescription process40.  
  These include: 
 Careful use of decimal points to avoid ambiguity.  
 Avoiding unnecessary decimal points: a prescription will be written as 5 ml 
instead of 5.0 ml to avoid possible misinterpretation of 5.0 as 50. 
 Always using zero prefix decimals: e.g. 0.5 instead of .5 to avoid 
misinterpretation of .5 as 5. 
 Avoiding trailing zeros on decimals: e.g. 0.5 instead of .50 to avoid 
misinterpretation of .50 as 50. 
 Avoiding decimals altogether by changing the units: 0.5 g is less easily 
confused when written as 500 mg. 
 "ml" is used instead of "cc" or "cm³" even though they are technically 
equivalent to avoid misinterpretation of 'c' as '0' or the common medical 
abbreviation for "with" (the Latin "cum"), which is written as a 'c' with a bar 
above the letter. Further, cc could be misinterpreted as "c.c.", which is an 
uncommonly used abbreviation for "take with meals" (the Latin "cum cibum"). 
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 Directions  written out in full in English.  
 Quantities given directly or implied by the frequency and duration of the 
directions. 
 Where the directions are "as needed", the quantity should always be specified. 
 Where possible, usage directions should specify times (7 am, 3 pm, 11 pm) 
rather than simply frequency (three times a day) and especially in relation to 
meals for orally consumed medication. 
 Avoiding unspecified or "as needed" instructions - instead, specific limits and 
indicators are provided. 
 For refills, the minimum duration between repeats and number of repeats 
should be specified. 
 Providing the indication for all prescriptions even when obvious to the 
prescriber, so that the pharmacist may identify possible errors. 
 Avoiding units such as "teaspoons" or "tablespoons." 
 Writing out numbers as words and numerals ("dispense #30 (thirty)") as in 
a bank draft or cheque. 
 The use of apothecary units and symbols of measure- pints (O), ounces  
(oz), drams (Z), scruples (?), grains (gr), and minims(?) - is discouraged given 
the potential for confusion e.g.  the abbreviation for a grain ("gr") can be 
confused with the gram,  and the symbol for minims (?), which looks almost 
identical to an 'm', can be confused with micrograms or meters and the symbol 
for pint (O) can be easily read as a '0'. Given the potential for errors, 
metric equivalents should always be used. 
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 The use of the degree symbol (°), which was commonly used as an 
abbreviation for hours (e.g., "q 2-4°" for every 2 - 4 hours), should not be 
used, since it can be confused with a '0'. Further, the use of the degree symbol 
for primary, secondary, and tertiary (1°, 2°, and 3°) is discouraged, since the 
former could be confused with quantities (i.e. 10, 20 and 30, respectively). 
Non-prescription drug prescriptions: 
Prescriptions are also used for things that are not strictly regulated as a prescription 
drug. Prescribers will often give non-prescription drugs out as prescriptions because 
drug benefit plans may reimburse the patient only if the over-the-counter medication 
is taken under the direction of a medical practitioner. Conversely, if a medication is 
available over-the-counter, prescribers may ask patients if they want it as a 
prescription or purchase it themselves. Pharmacists may or may not be able to price 
the medication competitively with over-the-counter equivalents. If the patient wants 
the medication not under prescription, the prescriber should usually be careful to 
give the medication name to the patient on a blank piece of paper to avoid any 
confusion with a prescription. This is applied to non-medications as well e.g. 
crutches, registered massage therapy may be reimbursed under some health plans, 
but only if given out by a prescriber as a prescription. 
2.2.3 Principles of Prescribing: 
 When we inscribe the symbol of Rx41 on a prescription its modern equivalent on a 
prescription symbolically gives the prescription the seal of success. But are our 
prescriptions always successful? Unsuccessful prescribing takes several forms: 
underprescribing, overprescribing, inappropriate prescribing, irrational prescribing, 
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and prescribing errors. There is evidence that suggests that there may be 
international variability of this kind42 e.g. there were marked discrepancies in a 
French hospital between the WHO-defined daily doses of antimicrobial drugs and 
the doses that were actually prescribed. This suggests that there are wide differences 
between prescribing habits in different countries. However in many countries it is 
recognized that pharmacists can play a major contribution in prevention of 
prescribing errors43.   
There have been previously published information on hospital prescribing errors and 
its predictors by Fijn R et al.45. Inappropriate prescribing and irrational prescribing 
also feature from time to time in the Journal46. In the UK General Medical Council's 
document Tomorrow's Doctors47 states that ‘graduate must know about and 
understand the principles of treatment, including the effective and safe use of 
medicines as a basis for prescribing, harmful interactions and be able to write safe 
prescriptions for different types of drugs’. This holds true for graduate doctors and 
any prescriber for that matter. But both in the United Kingdom48 and elsewhere49 
medical students have said that they feel that not enough time is devoted to 
therapeutics teaching.  
 
Before prescribing: 
As stated earlier the word prescribe comes from a Latin word meaning to write in 
advance of giving a medicine. But the actual writing is a late event in the prescribing 
process. It must be preceded by a number of other processes. First, the diagnosis 
must be accurately made and underpinned by an understanding of the basic 
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pathophysiology. If a drug is not appropriately matched to the pathophysiology of 
the disease the wrong choice may be made. For example, one would not use digoxin 
to treat atrial fibrillation if thyrotoxicosis was the cause – a beta-blocker would be 
preferred and although some forms of hypokalaemia respond to spironolactone, 
others do not50. Secondly, the prescriber must assess the balance of benefit to harm 
of a particular form of treatment (i.e. whether to treat or not treat at all). 
Thirdly, practical matters related to the choice of drug must be addressed, these 
include picking the right drug from a range of alternatives (for example, an ACE 
inhibitor versus a beta-blocker, atenolol versus bisoprolol), designing the dosage 
regimen, considering the susceptibilities of a patient that might lead to adverse drug 
reactions, and remembering possible interactions with other drugs, including herbal 
formulations and foods. 
Lastly, the prescriber and patient need to discuss the proposed treatment and its 
potential effects, the beneficial and adverse effects and the need for careful 
monitoring and dosage adjustment. All of this demands a thorough understanding of 
the pathophysiology of the problem and the pharmacology of the drug, including its 
pharmaceutical, pharmacokinetic, and pharmacodynamic properties, and how those 
properties are translated into a therapeutic effect via a chain of biochemical and 
physiological events51.  
Non-medical prescribing: 
Traditionally, prescribing has been limited to doctors and dentists, but in recent 
years this right has been extended to nurses, pharmacists, and in some circumstances 
other health-care workers, as both dependent and independent prescribers. In some 
  
 
77
countries this has been part of a governmental effort to give patients readier and 
more rapid access to medicines, and it has also led to the system known as Patient 
Group Directions. In this system a nurse or pharmacist, working to a plan described 
in a written statement formulated by the prescriber, can supply medicines to specific 
types of patients e.g. since 2000 levonorgestrel-only emergency contraception has 
been available from Patient Group Direction in some countries. This scheme allows 
pharmacists to supply such contraception to women over 16 years of age without a 
prescription, and although it is labeled as a form of supply, it can be regarded as a 
form of self-prescribing, since any young woman of the appropriate age and 
competence can obtain emergency contraception on demand. Furthermore, since 
2001 levonorgestrel-only has been available to purchase from a pharmacist over the 
counter, although it is expensive. It was found that emergency contraception was 
available much more quickly from pharmacies than from family planning clinics. 
There was a mean of 10% increase in the number of prevented pregnancies. 
However, what was not assessed was the potential harms of this system52. For 
example, if more young women have unprotected intercourse because they know 
that emergency contraception is available, the total number of unwanted pregnancies 
could actually increase. They might also refrain from using barrier methods, 
exposing themselves to the risk of sexually transmitted diseases.  
 
Guidelines and computerized prescribing:  
In recent years many types of guidelines have been formulated to help prescribers 
choose appropriate therapy for specific conditions. Some have been very successful, 
such as the British Thoracic Society's Asthma Guidelines53 and the UK 
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Resuscitation Council's Guidelines on Advanced Life Support54. Other guidelines, 
such as those formulated by the National Institute for Health and Clinical Excellence 
(NICE) and the UK's National Service Framework, have been specifically 
commissioned. 
There is direct evidence that guidelines are ineffective unless they are accompanied 
by either education or financial incentives55, e.g. in a retrospective chart review of 
Canadian patients with acute stroke the use of antihypertensive medications during 
the first 7 days was not in accord with recommended expert guidelines, and there 
was considerable variation in practice56. While, education about the use of 
guidelines on prescribing nutritional supplements in the UK significantly reduced 
total prescribing by 15% and reduced inappropriate prescribing from 77% to 59%57 
and in Australia the extent of use of antibiotics for upper respiratory tract infections 
prompted a study of an educational intervention based on prescriber feedback and 
management guidelines58. There was a reduction in antibiotic prescribing for upper 
respiratory tract infections and a more appropriate choice of antibiotic for tonsillitis 
or streptococcal pharyngitis. However, it was not clear whether this was the direct 
result of the educational intervention, or other influences on prescribing such as 
participation in vocational training for general practice, pressure from patients, and 
the perceived non-applicability of general guidelines in individual patients. 
 Computerized prescribing by the physicians may reduce inappropriate 
prescribing59,60 and cost savings may be possible61. However it is too soon to 
evaluate the potential impact of computerized methods in prescribing, while some 
studies have shown reduced prescribing errors62 others have not63, and studies have 
not been powered to detect differences in adverse events64. Furthermore, when 
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computers are used to aid in decision-making, the warnings that they give may be so 
numerous that prescribers become immune to them 65,66. In one study the 
computerized provision of patient profiles actually resulted in an increase in the 
number of prescriptions of two interacting drugs, although the durations of drug-
drug interaction episodes were significantly shorter, the authors concluded that 
prevention of prescribing errors would require more and urgent emphasis on an 
educational or monitoring programme67 and that to improve prescribing we should 
begin with education. 
Teaching good prescribing: 
The results of a study of how well final-year medical students performed in a 
prescribing exercise suggested that the root cause of prescribing errors was lack of a 
knowledge base that integrated scientific knowledge with clinical know-how68. The 
clinical section of the British Pharmacological Society has developed a curriculum 
that lays down guidelines for teaching safe and effective prescribing69. It develops 
the premise that a thorough understanding of basic principles translates into good 
prescribing, and lists essential attributes for prescribers under three headings 
concerning the use of drugs: knowledge and understanding, skills, and attitudes.  
 A few years ago, interactive case-based and interactive, case based evidence-based 
prescribing modules, adapted for computerized learning, were introduced into 
Australian teaching programs for senior medical students, funded by the National 
Prescribing Service, and following the tenets of the World Health Organization's 
‘Guide to Good Prescribing. It includes the establishment of local student 
formularies as a teaching tool, a concept that could be extended to the training of 
junior hospital doctors and other prescribes.  
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Teaching prescribing has become increasingly difficult, as drug therapy has become 
more complex and errors more common70. A proper curriculum, taught at the 
bedside or in the clinic by skilled practitioners (because good prescribing habits 
should be reinforced by practical example), and supplemented by computer-based 
material, properly funded, could help to mitigate this. Special study modules in 
prescribing would allow some students to expand their knowledge. Formal 
assessment of prescribing ability in final examinations would add incentive to the 
learning process.  
The question remains that who should undertake such a programs on prescribing 
issues? e.g. if one were to ask who should lead the way in teaching 
electrocardiography, the answer would be cardiologists, even though interpreting the 
electrocardiogram is a skill that all doctors should acquire and one that all doctors 
should be prepared to teach. Similarly, where prescribing is concerned, clinical 
pharmacologists should lead the way. However, despite calls for increased 
numbers71,72, there are still too few of them to undertake the whole burden of 
undergraduate teaching in practical drug therapy73. The aim therefore should be 
to recruit and train enthusiastic physicians, general practitioners, and specialist 
nurse prescribers to help. Clinical pharmacists and pharmacist prescribers, in 
partnership with clinicians, could also make a valuable contribution.  
Good prescribing is a means to avoid prescribing faults, at the same time is not an 
easy discipline to master. Good prescribing means prescribing the appropriate drug, 
in the correct, dosage of an appropriate formulation, at the correct frequency 
administration, and for the correct length of time. This definition includes not 
prescribing any drug at all if no prescription is called for e.g. someone can only 
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prescribe “counseling needed”. To achieve this requires, detailed knowledge of the 
pathophysiology of the diseases one intends to treat.   
The benefit: risk ratio in prescribing: 
Drugs are prescribed because of their potential benefit to the patient, but in every 
case this is accompanied by the risk of adverse effects. Before prescribing, the 
potential benefits from the treatment should be weighed against the risks. There are 
five factors for assessing the relative benefit and risk of a particular treatment 
according to the data on efficacy and adverse effects of the drugs:  
1.  The seriousness of the problem to be treated, 
2.  The efficacy of the time you intend to use, 
3.  The seriousness and frequency of possible adverse effects,  
4.  The safety of other drugs that might be used instead,  
5.  The efficacy of other drugs that might be used instead. 
The benefit: risk ratio will be high if the disease is   life-threatening, and the drug is  
highly effective and the only one available, and the risk of  serious adverse effects is 
negligible. At the other end of the spectrum, the benefit risk ratio will be low if the 
disease is trivial, the drug poorly effective with more effective and safer competitors 
and the risk of serious adverse effects high e.g. Phenylbutazone is a highly effective 
non-steroidal anti-inflammatory drug, which was used for many years in the treat-
ment of acute and chronic inflammatory conditions, such as acute gout, acute and 
chronic rheumatoid arthritis, and ankylosing spondylitis. However, the incidence of 
marrow aplasia in patients taking phenylbutazone is at the higher end of this range in 
old people and during prolonged therapy. While no other non-steroidal anti-
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inflammatory drugs of equal efficacy were available, the therapeutic benefit from 
taking phenylbutazone was-considered large enough to outweigh the relatively high 
risk of marrow aplasia. However, once other equally good drugs with fewer adverse 
effects became available, the risk of the adverse effects of phenylbutazone were seen 
to outweigh whatever benefit its use carried. It was therefore decided that it should 
no longer be prescribed as a first-choice anti-inflammatory drug.  
It may not always be possible to know what the relative benefits and risks are before 
giving a patient a drug. For example, there may be no published figures on the size 
of a particular risk and different patients maybe at different risk of the same adverse 
effect (for example in the case of an adverse effect that is genetically determined). 
Furthermore, the extent of therapeutic benefit due to a drug, particularly in the case 
of symptomatic relief, varies widely from patient to patient and often one's 
appreciation of the potential benefit only come after one has tried the treatment and 
assessed its effects. Nevertheless, one should always try to assess the likely benefit: 
risk ratio before instituting therapy. To illustrate some of the difficulties that can 
arise in assessing the benefit risk ratio, consider the following problems:  
1.  Is the benefit likely to be gained from a course of an antibiotic in treating 
urinary tract infection in a woman who is 2 months pregnant likely to be 
outweighed by the risk to the fetus? This will depend on whatever information 
is available at the time about the actual risk of teratogenesis from the antibiotic 
compared with the risk to the mother of renal damage due to an untreated 
infection, added to this will be the relative risks to the fetus of  her antibiotics. 
The antibiotic to be prescribed will depend on the causative organism and its 
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sensitivities e.g. Amoxicillin appears to be safe, but Trimethoprim should be 
avoided.  
2.  Is the benefit to be gained from treating an old lady with giant cell arthritis 
with the corticosteroid prednisolone likely to be greater than the risks of 
making her osteoporosis worse, of increasing the difficulty of treating her 
diabetes mellitus, and of exacerbating her hypertensive heart disease because 
of sodium and water retention? Here, apart from the pain that giant cell 
arthritis can cause, the main problem is that there is a high risk of blindness 
from untreated giant cell arteritis affecting the retinal arteries. The decision on 
whether or not to offer treatment in such a case will depend on the severity of 
the arteritis, the vessels it is affecting, the severity of the complicating 
conditions and the ease with which they too can be treated.  However, by 
thoughtful prescribing, it may be possible to lessen the risks of drug therapy 
and prescription errors while maintaining a high degree of efficacy.   
How to choose drug and is drug therapy indicated?  
This comprises of two parts: Is the intended treatment necessary? Is the potential 
benefit likely to be greater than the risk? Unnecessary prescribing is not uncommon, 
e.g.  
1. Acute bacillary dysentery due to Shigella infection is usually self-limiting and 
oral fluids are usually sufficient. The use of antibiotics is associated with the 
emergence of resistant strains, which are already a problem worldwide. If the 
condition is due to Shigella dysenteries type 1 or is severe or prolonged, the 
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choice of antibiotic depends on local sensitivities. Ciprofloxacin is often 
effective. 
2.  The prescription of cerebral vasodilators for patients with senile dementia. 
There is very little evidence that this type of drug (cerebral vasodilator) 
confers any benefit at all, and there is evidence that they may do harm by 
diverting blood flow from compromised areas of the brain to areas that are 
already well-perfused.  
3. The prescription of formulations of vitamins and minerals (for example iron) 
as 'tonics' in the absence of any evidence of vitamin or mineral deficiency. 
These formulations act only as placebos in such circumstances, and should be 
recognized as such by the prescriber.  
The main consideration in answering the question of whether drug therapy is 
necessary is the question of the size of the benefit: risk ratio. However, even if the 
benefit risk ratio is high, it may be worth waiting before starting therapy if-the 
disease is likely to be self-limiting (as in the case of acute diarrhoeas). Since that 
eliminates risk altogether.  
Which drug?  
 If drug therapy is indicated, one has to go through the process of deciding which 
particular drug to use. This involves further detailed questions, relating to the choice 
from among the classes of drugs available, the appropriate group of drugs within a 
class, and the particular drug within that group. 
Which therapeutic class of drug? 
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This is sometimes immediately obvious, for example an antibiotic for an infection, 
an antidepressant for depression, or a bronchodilator for an acute attack of asthma. 
However, in other cases, the decision can be more complicated, for example in the 
treatment of congestive heart failure the choice lies among diuretics, positive 
inotropic drugs, angiotensin-converting enzyme (ACE) inhibitors, and vasodilators, 
and in the treatment of hypertension the initial choice lies among diuretics, 
angiotensin-converting enzyme (ACE) inhibitors, beta-adrenoceptor antagonists and 
calcium channel blockers.  
Which group of drugs within the class? 
After confirmation of the diagnosis and while planning the treatment the clinician 
may decide on a particular class of drugs to be prescribed, e.g. in case of treatment 
of an infection. The therapeutic class is the antibiotics, but within that class there is a 
choice among several different groups of drug, for example, penicillins, 
cephalosporins, tetracyclines, aminoglycosides, macrolides, quinolones etc. The 
choice will depend on the sensitivities of the infecting organism, the site of 
infection, and particular features of the patient that may constitute contra-
indications. 
 Which particular drug in the group?  
Finally, the name of an individual drug has to be written on the prescription. To 
continue with the example of antibiotics if one decides to prescribe a tetracycline, 
one can choose from among tetracycline, i.e. oxytetracycline, minocycline, 
doxcyline, and several others. Again the choice will depends on many different 
factors.  
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How to make a rational choice? 
The factors that dictate the choice are numerous and are as follows:   
(i)  Pharmacokinetic considerations:  
1.  Absorption. One might choose bumetanide rather than furosemide for a patient 
with congestive cardiac failure, in which furosemide is erratically absorbed and 
bumetanide better absorbed. Of course, as an alternative, one could give 
furosemide intravenously, thereby circumventing the problem of absorption.  
2.  Distribution. If an antibiotic is well distributed to a particular tissue, that 
antibiotic may be the antibiotic of choice when that tissue is infected. For 
example, tetracyclines are concentrated in the bile, and lincomycin and 
clindamycin in bones. 
3.  Metabolism: Drugs that are extensively metabolized may be less useful in 
patients with severe liver disease. For example, one would generally avoid 
using opiate analgesics in patients with hepatic cirrhosis and there are also 
pharmacodynamic reasons for doing so. 
4.  Excretion: Similar considerations apply in renal insufficiency. One might for 
example, avoid the aminoglycoside antibiotics in patients with renal 
impairment if an alternative group of antibiotics is suitable. If a tetracycline is 
indicated in a patient with insufficiency, doxycycline would be the drug of 
choice, it does not accumulate in renal failure, as other tetracyclines do.     
(ii)  Pharmacodynamic considerations: 
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Sometimes the pharmacological effect of a drug or group of drugs is 
appreciably greater than that of another. For example, the sulfonylureas are 
more potent hypoglycemic drugs than the biguanides, and are usually used as 
first-line drug treatment. In patients with an acute myocardial infarction, the 
positive inotropic effects of beta-adrenoceptor agonists, such as dobutamine, 
are greater than those of the cardiac glycosides, such as which may in addition 
promote arrhythmias. 
(iii)  Therapeutic considerations: 
1.   Features of the disease: If one knows, or has a good reason to suspect, 
the identity of an infective organism, then one would choose an antibiotic 
appropriately. For example, one might choose ampicillin for a patient 
with a community-acquired bronchopneumonia, since the likeliest 
infecting organisms will be the pneumococcal (Streptococcus 
pneumonia) or Haemophilus influenza, both of which are likely to be 
sensitive to it is a quinolone or cephalospcrin would be an alternative in 
penicillin hypersensitivity. Sputum culture, with identification of true 
organism and of its sensitivity to different antibiotics, will help in making 
the choice. Other factors can determine the choice; for example, avoid 
quinolones in pregnant women. 
The severity of the disease can also influence the choice of a drug. For 
example, mild pain will generally respond to aspirin or paracetamol, 
while more severe pain requires more potent analgesics, such as codeine  
or even morphine. Moderate hypertension often responds to a single 
drug, such as a thiazide diuretic or beta adrenoceptor antagonist, while 
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severe hypertension often requires treatment with a combination of 
antihypertensive drugs. 
2.  Co-existing diseases: In the treatment of moderate hypertension one 
might choose a diuretic, such as bendroflumethiazide, a beta-
adrenoceptor antagonist, such as atenolol, an ACE inhibitor, such as 
lisinopril, or a calcium channel blocker, such as nifedipine. In a patient 
with left ventricular failure, a diuretic combined with an ACE inhibitor 
would be the logical choice; in a patient with co-existing angina pectoris 
without heart failure, a beta-adrenoceptor antagonist would be preferred.  
3.  Avoidance of adverse effects: One would avoid beta-adrenoceptor 
antagonists in a patient with asthma. In patients with penicillin 
hypersensitivity, an alternative antibiotic should be used.  
4.   Avoidance of adverse drug interactions. In patients taking warfarin, one 
often needs to be careful while choosing other drugs. For example, 
aspirin and some other non-steroidal anti-inflammatory drugs, which can 
cause gastrointestinal bleeding, should be avoided, barbiturates and 
chloral derivatives should be avoided since they induce the metabolism 
of warfarin. Drugs like tetracyclines, sulfonamides, chloramphenicol are 
avoided in treatment of infections since they inhibit the metabolism of 
warfarin.  
 
(iv)  Patient compliance: 
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Sometimes a drug is chosen simply because it can be taken once a day, in the 
hope that minimizing the frequency of drug administration will improve 
patient compliance. Thus, one might choose once-daily atenolol in preference 
to twice-daily propranolol. Modified-release formulations are also available 
for this reason. 
Which route of administration? 
The route of administration may be dictated by the drug chosen, for example, 
dopamine can only be given intravenously. However, sometimes the prescriber 
chooses a particular route of administration because it confers a particular 
therapeutic benefit e.g. glyceryl trinitrate, is usually given sublingually, since it is 
absorbed rapidly through the oral mucosa straight into the systemic circulation, thus 
avoiding its first-pass metabolism in the liver, and rapidly relieving angina pectoris 
during an acute attack. However, it can also be applied as a patch to the skin, 
through which it is absorbed slowly. In this way, it has been used to prevent attacks 
of angina pectoris. 
The rectal route can be used for a direct effect on the large bowel (for example 
prednisolone in the treatment of ulcerative colitis), or because another route is not 
available (for example diazepam in a patient in whom a seizure makes intravenous 
access difficult to obtain). The intramuscular route is sometimes used to ensure 
compliance, for example in the single-dose treatment of gonorrhea with 
intramuscular penicillin. The subcutaneous route is sometimes used because it 
allows easy administration of a drug by the patient or a relative. The subcutaneous 
route may provide a more prolonged effect by slow release of the drug, from the site 
of injection (for example the different formulations of insulin).  
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Which formulation? 
There are many different drug formulations for different circumstances. For 
example, oral formulations include tablets, capsules, granules, elixirs, and 
suspensions. Drugs for injection come as lyophilized powders for reconstitution 
before injection, or as solutions ready for injection; solutions come in single-dose 
ampoules, single-dose or multiple-dose vials, and half-litre or litre bottles for 
infusion. 
Where oral administration is concerned, drugs often come in more than one type of 
formulation, as the following examples show:  
 Lithium salts and theophylline come in several different ordinary and 
modified-release formulations, each with different absorption characteristics a 
formulation that produces adequate plasma lithium or theophylline concentra-
tions in one patient may not be suitable for another, and it is sometimes worth 
changing the formulation if plasma concentrations are suboptimal. 
  Iron salts are available as ordinary tablets for twice or thrice daily 
administration or as modified-release formulations for once-daily 
administration one would often choose the latter in the hope of improving 
patient compliance and reducing the adverse effects that the ordinary 
formulations have on the stomach, however, the iron in modified-release 
formulations is absorbed more erratically, and one might choose the ordinary 
tablets in a patient whose iron deficiency was not being corrected by a 
modified-release formulation. 
What dosage regimen? 
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A dosage regimen has three aspects: the dose of the drug, the frequency of its 
administration, and the timing of its administration. Usually these can be considered 
together, although in some cases they require separate consideration. 
Certain principles govern dosage regimens of drugs, and these principles show how 
dosage regimens should be altered, depending on the pharmacokinetic and 
pharmacodynamic characteristics of the prescribed drug, certain characteristics of 
the patient and the characteristics of the symptoms or disease being treated. 
(a)  Pharmacokinetic variability: 
Variation in absorption, distribution, and elimination of drugs from patient to 
patient means that one must be flexible in approach to dosages. If there is poor 
absorption, one may have to increase the dose or choose another route of drug 
administration, or indeed another drug. Dosages may have to be reduced if 
elimination is required (for example in hepatic or renal disease). For drugs that 
are subject to first-pass metabolism in the liver, one may have to use 
completely different dosage regimens. If the pharmacokinetics of the drugs are 
altered by another drug, then the dosage regimen may have to be altered. 
(b)  Pharmacodynamic variability: the dose-response curve: 
Dose-response curve shows how the effect of drug varies with dose, and that 
this is as true in the whole patient; as it is in an experimental tissue in vitro. 
Because the nature of the dose-response curve varies from patient to patient, 
flexibility in   prescribing is necessary, and if a therapeutic effect does not 
occur with the initial dosage chosen, an effect may be produced by making 
small dosage increments within a stated therapeutic dosage range. At the same-
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time, increasing the dosage will increase the risk of dose-related adverse 
effects, and part of the art of drug therapy lies in finding the regimen that 
produces, a beneficial effect while avoiding adverse effects.   
(c)  Characteristic of the patient: 
Dosage regimens may be different in old people from those in young people.  
Dosages should sometimes be calculated on the basis of body weight, giving 
heavier patients higher dosages than lighter patients so better to mention the 
weight on prescription. Conversely, if a drug is poorly distributed into body 
fat, a muscular patient may need a higher dosage than a fat patient of the same 
weight. This applies to digoxin, doses of which should be based on estimated 
lean body weight. 
(d)  Characteristics of the disease: 
Sometimes dosage regimens are different for the same drug in different 
diseases, because of the nature of the effect required or because, of some other 
aspect of dose-responsiveness. For example, the dosage of bromocriptine 
required for suppression of lactation is considerably lower than that needed for 
the relief symptoms in Parkinson’s disease. 
(e)  Choosing a dosage regimen for the individual patient. Dosage regimens in 
clinical practice cannot always be as precise as in theory, it is nevertheless 
possible to approach the problem of tailoring a regimen for an individual 
patient in a systematic manner.  
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1.  The dosage regimens recommended should be from a reliable source of 
information and according to careful study and clinical experience.  
2.   Consider the dose-related toxicity of the drug, i.e. does it have a low 
toxic therapeutic ratio, the toxic dose being little more than the 
therapeutic dose? If so (for example digoxin, phenytoin, warfarin, 
gentamicin and lithium), be particularly careful to give too much. 
3.  Decide on the initial dosage. In general, it is best to start with a dose that 
is at the lower end of the recommended range and to increase it gradually 
if a therapeutic effect or the optimal effect does not occur. For some 
drugs, this gradual increase in dosage from a small initial dosage is an 
important strategy in avoiding adverse effects (for example the 
Angiotensin Converting Enzyme inhibitors and L-dopa), while for others 
increasing dosages may be necessary because of tolerance (for example 
opiate analgesics).  
4.  Consider possible pharmacokinetic factors that alter dosage requirements 
(for example renal insufficiency or drug interactions). 
5.   Consider the dose-response curve for the patient and whether there are 
any factors that alter the Pharmacodynamics of the drug. For example, 
insulin requirements are greater in patients with ketoacidosis and dosages 
of narcoleptic drugs are lower in previously untreated patients. Drug 
interactions can alter the pharmacodynamic effects of drugs. 
6.  Consider other patient characteristics that influence dosages (for example 
age and weight). 
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Even when a dosage regimen has been instituted, there may still be room for 
improvement, and the patient's progress should he monitored carefully for 
evidence that the regimen is satisfactory (i.e. effective and safe).  
(f)  Frequency of drug administration:  
The frequency of drug administration is usually fixed for a given formulae not 
a given, drug if so, there is no need to make a separate decision about that. 
However, one needs to alter the frequency of drugs administration without 
necessarily altering the total daily dose.   
    If furosemide produces a satisfactory diuresis, the kidney is refractory to 
its effects for another six or so hours and the dose should be withheld for 
at least that length, of time, however, if a first dose has not proved 
effective, then another dose can be given soon after the first. 
   Although the duration of action of spironolactone is sufficiently long for 
once-daily administration, some patients complain of gastrointestinal 
symptoms and benefit from splitting the dose into two parts, one to be 
taken in the morning and one in the evening. 
   For symptomatic treatment, the frequency of symptoms regulates the 
frequency of dosage. For example, patients will take a tablet of glycleryl 
trinitrate as often as they suffer attacks of angina pectoris. 
    The use of corticosteroids is a special case in which adverse effects can 
be reduced in some diseases by giving twice the usual daily dose but only 
on alternate days. 
    The use of modified-release formulations to improve compliance and 
achieve prolonged action (for example modified-release theophylline). 
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(g)   Timing of drug administration: 
The study of the ways in which the pharmacokinetics and pharmacodynamics 
of drugs vary with time (for example diurnally or seasonally) is called 
chronopharmacology. Chronopharmacological studies have revealed many 
such variations, a few of which are relevant to the timing of drug therapy. 
Furthermore, variations with time in the presentation of diseases can affect the 
timing of drug administration. In most cases the timing of drug administration 
is fixed for a given formulation of a given drug and, if so, there is no need to 
make a separate decision about that. However, in some cases, timing may be 
important, as seen in the following examples:  
 Minimizing adverse effects: 
For some drugs, adverse effects can be minimized by taking them last 
thing in the night. For example, sleep can mask some of the adverse 
effects of the tricyclic antidepressants (dry mouth and drowsiness) and of 
cytotoxic drugs (nausea and vomiting). On the other hand, potent 
diuretics, such as bumetanide and furosemide, are generally taken in the 
morning to avoid the inconvenience of diuresis later in the day. 
If corticosteroids are being used as replacement therapy (for example in 
Addison's disease), they should be taken in two divided doses during the 
day, two-thirds in the morning and one-third at night, in order to mimic 
roughly the normal pattern of endogenous corticosteroid secretion. 
However, if corticosteroids are to be used for other purposes, they are 
best given as a single dose in the morning, in order to minimize their 
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inhibitory effects on adrenocorticotrophin hormone (ACTH) secretion by 
the pituitary gland and glucocorticoid secretion by the adrenal glands, 
which are normally at an ebb overnight. 
 The timing of symptoms:  
The occurrence of symptoms often dictates the timing of therapy, as in 
the treatment of attacks of angina pectoris or in the use of antacids. It is 
sometimes best to take non-steroidal anti inflammatory drugs last thing 
at night, in order to minimize their adverse effects on the stomach and to 
mitigate early morning stiffness in rheumatoid arthritis, but the 
occurrence of symptoms at other times will dictate different timing.  
 Timing in relation to meals:  
Some drugs are best taken before food (for example most penicilins, 
whose absorption is delayed by food and tetracyclines, whose absorption 
is impaired by calcium and other salts). Others are better taken with food 
(for example aspirin, in order to reduce gastrointestinal adverse effects, 
and griseofulvin, whose absorption is improved by food). 
 
For how long should treatment last?  
The duration of treatment depends on the nature of the disease or symptoms and to a 
great extent on collective experience, e.g. at one end of the scale, a single dose of 
aspirin relieves a headache. At the other end of the scale, chronic therapy for the 
individual’s lifetimes is usually required for the treatment of diabetes mellitus, 
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essential hypertension, hypothyroidism, pernicious anemia, and several other 
diseases.  
Difficulties and controversy often arise in relation to treatments of intermediate 
duration. For example, it is still not clear for how long treatment with warfarin 
should be continued in the treatment of deep venous thrombosis and pulmonary 
embolism. Currently anticoagulant treatments for a deep venous thrombosis is 
usually continued for 3 months, but there are those who advocate shorter periods 
(for example 6 weeks) in some cases.  
The duration of treatment of infections with antibiotics varies from infection to 
infection, and depends on the infecting organism, the site of infection, the response 
to treatment, and in a few cases the dosage of antibiotic. For example, streptococcal 
tonsillitis and pneumococcal pneumonia might require treatment with penicillin for 
7-10 days, non-gonococcal urethritis tetracycline for 10-21 days, and infective 
endocarditic due to ‘viridians’ streptococci intravenous penicillin for up to 6 weeks. 
However, in the last case, it is not clear what the minimum duration of treatment 
should be, and treatment should be, and treatment for 6 weeks may be unnecessarily 
long. In contrast gentamicin, given in conjunction with penicillin in this infection, is 
usually continued only for the firs 10-14 days. If amoxicillin is used in the treatment 
of a urinary tract infection, two large doses 12 hr apart may be sufficient to effect a 
cure, while treatment for several days is necessary if conventional doses are used.  
Tuberculosis is an example of a disease for which the duration of treatment is 
complex. Quadruple drug therapy (for example rifampicin, isoniazid, pyrazinamide 
and ethambutol) is usually given in the initial phase for 8 weeks, or until the 
organism’s sensitivities are known, when a change of drugs may be necessary. This 
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regimen is used because it takes several weeks to culture the infecting organism, and 
the risk of resistance to therapy is reduced by using several different drugs.  
Treatment is then continued with three drugs (say rifampicin, isoniazid, and 
pyrazinamide) for 6 months in pulmonary infections or longer in extrapulmonary 
infections. However, there are many different types of antituberculous regimens in 
use around the world, taking into account the resistance of Mycobacteria to 
antitubercular drugs, drug costs, patient compliance, and the problems of the 
delivery of medical care to the population.  
However, the principles underlying drug prescribing has been emphasized, it is not 
always easy in drug therapy to achieve optimal efficacy while keeping the risks of 
adverse effects to a minimum. However, thoughtful prescribing along these lines 
will help clinician to achieve good drug prescribing. Thus, prescribing is difficult. It 
requires a thorough knowledge and understanding of the pathophysiology of disease, 
the pharmacological properties of the relevant drugs. No single intervention can be 
relied upon to improve prescribing, and a combination of interventions may be 
required90. The main aims for teaching undergraduate medical students, health care 
providers and doctors to improve their prescribing should include: 
 Education, to be taken as often as possible (learning should be lifelong, 
updating oneself through authentic workshops).  
 Special study modules, to be taken as required. 
 Proper assessment in the final examination, to be taken once or twice. 
 A national prescription form for hospitals, to be applied uniformly. 
 Guidelines and computerized prescribing systems, to be taken as indicated.  
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The bottom line is that, if we do not increase the amount of time we spend teaching 
future prescribers, i.e. the undergraduate students, doctors, dentists, nurses, 
pharmacists, and others, we may soon be saying ‘See one, prescribe one, harm one’. 
2.3  Prescription Errors:  
2.3.1 Prescription Errors - a Component of Medications Errors:  
Medication errors are failures in any aspect of the treatment process (including the 
manufacturing or compounding, prescribing, transcribing (when relevant), 
dispensing and administration of a medicinal product, and the subsequent 
monitoring of its effects, failures that cause, or have the potential to cause harm to 
the patient. 
Medication errors are basically of two types: intercepted errors and actual errors, on 
the basis whether they reach the patient or not74.  
Both the types of errors are further divided into four categories: 
 Prescription error 
 Administration error 
 Transcription error 
 Dispensing errors. 
Prescription errors: 
1. No route specified. 
2.  As-needed order without an indication. 
3.  Drug is indicated but the dose is inappropriate. 
4.  As-needed order without a time interval. 
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5.  Dose change ordered without discontinuation of previous order. 
6.  Order is illegible. 
7.  Order is incomplete in specifying doses or frequency. 
Transcription errors: 
1.  Order is not transcribed at all. 
2. Order is transcribed incorrectly. 
3.  Allergy is not documented on the medication administration record. 
4.  Allergy is not documented on the order sheet. 
Administration errors: 
1.  Scheduled dose is not documented as administered. 
2.   Drug is administered without a physician order.  
3.   Dose missed because of late transcription. 
4.   Order is incorrectly entered in the pharmacy computer. 
Dispensing errors: 
1.   Wrong drug or dilution dispensed. 
2.   Wrong preparation dispensed. 
The intercepted errors (the error which has not reached the patient) are documented 
by preserving a copy of the indent. The actual errors or an “error of omission”, 
which does reach the patient in spite of auditing, are reported on a proper format 
called as quality variance report. Except administration error, rest all types of errors 
could be rectified by prescription auditing. The administration error could only be 
rectified by hospital rounds, which are also essential for adverse drug reaction 
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monitoring. Prescription errors, which are corrected and prevented by prescription 
auditing team, are called as intercepted error. 
What is a Medication Error Index?75,76  
This is required for categorizing medication errors as shown below: 
No Error. 
Category A: Circumstances or events that have the capacity to cause error. 
Error, No harm. 
Category B: An error occurred but the error did not reach the patient. 
Category C: An error occurred that reached the patient but did not cause patient 
harm. 
Category D: An error occurred that reached the patient and required monitoring to 
confirm that it resulted in no harm to the patient and/or required intervention to 
preclude harm. 
Error, Harm. 
Category E: An error occurred that may have contributed to or resulted in 
temporary harm to the patient and required intervention. 
Category F: An error occurred that may have contributed to or resulted in 
temporary harm to the patient and required initial or prolonged hospitalisation. 
Category G: An error occurred that may have contributed to or resulted in 
permanent patient harm. 
Category H: An error occurred that required intervention necessary to sustain life. 
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Error, Death. 
Category I: An error occurred that may have contributed to or resulted in the patient 
death. 
Classification of medication errors based on psychological theory:  
The best way to understand how medication errors happen and how to prevent them 
is to consider their classification, which can be contextual, modal, or psychological. 
Contextual classification deals with the specific time, place, medicines, and people 
involved. Modal classification examines the ways in which errors occur, e.g. by 
omission, repetition or by substitution. However, classification based on 
psychological theory77 is to be preferred, as it explains events rather than merely 
describing them. Its disadvantage is that it concentrates on human rather than 
systems sources of errors.  This approach yields four broad types of medication 
errors as shown in the figure below. Mistakes can be divided into (i) knowledge 
based errors and (ii) rule based errors while failures of skill can be divided into (iii) 
action based errors (slips, including technical errors) and (iv) memory-based errors 
(lapses). 
 
 
 
 
 
 
 
Errors 
When actions are intended but not performed 
Mistakes 
Errors in planning actions 
Skill based errors (slips and lapses)  
Errors in executing correctly planned actions 
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Knowledge based errors can be related to any type of knowledge general, specific, 
or expert. It is a general knowledge that penicillin’s can cause allergy to penicillin, a 
patient is allergic to penicillin is specific knowledge and knowing that 
cephalosporins can cause a cross-sensitivity reaction is an expert knowledge. 
Ignorance of any of these facts could lead to a knowledge-based error.  
Rule based errors can further be categorized as (a) the misapplication of a good rule 
or the failure to apply a good rule and (b) the application of a bad rule.  
An action-based error is defined as the performance of an action that was not what 
was intended78,79. A slip of the pen, when a doctor intends to write ditiazem but 
writes diazepam, is an example. Technical errors from a subset of action based 
errors. They have been defined as occurring when an outcome fails to occur or the 
wrong outcome is produced because the execution of an action was imperfect80. An 
example is the addition to an infusion bottle of the wrong amount of drug81. 
Memory based errors occur when something is forgotten; for example, giving 
penicillin, knowing the patient to be allergic, but forgetting. 
Action based 
errors (slips)   
Memory based 
errors (lapses) 
Technical 
Errors
Good rules not 
applied or 
misapplied 
Bad 
rules
Knowledge 
based errors 
Rule based 
errors
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This classification can help understand how errors can be prevented and strategies 
that help to reduce their occurrence. Knowledge based errors can obviously be 
prevented by improving knowledge, e.g. by ensuring that students are taught the 
basic principles of therapeutics82,83 and tested on their practical application84 and that 
prescribes are kept up to date. Computerized decision support systems can also train 
prescribers to make fewer errors85,86.  
Mistakes that result from applying bad rules, or misapplying or failing to apply good 
rules (rule based errors.), can be prevented by importing rules. Memory based errors 
are the most difficult to prevent. They are best tackled by putting in place system 
that detect such errors and allow remedial actions. Check lists and computerized 
systems can help.  
2.3.2 Predictors of Medication Errors and Prescription Errors:  
Error i.e. something incorrectly done through ignorance or inadvertence is a fact of 
human condition87. People tend to dial wrong numbers, take wrong turnings, and 
make slips of tongue. Psychologists have pointed out the inevitability of error in 
human actions88. Knowledge and error flow from the same mental sources, only 
success can tell the one from the other89. A conscious human action can be 
performed correctly and reach its intended goal. Errors arise when an action is 
intended but not performed .The human factors approach is now widely adopted in 
understanding medical errors and in seeking ways to reduce harm from errors 90,91.  
Forms of errors:  
An error is a disorder of an intentional act. The act can be considered in two parts: 
formulating the plan for action and executing it.    
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An error in formulating the plan is a mistake. Mistakes occur when people undertake 
non-routine tasks that require conscious (supervisory) attention, i.e. they require 
problem-solving, judgement, diagnosis, or theoretical knowledge92. Even if a task is 
routine, cognitive error is still possible, if it is ambiguous or poorly understood or if, 
for example, the staff are not adequately trained, so that they have to think out 
explicit solutions to the problems posed by the task. Mistakes can arise from a lack 
of knowledge, resulting in a poor plan, or from good plans applied in the wrong 
circumstances. An example of the former would be to begin warfarin treatment by 
giving three doses of 10 mg on successive days (10-10-10) before monitoring 
coagulation. Such a plan inevitably leads to over-treatment of many patients93. A 
mistake of the second type occurs when cardiopulmonary resuscitation is instituted 
on a patient whose cardiac monitor shows a flat-line trace, not because the patient 
has had a cardiac arrest, but because the leads have fallen off. 
An action is initiated with the intention of reaching a specific outcome. When all 
goes well, there is no error, and the intended outcome is achieved. Sometimes the 
plan will be wrong, or the information used in formulating the action is wrong, so 
that it is impossible to reach the intended outcome. Errors of this sort are labeled 
mistakes. If the plan is correct, and based on correct information, but there is 
distraction on the route from intention to outcome, then a slip or lapse results. Slips 
are errors of commission, whereas lapses are errors of omission.  
An error in executing a plan can occur either because one or more step in the plan is 
executed incorrectly - a slip or because one or more steps is omitted - a lapse. 
Picking penicillamine from a computer list of drug names when intending to 
prescribe penicillin V is a slip. Intending to write a prescription for penicillin V, but 
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forgetting to do so, constitutes a lapse. Actions do not take place in isolation, but as 
part of a system, a group of interacting entities of which the person performing the 
action is one. Hospital medication systems are very complex, and the entities 
involved include, at the very least, a medicine, a patient, one or several healthcare 
professionals, pharmacy and pharmacy staff, and ultimately the manufacturers and 
suppliers of the medicines94. 
Thus a medication error is taken to be a failure in the frequent process that leads to, 
or has the potential to lead to harm to the patient' 95. The treatment process includes 
the prescribing, transcribing, manufacturing or compounding, dispensing, and 
administration of a drug - a monitoring therapy. Each of these separate activities h 
many components. For example, a single prescription on our hospital drugs chart 
requires the prescriber to include 21 separate pieces of information, such as the 
patient date of birth and the time of administration of the prescribed drug. Each 
entails an action with the potential for error. 
The process of administration of intravenous injection which is particularly likely to 
result in harm to the patient has been examined in some detail96,97. At least a dozen 
of separate steps, and many sub-steps, are required to perform this task, some are 
trivial but others have the potential for serious error. The probability of undertaking 
multistep task without error is the product of the probabilities of carrying out each 
step without error.  The corollary of this is that a small risk at each step leads to a 
high probability of error overall. For example, if there are 2 steps, each of which is 
preformed without error 99% of the time, the overall process will be correct only 
80% of the time. Health-care professionals are more likely to make errors when they 
are inexperienced, inattentive, rushed, distracted, tired or depressed. 
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Factors that alter the risk of errors are dependent on:  
‐ The person performing action. 
‐ Training of health care professionals.  
‐ Site (Hospital, ward, intensive care unit). 
‐ Time (late after noon etc.).  
‐ Working conditions.  
‐ The patient.  
‐ The medicine. 
Why to keep a check on prescription errors:  
A zero medication error is an impossible thing to achieve because we are humans 
and not machine. So, the only way to get rid of medication errors is a thorough 
scrutiny of all the steps involved in medication process and prescription auditing is 
done at a very important step, i.e. before the medication are dispensed. ADR 
Monitoring should be a part of auditing e.g. the adverse drug reaction is monitored 
by searching for the tracer drugs like Avil injection and Effcorlin injection and 
checking the indications for which they were prescribed, during the hospital rounds. 
If any adverse drug reaction occurs it is reported on an ADR reporting form. All the 
details regarding the drug e.g. brand and generic name, doses, route of 
administration should be documented. The ADR should be described according to 
the signs and categorized according to the severity. The type of reaction should also 
be noted down (whether Type I, II, III or IV). All such activities, should be 
implemented in all the hospitals in India, where the patient load is too high, to be 
properly handled. 
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2.3.3 What are Prescribing Faults, Prescribing Errors and Balanced Prescribing? 
The two terms 'prescribing' and 'prescription' must be distinguished. 'Prescribing' is 
(i) the process of deciding what to prescribe and naming it (e.g. 'prescribe rest and 
relaxation') and (ii) the act of writing the prescription. Because of this ambiguity, it 
is best to use 'prescribing' to mean the decision-making process and 'prescription' to 
mean the act of writing the prescription3. 
Various types of faults can occur in the decision-making process: irrational 
prescribing, inappropriate prescribing, underprescribing, overprescribing and 
ineffective prescribing. These form a class of errors, but are different in type from 
the class of errors that can be made in the act of writing a prescription i.e. 
prescription errors. Adapting the definition of a medication error, a prescribing fault 
can be defined as 'a failure in the prescribing process that leads to, or has the 
potential to lead to, harm to the patient's previous definition, which resulted from a 
Delphi process (a form of committee), stated that a clinically meaningful prescribing 
error occurs when, as a result of a prescribing decision or prescription writing 
process, there is an unintentional significant (i) reduction in the probability of 
treatment being timely and effective or (ii) increase in the risk of harm when 
compared with generally accepted practice. This definition was developed by the 
researchers Dean B et al.12 in collaboration with a panel of 30 experts who were 
surveyed in the United Kingdom. This report grouped prescription errors into “errors 
in decision making” and “errors in prescription writing”. The first group was further 
subdivided into “inappropriate prescriptions” and “pharmaceutical issues” and the 
second group was further subdivided into errors due to “failure to communicate 
essential information” and “transcription errors” respectively.  
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I.  Errors in decision-making: 
      A.     Prescription inappropriate for patient: 
1.  Drug prescribed is contraindicated due to a co-existing clinical condition. 
 2.  Patient has clinically significant allergy to drug prescribed. 
 3.  Potential drug-to-drug interaction. 
  4.  Drug dose inappropriate for patient’s renal function. 
  5.  Drug dose below or above that recommended for patient’s clinical 
condition.   
6.  Drug dose giving serum levels significantly above or below therapeutic 
range.  
7.  Not altering dose when serum levels are outside therapeutic range.  
8.  Continuing a drug after adverse drug reaction.  
9.  Prescribing two drugs instead of one for same condition.  
10.  Drug not indicated for patient. 
B.     Pharmaceutical issues: 
1.  A drug for intravenous infusion in an incompatible diluent.  
2.  A drug in a greater concentration than recommended for peripheral 
administration. 
II.  Errors in prescription writing: 
A.  Failure to communicate essential information: 
1.  Wrong drug, dose, or route.  
2.  Illegible writing.  
3.  Using drug abbreviations or non-standard terminology.  
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4.  Ambiguous order.  
5.  Omission of route of administration.  
6.  Not specifying duration of intermittent intravenous infusion. 
7.  Omission of prescriber’s signature. 
B.   Transcription errors: 
1.  Upon admission to hospital failure to prescribe a drug the patient was 
already on. 
2.  Upon admission to hospital continuing a general practitioner’s 
prescribing error.  
3.  Incorrect transcribing when rewriting a patient’s drug chart. 
4.  Ordering “milligrams” while intending “micrograms”.  
5.  Upon admission to hospital unintentionally changing a pre-admission 
prescription.  
6.  At discharge writing a prescription unintentionally different from 
inpatient chart. 
A prescription is 'a written order, which includes detailed instructions of what 
medicine should be given and to whom, in what formulation and dose, by what 
route, when, how frequently, and for how long'. Thus, a prescription error can 
be defined as 'a failure in the prescription writing process that results in a 
wrong instruction about one or more of the normal features of a prescription.  
The 'normal features' include the identity of the recipient, the identity of the 
drug, the formulation and dose, the route, timing, frequency and duration of 
administration while a balanced prescribing defined as 'the use of a medicine 
that is appropriate to the patient's condition and, within the limits created by 
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the uncertainty that attends therapeutic decisions, in a dosage regimen that 
optimizes the balance of benefit to harm. 
The prescription order is the most frequent outcome of the outpatient physician 
visit. An estimated 61% of patient visits for a new medical problem will result 
in the patient receiving at least one prescription. Prescription containing errors 
communicate incompletely or inadequately to the pharmacist and may have 
serious detrimental consequences. Some errors will require the pharmacist 
simply to use additional professional judgment in the interpretation and 
execution of the prescription. Omissions may require further communication 
between pharmacist and the physician or at worst may prevent the patient from 
receiving medications at all.  
The types of errors associated with prescriptions may be those associated with 
incomplete details (omission) or those associated with incorrect details 
(commission), e.g.: 
Errors of omission Errors of commission  
Absence of legal requirements  Incorrect drug or indication for use  
Absence of dosage form  Incorrect drug  
Absence  of strengths  Incorrect indication for use  
Absence of dose  Incorrect dose/dosage regimen   
Dosage regimen Quantity duration of Rx  
Quantity/duration of treatment  Duplicate therapy drug interactions contraindication or inappropriate therapy  
Procedures or professional guidelines are typically available for dealing with 
omissions from prescription. Such omissions may however present the 
pharmacist with a legal or an ethical dilemma. On the other hand errors of 
commission represent a far greater threat to the safety of the patient if not 
identified and corrected, but are less easy to identify than omissions.  
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In reality, since pharmacist is not usually privy to diagnosis, ascertaining the 
appropriateness of a prescribed item might be difficult in some circumstances, 
e.g. whether or not the prescribed dose or dosage regimen lies within the usual 
range for the patient, however, where appropriate the condition being treated 
can be checked and information sought from appropriate texts or references for 
particular situations e.g. drug interactions, contraindications, incompatibilities 
and adverse effect. It is important to recognize that the role of computer 
systems is to support or supplement the pharmacist input, not to supplant.    
2.3.4 Prescription Errors and Prescribing Faults:  
The process of prescription generation and dispensing is governed by regulatory 
systems, the purpose of which is to maximize the safety and efficacy of the product 
supplied. Community pharmacists have an important role in checking prescriptions 
to ensure that they are appropriate to dispense. Several studies have shown that 
incorrect prescribing, inadequate information, given by the prescriber or the 
pharmacist and incorrect use of medications by the patients can cause suffering to 
the patients and expense to both the patient and the community98. 
Various studies99 have looked into the issues of poor control of safety in the 
prescribing system. The system can become unstable and vulnerable if management 
and clinical controls are not well defined. The magnitude of problem may not be 
defined until a major adverse event happens. Therefore it is important to monitor the 
performance of systems by paying attention to problems that may arise.      
Prescribing faults and prescription errors are major problems among medication 
errors. They occur both in general practice and in hospital, and although they are 
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rarely fatal they can affect patients' safety and quality of healthcare.  Prescription 
errors encompass those related to the act of writing a prescription, whereas 
prescribing faults encompass irrational prescribing, inappropriate prescribing, under 
prescribing, overprescribing, and ineffective prescribing, arising from erroneous 
medical judgement or decisions concerning treatment or treatment monitoring. 
Appropriate prescribing results when errors are minimized and when the prescriber 
actively endeavors to achieve better prescribing: both actions are required.  
Prevalence: 
The prevalence of prescribing faults and prescription errors has been quantified in 
prospective and restorative cohort studies. Internal or external reviews of 
prescriptions, performed mostly by experienced pharmacist direct interviews or 
voluntary reports from prescribers have been used as sources of information. 
Prescription errors account 70% of medication errors that could potentially result in 
adverse effects. A mean value of prescribing errors with potential for adverse effects 
in patients of about 4 in 1000 prescriptions was recorded in a teaching hospital100. 
Such errors are also frequent in ambulatory settings. However, given the 
inconsistency of the criteria used to identify errors and the various definitions used, 
it is not surprising that a recent meta-analysis showed that range of errors 
attributable to junior doctors, who are responsible for most prescriptions in the 
hospitals, can vary from 2 to 514 per 1000 prescriptions and from 4.2 to 82% of 
patients or charts reviewed. 
Sources:  
  
 
114
All procedures related to prescribing are error-generating steps. A prescribing fault 
can arise from the choice of the wrong drug, the wrong dose, the wrong route of 
administration, and the wrong frequency or duration of treatment but also from 
inappropriate or erroneous prescribing in relation to the characteristic of the 
individual patient or co existing treatments, it may also depend on inadequate 
evaluation of potential harm deriving from a given treatment. Errors in dose 
selection occur most commonly, and represent >50% of all prescribing faults.  
Inaccuracy in writing and poor legibility of handwriting, the use of abbreviations or 
incomplete writing of a prescription, for example by omitting the total volume of 
solvent and duration of a drug infusion, can lead to misinterpretation by healthcare 
personnel. This can result in errors in drug dispensing and administration. 
Unintended omissions - or failure to withdraw a drug - are also frequent. A critical 
point is the transcription of previous treatments at the time of admission to hospital, 
so called ‘medication reconciliation’. Unintended omission or changes in the dosing 
regimen are frequent, and account for 15-59% of medication errors101. Inaccurate 
medication history taking can cause omission of treatment, resulting in potential 
harm in more than one third of patients taking more than four drugs102 transfer of a 
patient’s care within the same institution or between a hospital and a general 
practitioner also favors prescribing faults due to omission103. According to the 
theories of human error, errors in prescribing, as in any other complex and high risk 
procedure, are occasioned by and depend on failure of individuals, but are generated, 
or at least facilitated, by failures in systems104 it might therefore be expected that the 
larger the number of prescriptions, and the more steps in the prescribing procedure, 
the higher the risk of error.  
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Inappropriate prescribing most often derives from a wrong medical decision, 
because of lack of knowledge or inadequate training. Junior doctors often work in 
stressful circumstances that are perceived as routine by experienced doctors. Errors 
are more frequently made by junior members of staff and inadequate knowledge or 
training often underlie inappropriate prescribing and other faults. Inadequate 
staffing, lack of skills and knowledge of relevant rules, tasks outside the routine, or 
taking care of another doctor’s patient have also been identified as conditions 
associated with prescribing faults. 
Adverse outcomes can be related to lack of knowledge or skill. Even the apparently 
simple act of transcribing previous medications and collecting information as a part 
of the medication history requires a knowledge of pharmacotherapy as well as 
adequate information about the patient’s clinical condition. Equally, the choice of 
dose requires information about the patient’s clinical status and immediate 
verification of the appropriateness of treatment.  
Factors related to patient can also result in errors, leading to adverse effects, since 
these are associated in most cases with identifiable clinical conditions, such as 
reduced renal and hepatic function or a history of allergy requiring atypical or 
unusual dosage and frequency. Polypharmacy and management of elderly patients or 
children are associated with inappropriate or potentially inappropriate prescribing 
and errors105. Monitoring of drug action is necessarily part of the prescribing process 
to allow optimization or adjustments of doses or treatments. In ambulatory care, 
prescribing faults are mostly related to the use of inappropriate doses and inadequate 
monitoring106.  
Prevention:  
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Acquisition of information through error reporting system is a prerequisite for 
preventing prescribing faults and prescription errors, as is the adoption of shred 
criteria for the appropriateness of procedures. Error reporting systems, but internal 
and external to healthcare institutions, have been widely used107. Reporting is 
usually voluntary and confidential, but must be timely and evaluated by experts, in 
order to identify critical conditions and allow systems analysis. Prescribers should 
be informed and become aware of errors that have been made in their environment 
and of the conclusions of the analysis.  
Spontaneous reporting is about 10 times less effective in directing errors and 
potential adverse effects than active interventions, such as chart review and patient 
monitoring108. Active systems oriented interventions aimed at importing processes, 
rather than individual performance should, therefore, be advocated109, three major 
intervention strategies can be adopted: 
 Reduction of complexity in the act of prescribing by the introduction of 
automation. 
 Improved prescribers knowledge by education and the use of on line aids.  
 Feedback control systems and monitoring of the effects of intervention110. 
The use of automated prescribing systems is recommended as an effective tool to 
reduce medication errors. They can reduce the risk of harm that arises from 
prescribing faults and improve the quality of medical care by reducing errors in drug 
dispensing and administration. Computerized advice can give significant benefits by 
guiding the prescription of optimal dosages. This should translate into reduced time 
to therapeutic stabilization, reduced risks of adverse effects, and eventually reduced 
lengths of hospital stay111. Nevertheless, electronic systems are not yet widely 
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available, are expensive, and require training. Comprehensive interventions aimed at 
improving patient safety using a systematic approach are progressing in different 
institutions, with the use of uniform medication charts, on which all the relevant 
clinical information is shown along with the prescriptions, so that transcription is 
abolished. This approach has been validated as relatively simple alternative to 
electronic drug prescribing and dispensing systems to a single uniform medication 
chart forces staff to develop interdisciplinary collaboration and procedures that 
allow immediate feedback control both among prescribers and between prescribers 
and other staff (e.g. non prescribing nurses). The input of a hospital pharmacist has 
been regarded as a major contribution to the identification and reduction of error and 
is therefore recommended dif it can be afforded.  
Education and system approaches: 
Education of medical students and junior doctors is highly advisable. Training and 
feedback control of prescribing by tutors and senior doctors should be associated 
with availability of online references for immediate identification and verification of 
potential prescribing faults. The choice of treatment should generally be in line with 
approved guidelines, although flexibility may be necessary in individual cases.  
Constraints can minimize omissions, for example the introduction of check lists or 
strict rules in writing prescription, and the use of well structured medication charts, 
as mentioned above. Handwritten prescription should not contain ambiguous 
abbreviations or symbols. Frequent and immediate review of prescriptions as well as 
monitoring of potential harms deriving form treatment should be encouraged. 
Polypharmacy requires special attention. Potentially inappropriate medication 
should be avoided if possible and carefully monitored when used.   
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Careful evaluation of drug-drug interactions and all types of adverse reactions is 
necessarily part of programme aimed at improving patient safety and may require 
monitoring of plasma drug concentrations and evaluation of biomarkers of beneficial 
or adverse effects. Audit can contribute to appropriate prescribing and error 
reduction112. Interventions aimed at improving prescribing and reducing errors are a 
vital component in improving patient safety. As depicted in Dean’s definition of a 
prescribing error12, following points have to be kept in mind:  
 Prescribing a drug for a patient for whom, as a result of a co-existing clinical 
condition, that drug is contraindicated. 
 Prescription of a drug to which the patient has a documented clinically 
significant allergy. 
 Not taking into account a potentially significant drug interaction.  
 Prescribing a drug in a dose that is inappropriate for the patient’s renal 
function.  
 Prescription of a drug in doses below that recommended for the patient’s 
clinical condition.  
 Prescribing a drug with a narrow therapeutic index, in a dose predicted to give 
serum levels significantly above the desired therapeutic range. 
 Writing a prescription for a drug with a narrow therapeutic range in dose 
predicted to give serum levels significantly below the desired therapeutic 
range. 
 Not altering the dose following steady stage serum levels significantly outside 
the therapeutic range.  
 Continuing a drug in the event of a clinically significant adverse drug reaction.  
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 Prescribing two drugs for the same indication when only one of the drugs is 
necessary.  
 Prescribing a drug to be given by intravenous infusion in a dilutent that is 
incompatible with the drug prescribed.  
 Prescribing a drug to be infused via an intravenous peripheral line, in a 
concentration greater that that recommended for peripheral administration.  
 Failure to communicate essential information prescribing a drug, dose or route 
that is not that intended.  
 Writing illegibly. 
 Writing a drug’s name using abbreviations or other nonstandard nomenclature.  
 Writing an ambiguous medication order prescribing ‘one tablet’ of a drug that 
is available in more than one strength of tablet. 
 Omission of the route of administration for a drug that can be given by more 
than one route. 
 Prescribing a drug to be given by intermittent intravenous infusion, without 
specifying the duration over which it is to be infused. 
 Omission of the prescriber’s signature. 
 On admission to hospital, unintentionally not prescribing a drug that the 
patient was taking prior to their admission.  
 Continuing a general practitioner’s prescribing error when writing a patient’s 
drug chart on admission to hospital. 
 Transcribing a medication order incorrectly writing ‘milligrams’ when 
‘micrograms’ was intended.  
 Writing a prescription for discharge medication that unintentionally deviates 
from the medication prescribed on the inpatient drug chart.  
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 On admission to hospital, writing a medication order that unintentionally 
deviates from the patient’s pre-admission prescription.  
 Prescribing a drug in a dose above the maximum dose recommended.  
 Mis-spelling a drug name.  
 Prescribing a drug in a dose that cannot readily be administered using the 
dosage forms available.  
 Prescribing a dose regime (dose/frequency) that is not that recommended for 
the formulation prescribed. 
 Continuing a prescription for a longer duration than necessary.  
 Prescribing a drug that should be given at specific times in relation to meals 
without specifying this information on the prescription.  
 Unintentionally not prescribing a drug for a clinical condition for which 
medication is indicated.  
2.4  Detection and Prevention of Medication Errors and Prescription 
Errors: 
In order to build safer systems we must be able to learn from previous errors, and 
detection is the first crucial 'step’. Scientific societies and surveillance agencies, 
views, original studies, and case reports may warn us to be on the alert and promote 
knowledge of risks and improved performance. For this purpose, reports, alerts and 
recommendations are available on the web, issued by national and federal healthcare 
systems, regulatory agencies, and non-profit-making organizations - the Food and 
Drug Administration (FDA), European Medicines Agency (EMEA), United States 
Pharmacopeia (USP-MEDMARX), UK - National Health Service (NHS), Veterans 
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Health Administration (VHA), Australian Patient Safety Foundation (APSF), Joint 
Commission on the Accreditation of Healthcare Organizations (JCAHO). 
Prescription auditing to identify and detect prescription errors is processed by 
bringing information on patterns of existing practice together with information on 
appropriate practice is an essential component of efforts to improve healthcare. This 
is possible only when each and every prescription in the hospital is audited by a 
prescription auditing team. The process of prescription auditing in its broad sense 
include prescription monitoring, drug utilisation studies, prescription pattern studies, 
study of prescription habits of doctors, adverse drug reaction monitoring, drug 
interaction monitoring, criteria based prescription auditing and many other activities. 
But the grass-root activities include checking the prescription for drug name (brand 
name or generic), strength, formulation, dose, routes of administration, frequency, 
duration of treatment and drug allergies. According to studies cited in the Institute of 
Medicine report, To Err Is Human: Building a Safer Health System, 44,000 to 
98,000 Americans die each year as a result of medical errors113.  
In Indian scenario, a proper reporting of medication errors in the hospital is not 
available, but out of all visits to the medical emergency department - six per cent are 
drug-related.  
The approaches used to detect errors are likely to be different in research and routine 
care114. In order to prevent medication errors and reduce the risks of harm, 
organizations need tools to detect them115.  Any system must then be able to analyze 
errors and identify opportunities for quality improvement and system changes. The 
major methods for detecting adverse events are chart review, computerized 
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monitoring, incident reporting, and searching claims data. Medication errors are 
mainly detected by means of direct observation and voluntary reporting by doctors, 
pharmacists, nurses, patients, and others.  
Medication errors pose a major threat to patient safety. In England and Wales, over 
50000 medication incidents in National Health Service hospitals are reported 
annually to the UK National Patient Safety Agency116. Multiple factors are involved 
in these events, including faulty supply and labelling and errors of administration, 
but poor prescribing is probably the most common cause of avoidable events, 
accounting for over half of all preventable hospital medication errors. Most courses 
and serious hospital medication errors concern dose, and around 90% involve junior 
doctors who have recently graduated from medical school making them an important 
potential target of intervention to improve patient safety. Thus, prescribing is a 
complex and challenging task that requires diagnostic skills, knowledge of 
medicines, communication skills, an understanding of the principles of clinical 
pharmacology, appreciation of risk and uncertainty, and, ideally, experience. It is an 
anomaly that the hospital doctors who have least experience an expected to prescribe 
most often. It is also apparent the demands on new prescribers are increasing 
progressively, owing to several important trends, including (i) the availability of an 
increasing number of licensed medicine with complex actions, (ii) an increasing 
number of indications for drug treatment, (iii) greater complexity of treatment 
regimens, leading to inappropriate polypharmacy, and (iv) more elderly and 
vulnerable patients. Although errors are inevitable in these circumstances, the 
important challenge for a health service is to minimize risk. This will require a 
number of approaches, including changes to system practices (e.g. labelling, team 
work, checking). The potential influence of education and training as a means of 
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improving knowledge and skills to prevent medication errors should be the main 
aims.  
Undergraduate medical education has undergone considerable transformation in the 
last two decades. These changes have come in response to concerns that students 
were overburdened with scientific facts and were being taught in rigid traditional 
discipline-based courses, with little regard to social sciences, notably 
communication skills. This heralded a major change in direction, promoting a 
reduction in factual burden integration of the curriculum 'both vertically and 
horizontally', and learning based on body systems.  These changes had an adverse 
effect on the teaching of clinical pharmacology and therapeutics (CPT), a traditional 
discipline that is factually rich and not organ-based. Identifiable courses and 
assessments in pharmacology and clinical pharmacology and therapeutics 
disappeared in many schools, along with the teachers and departments who had 
delivered them117. As a result, many medical students now have little exposure to 
clinical pharmacologists or indeed any CPT or teaching about practical prescribing. 
This lack of specialists in a discipline dedicated to fostering safe and rational use of 
medicines has even led some schools to call on pharmaceutical company support for 
teaching118. The current standards set out for training nurse prescribers in the UK a 
minimum of 26 days, with an additional 12 days of supervised learning practice119 
would be the envy of many medical students120. Although there has been a growing 
perception, highlighted by clinical pharmacologists and others, that medical school 
education may have been lacking121 this view has been challenged122,123.  A number 
of health service hospitals have now indicated their own concerns about prepared-
ness of new doctors to prescribe and have developed their own assessments, 
sometimes with important consequences124. 
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Medical students themselves have expressed concerns about their training at 
individual medical schools125,126. Weaknesses were identified both in the 
pharmacological knowledge underpinning prescribing, and the practical elements of 
calculating dosage, writing up scripts, drug sheets, etc. Prescribing was also the 
main area of practice in which errors were reported by respondents, indicating a 
significant potential risk. Risks were reduced, but not removed, by support from col-
leagues, with newly qualified doctors speaking particularly highly about the help 
received from pharmacists127. According to one of the studies conducted by Heaton 
there are views of 2413 medical students regarding undergraduate preparation for 
prescribing128. The questions raised about undergraduate training are of obvious 
relevance to a discussion on medication errors, given that recent graduates undertake 
a substantial proportion of hospital prescribing and make many of the recorded 
errors.  Review of these events suggests that failures in education and training are a 
factor. In a prospective study, 88 potentially serious prescribing errors made in a 
London teaching hospital were identified, 41 prescribers who had been involved 
were then interviewed, and the findings were analyzed using human error theory. 
Multiple contributory factors were identified, but 24 doctors (59%) cited their lack 
of 'skills and knowledge' as important. In another prospective study, 334 medication 
errors were identified among admissions to 11 medical and surgical units in two 
tertiary-care hospitals in the USA over a 6-month period, those involved were 
interviewed129. The authors concluded that failure in the 'dissemination of drug 
knowledge particularly among doctors, accounted for 29% of the errors. Both 
reports show that error is usually multifactorial, but that knowledge of medicines 
and prior training are important. 
Do educational interventions reduce medication errors? 
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Is there any evidence that educational interventions alone can reduce prescribing 
errors? Some defend the status quo on the basis of the paucity of research linking 
variations in early education experience to subsequent errors. There are obvious 
difficulties in delivering such evidence because of the large numbers of students 
required, the long and detailed follow-up, difficulty detecting medication-related 
events and measuring the quality of prescribing practice, achieving random 
allocation of learning experience, constant change in curricula, and overcoming the 
confounding effects of other relevant factors such as working environment and 
postgraduate education. However, several studies have shown that educational 
interventions can improve prescribing performance, although most have relied on 
assessments early after intervention and under controlled conditions rather than on 
hospital wards. Ross and Loke recently reviewed the literature for trials of 
educational interventions aimed at improving medical student or junior doctor 
prescribing130. After screening 3189 records they found only 11 controlled trials and 
four 'before and after' trials that met relevant quality criteria. All but one small study 
of prescribing errors amongst paediatric residents demonstrated evidence of 
improved prescribing131.  
This careful review suggests, first, that the available evidence supports efforts to 
support more intensive educational interventions, and second, that further and better 
studies are needed.  
When is the ideal time to provide education? We are among many commentators 
who believe that the undergraduate stage is a critical period, because courses are of 
prolonged duration (5-6 years full time), are undertaken when long-term attitudes 
and skills can best be developed, and are the only preparation available before the 
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assumption of legal responsibility for prescribing. In contrast, postgraduate 
interventions are significantly limited by time constraints imposed by clinical 
schedules, are more difficult to supervise effectively, and compete with other 
training requirements (e.g. resuscitation skills). However, postgraduate education 
does have the potential advantage that it would be delivered when prescribing skills 
are frequently being practiced in a clinical setting. Prescribing and therapeutics is 
one of the most rapidly changing aspects of any doctor's clinical practice, and 
keeping up to date throughout a career that may last several decades presents a 
major challenge. All will require the necessary time to be set aside for continuing 
professional development of relevant knowledge and skills and should ideally 
receive other support in the form of bulletins, audits, and feedback on prescribing 
activity. The central importance of prescribing as an influence on the quality of 
medical care should make it a focus within any appraisal and revalidation processes. 
Which methods of education might be most effective? The rise of problem-based 
learning has been a major educational trend, and prescribing education lends itself 
extremely well to this format, although in one recent study there was no benefit over 
more traditional didactic methods132. An alternative and increasingly popular 
approach is the development of e-learning packages to support rational 
prescribing133,134, allowing learning opportunities to be taken up flexibly at times 
that best suit learners, a major potential advantage for postgraduates. However, 
evidence of efficacy is still awaited. 
Recommendations for improved training in prescribing: 
Irrefutable evidence that more prescribing training will reduce the harm patients 
suffer from medication errors has yet to emerge. However, the combination of 
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widely voiced concerns about existing education, growing challenges faced by 
prescribers, and the relative ease with which errors are identified has led many to 
advocate precautionary change135. Guidance should be directed to recognize the 
differing ethos of medical curricula adopted in medical schools around the world. 
These range from a more traditional style, with preclinical phases consisting of 
traditional sciences taught as disciplines, often by lecture, through to those that are 
based entirely on problem-based learning in small groups.  
All new medical graduates should be able to: 
•  Establish an accurate drug history. 
•  Plan appropriate therapy for common indications. 
•  Write a safe and legal prescription. 
•  Appraise critically the prescribing of others. 
•  Calculate appropriate doses. 
•  Provide patients with appropriate information about their medicines.  
•  Access reliable information about medicines. 
•  Detect and report adverse drug reactions. 
Recommendations for improving the prescribing education for medical students and 
junior doctors: 
1.  Prescribing and therapeutics should be identified as an important vertical 
theme that is visible throughout the medical curriculum, integrating with and 
identifiable within relevant horizontal modules. 
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2.  Students' core learning objectives should be clearly identified, including 
knowledge and understanding about drugs, skills related to the prescribing of 
drugs, and attitudes towards drug therapy. 
3.  The factual burden imposed by the large numbers of medicines that are 
encountered should be eased by prioritizing learning around a core list of about 
100 commonly used drugs (a student formulary). 
4.  There should be an identifiable and robust assessment that tests whether the 
knowledge and skills outcomes identified above have been achieved, although 
this might form part of an integrated assessment, it should never be possible to 
compensate for a poor performance in prescribing by a good performance in 
other items. 
5.  Each medical school should identify an individual teacher to oversee this area 
of the curriculum, who will champion the importance of prescribing as a 
clinical skill and will ensure that the relevant opportunities are available to 
allow the relevant learning outcomes to be met. 
6.  Prescribers should have time to update and reflect on their prescribing 
practices, dedicated training events should be provided at least once a year. 
7.  Prescribers should get feedback in the form of quality markers of prescribing 
relevant to their area of clinical practice. 
8.  Prescribers should, in the first year after graduation, receive genuine 
supervision that allows them to discuss problems and seek advice in a non-
judgemental way. 
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9.  Prescribers should not be pressurized into prescribing medicines of which they 
have little experience or understanding. 
10.  Whenever possible, errors that are identified should be drawn to the attention 
of the individuals concerned to afford a blame-free learning opportunity, all 
clinical units, including junior and senior doctors, should review and discuss 
prescribing incidents at regular intervals. 
11.  E-learning resources should be made available to support continuing 
professional development for prescribers at all levels. 
12.  Prescribing champions should be present in all large healthcare organizations 
to oversee the processes outlined above. 
2.5  Recommendations for Prevention of Medication Errors and  
Prescription Errors: 
1.  Provision of sufficient undergraduate learning opportunities to make medical 
students safe prescribers.  
2.  Provision of opportunities for students to practice skills that help to reduce 
errors. 
3.  Education of students about common types of medication errors and how to 
avoid them. 
4.  Education of  prescribers in taking accurate drug histories. 
5.  Assessment in medical schools of prescribing knowledge and skills and 
demonstration that newly qualified doctors are safe prescribers. 
6.  European harmonization of prescribing and safety recommendations and 
regulatory measures, with regular feedback about rational drug use. 
7.  Comprehensive assessment of elderly patients for declining function. 
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8.  Exploration of low-dose regimens for elderly patients and preparation of 
special formulations as required. 
9.  Training for all health-care professionals in drug use, adverse effects, and 
medication errors in elderly people. 
10.  More involvement of pharmacists in clinical practice. 
11.  Introduction of integrated prescription forms and national implementation in 
individual countries. 
12.  Development of better monitoring systems for detecting medication errors 
based on classification and analysis of spontaneous reports of previous 
reactions, and for investigating the possible role of medication errors when 
patients die. 
13.  Use of information technology systems, when available, to provide methods of 
avoiding medication errors; standardization, proper evaluation, and 
certification of clinical information systems. 
14.  Nonjudgmental communication with patients about their concerns and 
elicitation of symptoms that they perceive to be adverse drug reactions. 
15.  Avoidance of defensive reactions if patients mention symptoms resulting from 
medication errors.  
Recommendation 1:  Provision of sufficient undergraduate learning opportunities to 
make medical students safe prescribers. 
There is evidence that changes in the style of modern medical school curricula may 
have reduced the visibility of traditional scientific disciplines that underpin safe 
prescribing, such as pharmacology and clinical pharmacology. There is also 
evidence that poor knowledge and preparation underlie a promotion of errors made 
by junior doctors and that focused education in prescribing can improve 
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performance136. It is also a perception among medical students that of all the clinical 
skills that they will be expected to practise after graduation, the one for which they 
are least well prepared is prescribing. It is clear that high-quality learning can 
flourish in different styles of curriculum. However, whatever the setting, learning 
should be based on enthusiastic leadership, ample sessions that focus on safe 
prescribing practices, and provision of online learning resources. 
Recommendation 2:  Provision of opportunities for students to practice skills that 
help to reduce errors. 
Much of the medical school curriculum is devoted to the acquisition of knowledge, 
and sometimes its application to the skills required in the clinical environment is 
forgotten. Students should be encouraged to practice relevant clinical skills as soon 
as possible. These might include taking medication histories, writing new 
prescriptions and reviewing lists of established prescription medicines in relation to 
the patient's clinical history, calculating drug doses, preparing and administering 
medicines under supervision. 
Recommendation 3: Education of students about common types of medication 
errors and how to avoid them. 
Medical students are often unaware of the potential hazards posed by medicines 
when they are prescribed in error, or of the frequency with which this occurs. They 
should be taught about drugs that are used commonly and pose particular challenges 
(e.g. anticoagulants, insulin, diuretics) how to monitor the effects of drugs so that 
potential dangers can be avoided, and the important contribution to error reduction 
made by good communication and record keeping. 
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Recommendation 4: Education of prescribers in taking accurate drug histories e.g.  
taking an accurate medication history. 
An accurate medication history is an important element in patient safety. Inaccurate 
histories, particularly on admission to hospital, can lead to prescribing errors, such 
as duplication of drugs or unintended discontinuation of medications, with 
consequent unwanted interactions, failure to detect drug-related pathology, and loss 
of efficacy of established therapy. In all, 67% of medication histories have at least 
one prescription error, 22% of which have the potential to harm the patient 
significantly137. Specific drugs are associated with increased risks of errors in the 
drug history; these include commonly prescribed agents such as anticoagulants and 
analgesics.  
A medication history should elicit specific information from the patient. This should 
include the details of all prescription medications, over-the-counter drugs, and 
herbal and other alternative remedies. Drug allergies and previous intolerances 
should be accurately documented, the dose of the drug, the reaction suffered, and its 
temporal relation to the drug should be described and susceptibility factors should be 
sought. The history should be supplemented by examination of the patient, looking 
for the effects of drugs, and, when appropriate, by relevant laboratory 
investigations138. In addition, one should attempt to ascertain adherence to treatment, 
from the patient, general practitioner, or family, recognizing that accurate 
information may be difficult to obtain. Pharmacists obtain better medication 
histories than physicians and reduce the rate and severity of medication errors during 
acute admissions. Furthermore, pharmacists attending medical or surgical post-take 
(admission) ward rounds improve drug history documentation, reduce prescribing 
costs, and prevent adverse drug reactions.  
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.Recommendation 5: Assessment in medical schools of prescribing knowledge and 
skills and demonstration that newly qualified doctors are safe prescribers.  
 Prescribing is probably the practical skill that is most commonly required of all new 
doctors, but of all the skills that newly qualified doctors are expected to have 
mastered, they are least confident about prescribing. Medical schools should have 
effective assessments in place that discriminate between students who have 
sufficient knowledge and skills for safe medication practices and those who do not. 
The required standard will differ to some extent, depending on the level of 
supervision available after graduation. Postgraduate assessment should also be 
encouraged, as part of appraisal. 
Recommendation 6: European harmonization of prescribing and safety 
recommendations and regulatory measures, with regular feedback about rational 
drug use e.g. identifying hazardous systems. 
Hazards abound in clinical practice. They include: 
•  Hazardous drugs: These need not be new drugs, even well-established drugs 
are often subject to medication errors.  
•  Hazardous patients: Patients present several risk factors for medication errors, 
there is limited knowledge about how to estimate individual patient risk, 
although elderly patients constitute a readily identifiable group139. 
•  Hazardous professionals: There is a lack of specialists (clinical 
pharmacologists and clinical pharmacists) trained in the specific problems of 
medication safety. Consequently, many prescribers are not adequately trained 
in practical prescribing. 
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Some settings are more susceptible to involvement in medication errors, such as 
nursing homes, geriatric home care, surgical departments, intensive care units, and 
ambulatory care. 
Hazardous drugs: Several studies have confirmed persistent problems in prescribing 
well-established medications140. Although there is often a huge amount of 
knowledge about such medications, less attention is paid to the major safety 
problems. In some cases safer alternatives to some older risky medications (e.g. 
warfarrin, amiodarone) are not available. . 
Recommendation 7: Comprehensive assessment of elderly patients for declining 
function141. 
Old patients: Many problems that lead to medication errors particularly affect 
elderly patients, in whom cognitive impairment, renal insufficiency, dependence on 
care takers, and polypharmacy are the major predictors of drug-related hospital 
admissions. Instruments for determining individual patient risk, particularly in 
patients with multiple comorbidities and several susceptibility factors, are not 
available for clinical use. There is a lack of professionals specifically trained in 
geriatrics, geriatric pharmacology, and pharmacoepidemiology. Clinicians do not 
routinely apply even basic safety recommendations and insufficient attention is paid 
to well-known risks. There have been few studies on the long-term efficacy in 
elderly patients of safer low-dose regimens for frequently used medications. In 
practice, most substances are usually prescribed in too high doses or in low-dose 
regimens with no evidence of primary or secondary long-term benefit in elderly 
patients. Drug formulations that contain low doses are less often available. 
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Recommendation 8: Exploration of low-dose regimens for elderly patients and 
preparation of special formulations as required. 
Recommendation 9: Training for all health-care professionals in drug use, adverse 
effects, and medication errors in elderly people.  
Recommendation 10: More involvement of pharmacists in clinical practice.  
Hospital care takes place in a complex and hierarchical organization encompassing 
different disciplines, which converge at the bedside. Many findings, decisions, and 
actions take place simultaneously and often acutely. In hospitals, medication and 
other errors can have many different causes and explanations and often occur at the 
bedside, where the different disciplines interact. Incidental distraction of attention is 
likely, and in the case of a specialized activity, such as checking and administering 
medicines, can lead to suboptimal performance. These types of errors typically occur 
in the absence of the pharmacist. 
In the past few decades, the profession of clinical pharmacy has developed the 
specialism of pharmaceutical care, which aims at ensuring optimal individual 
pharmacotherapy and appropriate and errorless drug handling. Involvement of 
clinical pharmacists in almost the entire medication process, from dispensing to 
administration to the patient, can reduce medication errors142. This can be achieved 
through special medication ward rounds143, the use of computer-assisted and 
barcode-controlled bedside dispensing, and an extra check whenever a 
pharmaceutical formulation is modified before administration (e.g. crushing a 
capsule for a patient with an nasogastric tube144,145, entered via an unusual route, or 
injected into an intravenous line. 
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Recommmendation 11: Introduction of integrated prescription forms and national 
implementation in individual countries, e.g. using uniform prescription forms. 
Although electronic prescription systems improve prescribing quality, they are 
expensive and can generate new types of errors. Integrated prescription forms have 
also been developed for use in hospitals, with the aim of reducing errors in 
prescribing and drug dispensing. The prescription is handwritten by the doctor and 
countersigned by the nurse after administration. The potential advantages are that a 
single sheet of paper contains all the necessary information about the patient's care, 
transcription is avoided, communication between physicians and nurses is 
simplified, and feedback control is facilitated. Although training is required, it is not 
time- consuming. In addition, uniform prescription charts can be easily implemented 
at low cost. To improve communication between medical staff and nurses, 
cooperation should be encouraged, verbal prescription should not be allowed, and 
only a limited number of abbreviations should be permitted. Feedback control must 
include immediate notification of errors by medical staff and pharmacists (potential 
harm deriving from prescription) as well as nurses (incorrect writing), while the 
prescriber can monitor actual drug administration. Frequent (e.g. daily) review of 
prescriptions allows identification of potential harm from drug - drug interactions 
and adverse drug reactions. Audits should be performed periodically to evaluate the 
appropriateness of the procedures and encourage implementation of the prescription 
form. Most errors made by junior hospital doctors occur shortly after they come to a 
new hospital, national prescription forms would help to mitigate this effect. 
Recommendation 12: Development of better monitoring systems for detecting 
medication errors, based on classification and analysis of spontaneous reports of 
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previous reactions, and for investigating the possible role of medication errors when 
patients die, e.g. bar-coded medication administration.  
Before the administration of a medication in hospitals and other institutionalized 
care settings, the 'five rights' must be verified: the right patient, drug, dose, route, 
and time. Traditionally, the nurse does this by visually checking the medicine and 
the patient. However, there is evidence to suggest that this traditional method does 
not adequately protect the patient from medication-related harm. About 35% of all 
medication errors occur at the administration stage, and these errors are more likely 
to affect the patient.   
In bar-coded medication administration a nurse typically scans a bar code on the 
employee identification bandage', the patient's wristband, and the medication to be 
administered. The portable computer at the bedside sends information to a server, 
which checks the prescription, System can generate warnings or approvals, provide 
administration, instructions and information about the drug or deliver reminders for 
further actions. After administration, the system documents the activity in the 
patient's medication record for future use. 
Case studies and anecdotal reports suggest that barcoded medication administration 
can produce significant reductions of at least 50% in the number and types of 
medication administration errors146. Besides patient safety, secondary reasons for 
implementing bar coded medication administration include improved workflow, 
documentation, billing, and public relations.  
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Recommendation 13: Use of information technology systems, when available, to 
provide methods of avoiding medication errors, standardization, proper evaluation, 
and certification of clinical information systems. 
However, digital communication is not only fast, convenient, and inexpensive, but 
can also provide a high degree of security, through the use of encryption algorithms. 
The secure e-mail provider (Z mail) is a fine example of a service that offers an 
economical and secure means to send medical information over the internet. In 
addition, most broadband telephony providers are also integrating encryption 
options into their services, making them more attractive for use in medical 
communication (such as telemedicine and long-distance telephony). Finally, as the 
options for digital communication become increasingly available, reliable, and 
secure, they will also be increasingly used for sending medical information. 
Published research strongly suggests that modern information systems have a 
substantial role in preventing medication errors at each step of the medication 
process. Computerized order entry and decision support systems reduce errors at the 
prescription stage by producing legible orders, by ensuring the correct dose and 
route, and by providing point-of-care alerts about potential drug allergies or drug-
drug interactions. In a closed-loop system, the electronic orders are automatically 
transmitted to the pharmacy, altogether eliminating errors of transcription. 
Automated dispensing devices and robots ensure that the medication being 
dispensed is matched accurately against the physician's order.  
The usefulness of information systems derives from their ability to organize and link 
multiple pieces of information with consistency and reliability. A good informatics-
enabled medication process will spare the clinicians repetitive boring tasks, so that 
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they can focus on complex clinical decision-making and communicating with each 
other and their patients. 
Recommendation 14: Nonjudgmental communication with patients about their 
concerns and elicitation of symptoms that they perceive to be adverse drug reactions, 
i.e. communicating with patients. 
Patients' attitudes to medicines influence the ways in which they use them. Some 
carry out their own evaluations of prescribed medicines, using their own criteria Up 
to 50% are non-adherent, in the sense that they do not take the medicine 'as 
prescribed and few solutions to this longstanding problem have been identified. 
Blind adherence to medication can lead to harm if patients are insufficiently 
informed about the dangers of prescribed medicines. All of this suggests that it is 
better to engage with patients' own evaluations and aim for shared goals rather than 
ignoring or condemning 'non-adherence. Such an approach requires further research 
and development. 
Recommendation 15: Avoidance of defensive reactions if patients mention 
symptoms resulting from medication errors. 
CHAPTER – III 
 
MATERIAL AND 
METHODS 
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CHAPTER - III 
MATERIAL AND METHODS 
A prospective study of out patient prescriptions was conducted in Anand district from 
January 2008 to May 2010. Prescriptions were collected from pharmacy stores catering to 
clinicians from multiple specialities. Clinicians near the pharmacy stores were informed 
about the aims of our study and their informed consent (Annexure-I) was taken. The 
collection of prescriptions was started a month after the consent to minimize bias in 
prescription writing. 
Prescriptions were collected as Xeroxes/Scans of the original document which the patients 
presented at the pharmacy and in some cases as duplicate printouts of the prescriptions 
when they were computer generated printouts.  
From rural areas in Anand district the approach was similar except that in the majority of 
the cases the pharmacy stores were within the clinician’s hospital premise.  
Inclusion criteria: 
Allopathic private practitioners/consultants in Anand district prescribing medicines to 
patients. 
Exclusion criteria: 
Institutional prescriptions 
Non-availability of clinician’s consent 
In all, 979 prescriptions were collected from the urban–rural practices. i.e. 749 urban (549 
manual + 200 computer generated) and 230 rural (191 manual + 39 computer generated). 
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Analysis: 
The prescription copies so obtained were analysed as per WHO guidelines for “Prescription 
Writing Errors”. An error-scoring sheet (checklist) was prepared and each prescription was 
analysed on various parameters as per the checklist given below: 
(A) Patient details: Name, age, sex, weight, address and date of prescription. 
(B) Clinician details: Qualification, address, registration number and signature. 
(C) Drug details: Mention of generic or brand name, dosage form, route, dose, unit, 
frequency, duration of treatment, quantity, signa.  
(D) Other information: Mention of allergy status, specific drug communication, 
mention of abnormality in liver/kidney/cardiac condition, refill mentioned or not, 
dispense as written, follow up, history of intake of other medicines and legibility 
status of the prescription. 
The data obtained was entered in MS office Excel 2003 and further analysis was done using 
‘SPSS Data’ (Statistical Package for the Social Sciences). Comparative analysis was done 
between urban/rural prescriptions to study the error rates and types of errors in prescription 
writing.  
Analysis was done in the following way: 
Overall prescription writing error rates were found for urban and rural prescriptions in 
Anand district separately for various parameters. 
Prescription writing errors in urban and rural prescriptions were compared with each other. 
Computerized prescriptions were analysed and compared with manual prescriptions. 
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The clinicians not using computers were then interviewed to find out their views on using 
computers for prescription writing and the problems they faced if they had used them in the 
past. 
In pursuance of our aim to find ways and means to reduce prescription errors, we introduced 
a prescription writing format to aid the prescription writing to some of the clinicians already 
participating in our study in the urban setup. They were provided their respective letter- 
heads with a format printed for prescribing (structured format prescriptions - Annexure-II).  
We collected xerox or scanned copies of 206 such prescriptions from pharmacy/stores 
catering to them. Thus as already mentioned above, the previous data (from analysis of 
manual prescriptions) was compared to the prescription writing error rates in the structured 
formatted prescriptions. Data was compared using the chi square test.  
CHAPTER – IV 
 
RESULTS 
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CHAPTER - IV 
RESULTS 
Table-1: Break-up of overall prescriptions (n = 979) 
Urban vs Rural 
Prescriptions Urban Rural Total 
Manual 549 73.29% 191 83.04% 740 
Computerized 200 26.70% 39 16.95% 239 
Total 749 76.50% 230 23.49% 979 
 
The table above depicts the break-up of overall prescriptions. Total number of prescriptions 
collected were 979. 
Out of these 979 prescriptions, 749 prescriptions were collected from the urban areas. Of 
these, 549 were handwritten (manual-urban = 73.29%) and 200 were computer generated 
(26.70%).  
Out of the 230 prescriptions collected from the rural areas, 191 were handwritten (manual-
rural = 83.04%) and 39 were computer generated (16.95%) thus showing a higher usage of 
computers in the urban practice. 
Table-2: Speciality-wise distribution of prescriptions (n = 979) 
Urban vs Rural 
  Urban Rural 
Physicians 177 18.07% 31 3.16% 
Surgeons 29 2.96% 50 5.10% 
Gynaecologists 53 5.41% 48 4.90% 
Paediatricians 253 25.84% 0 0.00% 
Otolaryngologists 28 2.86% 0 0.00% 
Ophthalmologists 28 2.86% 25 2.55% 
Orthopaedics 6 0.61% 10 1.02% 
Chest physicians 28 2.86% 0 0.00% 
Dermatologists 27 2.75% 0 0.00% 
Psychiatrists 34 3.47% 0 0.00% 
Gen. practitioners 86 8.78% 66 6.74% 
Total 749 76.50% 230 23.50% 
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The table above depicts the speciality wise distribution of prescriptions out of total random 
collection of 979 from both the urban and rural settings.  
In all, 18.07% of the prescriptions were from the urban physicians while 3.16 % were from 
rural physicians. 2.96 % of the prescriptions were from urban surgeons, while 5.10 % 
prescriptions from rural surgeons. Similarly, 5.41% prescriptions were from the urban 
gynaecologists as compared to 4.90 % from the rural gynaecologists. There were 25.84% of 
the prescriptions from urban pediatrician while none from the rural areas. There were 2.86% 
prescriptions from the urban otorhinolaryngologists while none from rural category. There 
were 2.86% prescriptions from the urban ophthalmologists as compared to 2.55% 
prescriptions from the rural areas. 0.61% prescriptions were from the urban orthopaedic 
surgeons as compared to 1.02 % in the rural setting. There were prescriptions from the 
urban chest physicians 2.86%, from the urban dermatologists 2.75%, urban psychiatrist 
3.47% while none from the rural facilities. However there were 8.78% prescriptions from 
the urban general practitioners as compared to 6.74% from rural general practitioners. 
Thus out of a total of 979 prescriptions, 749 (76.50%) prescriptions were collected from 
urban private practitioners of the above mentioned categories whereas 230 (23.50%) 
prescriptions were from rural setting. 
Table-3: Speciality-wise distribution: Manual versus computer generated (n = 979) 
  Manual Computerised 
Physicians (n = 208) 179 86.05% 29 13.94% 
Surgeons (n = 79) 40 50.63% 39 49.36% 
Gynaecologists (n = 101) 101 100% 0 0% 
Paediatricians (n = 253) 115 45.45% 138 54.54% 
Otorhinolaryngologists (n = 28) 28 100% 0 0% 
Ophthalmology (n = 53) 53 100% 0 0% 
Orthopaedics (n = 16) 16 100% 0 0% 
Chest physicians (n = 28) 28 100% 0 0% 
Dermatologist (n = 27) 27 100% 0 0% 
Psychiatrist (n = 34) 1 2.94% 33 97.05% 
Gen practitioners (n = 152) 152 100% 0 0% 
Total (n = 979) 740 75.58% 239 24.41% 
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As seen in the table, out of the total 208 prescriptions from the physicians, 86.05% were 
manual while only 13.94% were computer generated. Out of 79 prescriptions from the 
surgeons, 50.63% were manual while 49.36% were using computer generated. Out of a total 
of 253 prescriptions from pediatricians 45.45% were manual while 54.54% were computer 
generated. The gynaecologists, otorhinolaryngologists, opthalmologists, orthopaedic 
surgeons, chest physicians, dermatologists and the general practitioners were not using any 
computer software for prescription writing. Out of 34 prescriptions of psychiatrists, 97.05% 
were computer generated. Thus out of 979 prescriptions 75.58% of the prescriptions were 
written manually while 24.41% of the prescriptions in the study were computer generated 
respectively.  
Table-4(A): Analysis of overall prescription writing errors  (n = 979) 
Clinician details Mentioned % Not mentioned % 
 Name  979 100% 0 0.0% 
 Qualification 955 97.54% 24 2.45% 
Contact number 766 78.24% 213 21.75% 
 Address 979 100% 0 0.00% 
 Regn. number 361 36.87% 618 63.12% 
Esoteric symbol 783 79.97% 196 20.02% 
Signature 656 67.00% 323 32.99% 
 
Prescribing doctor’s name was mentioned in all the 979 prescriptions and qualifications in 
97.54 % instances. 78.24% prescription mentioned the doctors contact numbers, while 
21.75 % prescriptions provided no contact numbers for the patient to contact the clinician 
(only 9.29% prescriptions had the doctor’s personal mobile number mentioned). All 
prescriptions had the doctor’s hospital/clinic address. 36.87% had the registration number 
mentioned. Esoteric symbol was written in 79.97% of the overall prescriptions while 
doctor’s signature was there in only 67.00% prescriptions. 
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Table-4(B): Analysis of overall prescription writing errors (n = 979) 
Patient Details Mentioned % Not Mentioned % 
 O.P.D. number 284 29.00% 695 71.00% 
 Name 907 92.64% 72 7.36% 
 Age 456 46.57% 523 53.43% 
Sex 351 35.85% 628 64.15% 
Weight 233 23.79% 746 76.21% 
Address 117 11.95% 862 88.05% 
 Contact number 0 0.00% 979 100% 
 Date of prescription 925 94.48% 54 5.52% 
 
From the table above it is evident that O.P.D. number was mentioned in only 29.0% 
prescriptions, while 71.00% bore no O.P.D. number and therefore would be difficult to 
sequence or recall for future reference. Although 92.64% prescriptions bore the name of the 
patient, only 34.01% prescriptions had mentioned the full name, while partial name was 
written in 58.6%. Age was mentioned in almost half the prescriptions i.e. 46.57% but sex 
and weight were mentioned in only 35.85% and 23.79% prescriptions respectively. Patient’s 
contact address details were present in just 12% of the prescriptions while none bore the 
contact number of the patient. A vast majority (94.48%) had the date of prescribing 
mentioned.  
Table-4(C-i): Analysis of overall prescribed items (n = 3069) 
Prescriptions (n = 979) 
Drug items (n = 3069) 
Manual Computerized 
Urban 1854 595 
Rural 420 200 
 
The table above depicts total number of items prescribed by clinicians in the Anand District 
using manual and computerised modes of prescribing. In our study, a total of 3069 items 
were prescribed. 
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Table-4(C-ii): Analysis of overall prescription writing errors in drug items (n = 3069) 
 Mentioned % Not Mentioned % 
Generic name 62 2.02% 3007 97.97% 
Brand name 3007 97.97% 62 2.02% 
Route 2140 74.59% 729 25.41% 
Dosage form 2490 81.13% 579 18.86% 
Dose 1567 51.05% 1502 48.94% 
Unit (mg, g, ml etc) 708 23.70% 2279 76.30% 
Frequency of administration 2456 80.02% 613 19.97% 
Duration of treatment 967 31.50 % 2102 68.49% 
Quantity to be dispensed 2638 85.95% 431 14.04% 
Signa 1959 63.83 % 1110 36.17% 
 
Total 3069 items were prescribed in the 979 prescriptions included in the study. 
Generic names were mentioned in just 2.02% of the prescriptions as compared to 97.97% 
brand names. 
Route of drug administration was mentioned in 74.59% of overall prescriptions. 
The dosage form was mentioned in 81.13% but unfortunately the dose in only 51.05 %. 
Unit was mentioned in only 23.70% of the collected prescriptions. The frequency was 
mentioned in 80.02% of the prescriptions, the quantity in 85.95 %, duration of medication 
in only 31.50 % while signa was mentioned in 63.83 % of the prescriptions respectively. 
Table-4(D): Others - Analysis of overall prescription writing errors (n = 979) 
 Mentioned % Not mentioned % 
Allergy 0 0.005 979 100% 
Status: RS/ CVS/Liver /Kidney 0 0.00% 979 100% 
Refill 0 0.00% 979 100% 
Follow Up 186 19.00% 793 81.00% 
Dispense as written 0 0.00% 979 100% 
Specific drug communication 6 0.61% 973 99.30% 
History of intake of other medicine 0 0.00% 979 100% 
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In the given table allergy was not mentioned in overall prescriptions. Status of respiratory/ 
cardiac/liver/kidney functioning as well as history of intake of other medicines was not 
mentioned in any of the prescriptions. Refill was not mentioned in any of the prescriptions, 
follow up was mentioned in 19.0%, while ‘dispense as written’ was not mentioned in any 
prescriptions. Specific drug communication or drug information was mentioned in only 6 
out of 979 prescriptions while history of intake of other medicines was not mentioned at all. 
In the given table 72.97% prescriptions were legible, while 27.02% were poorly legible. 
Table-5(A): Clinician details - Comparative analysis of Prescription writing errors 
between Urban manual n = 549 and Rural manual Prescriptions (n = 191) 
 
Clinician Details 
Error rate - manual prescription (No =740) 
Mentioned Not mentioned 
Overall 
(740) 
Urban 
(549) 
Rural 
(191) 
Overall 
(740) 
Urban 
(549) 
Rural 
(191) 
Name 
p value NA 
740 
(100%) 
549  
(100%) 
191  
(100%) 
0 
(0.00%) 
0 
(0.00%) 
0 
(0.00%) 
Qualification 
p value 0.000* 
716  
(97%) 
525 
(95.60%) 
191 
(100%) 
24 
(3%) 
24 
(4.4%) 
0 
(0%) 
Address 
p value 0.186 
735  
(99%) 
544  
(99.1%) 
191  
(100%) 
5 
(1%) 
5 
(0.9%) 
0 
(0%) 
Registration No. 
p value 0.337 
121 
(16%) 
94  
(17.1%) 
27 
(14.10%)
619  
(84%) 
455 
(82.9%) 
164 
(85.9%) 
Esoteric symbol 
p value 0.000* 
544 
(74%) 
423  
(77.00%) 
121  
(63%) 
196  
(27%) 
126 
(23.0%) 
70 
(37%) 
Signature 
P value 0.000* 
453 
(61.22) 
361 
(65.76) 
92 
(48.17) 
287 
(38.78%) 
188 
(34.24%) 
99 
(51.83%)
 
*  Highly significant (p value less than 0.000). 
 
There was mention of doctor’s name in all the prescriptions i.e. 100%. Doctor’s 
qualification was mentioned in 95.60 % of urban manual prescription while in all 100% of 
the rural prescription. Doctor’s contact address was mentioned in 99.1% of the urban 
manual prescriptions while in all the rural prescriptions i.e. 100% it was mentioned. 
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Doctor’s registration number was mentioned in only 17.1% of the prescriptions in the urban 
manual prescriptions, while it was mentioned only in 14.1% of rural prescriptions.   
The esoteric symbol was mentioned in 77.00% of the urban manual prescriptions and in 
only 63.00% of rural prescriptions.  
While 87.8% urban practitioners mentioned their contact numbers on the prescriptions only 
62.8% rural prescriptions mentioned the contact numbers of the clinicians. Doctors 
signature was mentioned in 65.76% of the urban manual practioners. 
Table-5(B): Comparative analysis of prescription writing errors between urban 
manual (n =549) and rural manual prescriptions (n= 191) 
 
Variables 
 
Manual Prescriptions (No =740) 
Mentioned Not mentioned 
Overall 
(740) 
Urban 
(549) 
Rural 
(191) 
Overall 
(740) 
Urban 
(549) 
Rural 
(191) 
OPD Number 
p value 0.829 
45 
(6%) 
34 
(6.2%) 
11 
(5.8%) 
695 
(94%) 
515 
(93.8%) 
180 
(94.2%) 
Name 
p value 0.000* 
668 
(90%) 
477 
(86.9%) 
191 
(100%) 
72 
(10.0%) 
72 
(13.1%) 
0 
(0%) 
Age 
p value 0.000* 
217 
(29%) 
140 
(25.5%) 
77 
(40.3%) 
523 
(71%) 
409 
(74.5%) 
114 
(59.7%) 
Sex 
p value 0.005** 
112 
(15%) 
95 
(17.3%) 
17 
(8.9%) 
628 
(85%) 
454 
(82.7%) 
174 
(91.1%) 
Weight 
p value 0.000* 
62 
(8%) 
62 
(11.3%) 
0 
(0%) 
678 
(92%) 
487 
(88.7%) 
191 
(100%) 
Address 
p value 0.000* 
117 
(16%) 
51 
(9.3%) 
66 
(34.6%) 
623 
(84%) 
498 
(90.7%) 
125 
(65.4%) 
Contact no.  
p value NA 
0 
(0.00%) 
0 
(0.00%) 
0 
(0.00%) 
740 
(100%) 
549 
(100%) 
191 
(100%) 
Date of prescription 
p value 0.000* 
686 
(93%) 
495 
(90.2%) 
191 
(100%) 
54 
(7%) 
54 
(9.8%) 
0 
(0.00%) 
 
*  Highly significant (p value less than 0.000). 
** Significant (p value less than 0.005). 
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Here patient’s o.p.d number was mentioned in only 6.2% of the urban prescriptions, and in 
only 5.8% in the rural manual prescriptions. 
Patient name was mentioned in 86.9% of urban prescriptions, while in all 100% rural 
prescriptions it was mentioned. Age was mentioned in 25.5% of urban manual prescriptions 
and in 40.3% of rural manual prescriptions.  
Patient sex was mentioned in 17.3% and 8.9% prescriptions only in urban manual and rural 
manual prescriptions respectively. Weight was mentioned in 11.3% of the prescriptions in 
urban setting while none of the rural prescriptions mentioned the patient weight. 
Patient address was mentioned in only 9.3% of the urban prescriptions while in 34.5% 
prescriptions in the rural setting. The contact number of the patient was not mentioned in 
any of the prescriptions. 
Date of prescription order writing was mentioned in 90.2%, of urban manual prescriptions 
while it was mentioned in all the prescriptions collected from the rural practitioners. 
Table-5 C(i): Analysis of prescription writing errors of urban manual prescriptions - 
drug details (urban) - total drug items (n = 1854) 
 
 Urban (Items prescribed = 1854) 
 Mentioned Not mentioned 
Generic  55 2.97% 1799 97.03% 
Brand 1799 97.03% 55 2.97% 
Dosage form 1434 77.35% 420 22.65% 
Route 1449 78.16% 405 21.84% 
Dose 876 47.25% 978 52.75% 
Unit 258 13.92% 1596 86.08% 
Frequency of administration 1438 77.56% 416 22.44% 
Duration of treatment  1352 72.92% 502 27.08% 
Quantity to be dispensed 1335 72.00% 519 28.00% 
Signa 1156 62.35% 698 37.65% 
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In the given table very few prescribed items in the urban prescriptions had the mention of 
the generic names i.e. only 2.97% while brand names were preferred overwhelmingly i.e. 
(97.03%). Dosage form and route were mentioned in only about 77.35% and 78.16 % items 
respectively. Less than half the items had dose mentioned (47.25%). Units were mentioned 
in less than 14.00% items. While the frequency of taking the prescribed drug item was 
mentioned in 77.56%, both the quantity and duration of treatment were written in around 
72.00% of the prescriptions. Signa was mentioned in 62.35% of the prescribed items in the 
urban prescriptions.  
Table-5 C(ii): Analysis of prescription writing errors of rural manual prescriptions - 
drug details (rural) - total drug items (n = 420) 
 
 Rural (Items prescribed = 420) 
 Mentioned Not mentioned 
Generic 1 0.24% 419 99.76% 
Brand 419 99.76% 1 0.24% 
Dosage form 293 69.76% 127 30.24% 
Route 256 60.95% 164 39.05% 
Dose mention 118 28.09% 302 71.90% 
Unit 12 2.86% 408 97.14% 
Frequency of administration 309 73.57% 111 26.43% 
Duration of treatment 325 77.38% 95 22.62% 
Quantity to be dispensed 300 71.42% 120 28.57% 
Signa 208 49.52% 212 50.48% 
 
As in the previous table for urban prescriptions, there was a very minimal use of generic 
names for drug items in rural category also i.e. only in 0.24% of the prescribed items. Brand 
names were overwhelmingly used in 99.76% in rural manual prescriptions. Dosage form 
was mentioned in 69.76% of prescribed items, route in 60.95%, while dose mentioned in 
only 28.09% of the prescriptions. Unit was mentioned in 2.86% of prescribed items only. 
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Frequency and duration of treatment were mentioned in 73.57% and 77.38% of the 
prescribed items respectively. Signa was mentioned in only 49.52% of prescribed items. 
Table-5C(iii): Comparative analysis of urban and rural drug items 
(n=1854 + 420 drug items)  
  
 
Urban items prescribed = 1854 Rural items prescribed = 420 
Mentioned Not mentioned Mentioned Not mentioned 
Generic 
p value 0.000* 55 2.97% 1799 97.03% 1 0.24% 419 99.76% 
Brand 
p value 0.000* 1799 97.03% 55 2.97% 419 99.76% 1 0.24% 
Dosage form  
p value 0.000* 1434 77.35% 420 22.65% 293 69.76% 127 30.24% 
Route 
p value 0.000* 1449 78.16% 405 21.84% 256 60.95% 164 39.05% 
Dose 
p value 0.000* 876 47.25% 978 52.75% 118 28.09% 302 71.90% 
Unit  
p value 0.000* 258 13.92% 1596 86.08% 12 2.86% 408 97.14% 
Frequency of 
administration 
p value 0.000* 
1438 77.56% 416 22.44% 309 73.57% 111 26.43% 
Duration of 
treatment  
p value 0.000* 
1352 72.92% 502 27.08% 325 77.38% 95 22.62% 
Quantity to be 
dispensed  
p value 0.000* 
1335 72.00% 519 28.00% 300 71.42% 120 28.57% 
Signa  
p value 0.000* 1156 62.35% 698 37.65% 208 49.52% 212 50.48% 
*  Highly significant (p value less than 0.000). 
In the table above the total number of drug items prescribed were 2274 i.e. 1854 in the 
urban manual and 420 in the rural manual prescriptions. Only 2.97 % prescriptions in urban 
manual prescriptions mentioned the drugs by generic names while only 0.24% prescriptions 
in the rural setting mentioned the drug items by the generic names. 
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Dosage form of the prescribed items was mentioned in 77.35% of the urban manual 
prescriptions almost similar to 69.76% in rural manual prescriptions. 
Dose of the prescribed drug items was mentioned in 47.25% of the urban prescriptions 
while in rural setting it was mentioned in 28.09% prescriptions only. 
Unit e.g. mg, gm, ml, was mentioned only for 13.92% prescribed items in urban manual 
prescribed items whereas in still lesser prescriptions of prescribed items in rural manual 
prescriptions (2.86%). 
However, frequency was mentioned in 77.56% of the prescribed items in urban 
prescriptions while it was mentioned in 73.57% of the prescribed items in rural manual 
prescriptions. 
Duration of treatment was mentioned in 72.92% of urban manual prescribed items while it 
was comparable at 77.38% of the prescribed items in rural prescriptions. 
An important component of prescription writing i.e. signa was mentioned in 62.35% of the 
prescribed items for urban manual prescriptions while in just about half of the prescriptions 
in the rural setting. 
Quantity of the prescribed items to be bought by the patients was mentioned in 72.00% of 
the drugs in the urban manual prescriptions, while in 71.42% items in the rural manual 
prescriptions.  
Table-5 D(i): Comparative prescription writing errors between urban manual n= 549 
and rural manual prescriptions n=191 - others - allergy/sensitivity (Y/N) 
 
Allergy/ 
Sensitivity 
Overall Urban Rural 
Count % Count % Count % 
Mentioned 0 0.00% 0 0.00% 0 0.00% 
Not mentioned 740 100.00% 549 100.00% 191 100.00%
Total 740  549  191  
 
 154
There was no mention of allergy or sensitivity status in either urban or rural prescriptions 
i.e. it was 0% in both the categories.  
Table-5 D(ii): Specific drug communication 
 
Overall Urban Rural 
Count % Count % Count % 
Mentioned 0 0% 0 0% 0 0% 
Not mentioned 740 100% 549 100% 191 100% 
Total 740  549  191  
 
There was no mention of specific communication of drugs or any drug information in either 
urban or rural prescriptions i.e. it was 0% in both the categories. 
Table-5 D(iii): Drug : Status: CVS /RS/L/K 
   
 
Overall Urban Rural 
Count % Count % Count % 
 Mentioned 0 0% 0 0% 0 0% 
Not mentioned 740 100% 549 100% 191 100% 
Total 740  549  191  
 
There was no mention of respiratory /cardiac/liver/ kidney condition of patient in either 
urban or rural prescriptions i.e. it was 0% in both the categories. 
Table-5 D(iv): Dispense as written 
   
 
Overall Urban Rural 
Count % Count % Count % 
 Mentioned 0 0% 0 0% 0 0% 
Not mentioned 740 100% 549 100% 191 100%
Total 740  549  191  
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There was no mention of dispense as written in either urban or rural prescriptions i.e. it was 
0% in both the categories. 
Table- 5 D(v): Follow-up 
   
 
Overall Urban Rural 
Count % Count % Count % 
 Mentioned 42 5.67% 42 7.65% 0 0% 
Not mentioned 698 94.32% 507 92.34% 191 100% 
Total 740  549  191  
 
There was mention of Follow up particulars in 7.65% urban and no mention in rural 
prescriptions respectively. 
Table-5 D(vi): History of intake of other medicine 
   
 
Overall Urban Rural 
Count % Count % Count % 
 Mentioned 0 0% 0 0% 0 0% 
Not mentioned 740 100% 549 100% 191 100% 
Total 740  549  191  
 
There was no mention of any history of intake of other medicines in either urban or rural 
prescriptions i.e. it was 0% in both the categories. 
Table-5D(vii): Legible/poorly legible   
  
 
Overall Urban Rural 
Count % Count % Count % 
Legible 540 72.97% 415 75.59% 125 65.45% 
Poorly legible 200 27.02% 134 24.41% 66 34.55% 
Total 740  549  191  
 
P Value : 0.000* 
*  Highly significant (p value less than 0.000). 
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In about 72.97% of the prescriptions there was good legibility while poor legibility in 
27.02% of the overall prescriptions. In urban category legibility was in 75.59%, while in 
rural it was 65.45% and there was poor legibility in 24.14% of prescriptions in the urban set 
up while 34.55% of the rural prescriptions in rural were having poor legibility. 
Table-5 D(viii): Refill mentioned (Y/N) 
  
 
Overall Urban Rural 
Count % Count % Count % 
 Mentioned 0 0% 0 0% 0 0.00% 
Not mentioned 740 100.0% 549 100.0% 191 100.00 %
Total 740  549  191  
 
As seen in the table overall refill was not mentioned in any prescriptions. 
Table-6 A: Analysis of prescription writing errors in urban computer generated 
prescriptions  n=200 
 
Clinician details Mentioned % Not mentioned % 
 Name 200 100% 0 0.00% 
 Qualification 200 100% 0 0.00% 
Contact no. 164 82% 36 18% 
 Address 200 100% 0 0.00% 
 Reg. No. 200 100% 0 0.00% 
Esoteric symbol 200 100% 0 0.00% 
Signature 164 82.00% 36 18% 
 
The given table depicts that doctors details like full name, qualification, address for 
correspondence, registration number, esoteric symbol, date of issue of prescription were 
mentioned in all the computer generated prescriptions i.e. 100%. Doctors contact number as 
well as doctors signature was there in 82.00% of the prescriptions. 
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Table-6 B: Analysis of prescription writing errors in urban computer generated 
prescriptions  n = 200 
 
Patient details Mentioned Not mentioned 
 O.P.D. No. 200 100% 0 0.00% 
 Name 200 100% 0 0.00% 
 Age 200 100% 0 0.00% 
 Sex 200 100% 0 0.00% 
 Weight 171 85.50% 29 14.50% 
 Address 0 0.00% 200 100.00% 
 Contact no. 0 0.00% 200 100.00% 
Prescription date 200 100% 0 0.00% 
 
The patient particulars, like the O.P.D. numbers, patient’s full name, age, sex were 
mentioned in all the computer generated prescriptions, i.e. 100%. While weight was 
mentioned in 85.50% of the computer-generated prescriptions, patients address, patient 
contact number was not mentioned. Date of issue of prescription was mentioned in all the 
prescriptions. 
Table-6 C: Analysis of prescription writing errors of prescribed items of computer 
generated prescriptions n = 200 (595 prescribed items) 
 
 Drug details 
Urban items prescribed = 595 
Mentioned Not mentioned 
Generic 3 0.50% 592 99.49% 
Brand 592 99.49% 3 0.50% 
Dosage form 435 73.10% 160 26.89% 
Route 435 73.10% 160 26.89% 
Dose 519 87.22% 76 12.77% 
Unit 434 72.94% 161 27.05% 
Frequency of administration 567 95.29% 28 4.70% 
Duration of treatment 567 95.29% 28 4.70% 
Quantity to be dispensed 569 95.63% 26 4.36% 
Signa 567 95.29% 28 4.70% 
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There were a total of 595 prescribed drug items in the computer generated prescriptions 
category. Almost all drug items were prescribed by brand names (99.49%). Dosage form 
was mentioned for 73.10% of the prescribed items, route was mentioned in 73.10% of the 
prescribed item. In 87.22% prescribed items dose was mentioned. Units were mentioned in 
72.94% of the prescribed items. There was mention of frequency in 95.29% of the 
prescribed items, while in 95.29% duration of treatment was mentioned. In 95.63% quantity 
of prescribed items was mentioned, signa was mentioned in 95.29% for the prescribed 
items. The computer generated prescriptions were 95% free of errors in the mention of 
quantity, frequency, duration of treatment and signa. 
Table-6D: Analysis of prescription writing errors in computerised prescriptions (n = 200) – 
Others 
 
Drug : Allergy/sensitivity 
Mentioned 0 0.00% 
Not mentioned 200 100% 
Specific communication of drugs 
Mentioned 6 3.00% 
Not mentioned 194 97.00% 
Drug : Status: RS/CVS/L/K 
Mentioned 0 0.00% 
Not mentioned 200 100% 
Refill 
Mentioned 0 0.00% 
Not mentioned 200 100% 
Follow up 
Mentioned 186 93.00% 
Not mentioned 14 7.00% 
Dispense as written 
Mentioned 33 16.50% 
Not mentioned 167 83.50% 
History of intake of other medicine  
Mentioned 0 0.00% 
Not mentioned 200 100% 
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All the prescriptions were in the typed format so there was no question of illegibility or poor 
legibility. Therefore all 200 prescription were legible. Date of issue of prescription was 
mentioned in all the prescriptions (100%). However, there was no mention of respiratory 
/cardiac/ liver / kidney status of the patient or allergic status of the patient, history of intake 
of other medicines or refill in any of the computerized prescriptions. There was mention of 
the specific communication of the drugs or drug information in only 3% of the 
prescriptions, follow up was mentioned in 93.0% of the prescriptions collected, while 
dispense as written was a mention in 16.50% of the prescriptions.  
Table-7A: Comparative analysis of difference between prescription writing errors in 
urban manual prescriptions (n = 549) and structured format prescriptions 
(n = 206)  
 
Doctor details 
Prescription Type 
Manual Format 
Count N % Count N % 
Name 
 Mentioned 549 100.00% 206 100.00% 
Not mentioned 0 0% 0 0%  
Qualification 
p value 0.002* 
Mentioned 525 95.63% 206 100.00% 
Not mentioned 24 4.37% 0 0.00% 
Address  
p value 0.169 
Mentioned 544 99.09% 206 100.00% 
Not mentioned 5 0.91% 0 0% 
Reg. No 
p value 0.000* 
Mentioned 94 17.12% 120 58.25% 
Not mentioned 455 82.88% 86 48.75% 
Esoteric symbol 
p value 0.000* 
Mentioned 423 77.05% 206 100% 
Not mentioned 126 22.95% 0 0.00% 
 Signature 
p value 0.000* 
Mentioned 361 65.76% 206 100.00% 
Not mentioned 188 34.24% 0 0% 
 
*  Highly significant (p value less than 0.000) 
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In the given table name of the doctor was mentioned in all the urban manual prescriptions as 
well as in the prescriptions of the structured format. 
Qualification of the doctors was mentioned in 95.63% of the urban manual prescriptions 
while it was mentioned in 100% prescriptions of structured format. 
Address of the doctor was mentioned in 99.09% of the urban manual prescriptions while it 
was mentioned in all 100% structured format. 
There was a mention of the registration number in only 17.12 % prescriptions in the urban 
manual category while 58.25% doctors mentioned their registration number in the 
structured format. The esoteric symbol was printed in 77.05% of prescriptions in the urban 
manual prescriptions but it was mentioned in all structured format prescriptions. 
prescriber’s signature was there in 65.76% of the urban manual prescriptions while it was 
there in 100% of the structured format. 
Table-7B: Comparative analysis of prescription writing errors in urban manual 
prescriptions (n= 549) and structured format prescriptions (n= 206) 
Patient details 
Prescription type 
Manual Format 
Count % Count % 
OPD No.  
p value 0.00* 
Mentioned 34 6.19% 34 16.50% 
Not mentioned 515 93.81% 172 83.50% 
Name  
p value 0.00* 
Mentioned 477 86.89% 206 100.00% 
Not mentioned 72 13.11% 0 0% 
Age  
p value 0.00* 
Mentioned 140 25.50% 154 74.76% 
Not mentioned 409 74.50% 52 25.24% 
Sex  
p value 0.00* 
Mentioned 95 17.30% 153 74.27% 
Not mentioned 454 82.70% 53 25.73% 
Weight  
p value 0.00* 
 Mentioned 62 11.29% 62 30.10% 
Not mentioned 487 88.71% 144 69.90% 
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Patient details 
Prescription type 
Manual Format 
Count % Count % 
Address  
p value 0.00* 
Mentioned 51 9.29% 167 81.07% 
Not mentioned 498 90.71% 39 18.937% 
Contact No. 
p value 0.00* 
Mentioned 0 0% 25 12.14% 
Not mentioned 549 100% 181 87.86% 
Date of prescription  
p value 0.00* 
Mentioned 495 90.16% 204 99.03% 
Not mentioned 54 9.84% 2 0.97% 
*  Highly significant (p value less than 0.00). 
Here in the table above o.p.d number was mentioned in 6.19% of prescriptions in the urban 
manual prescriptions while after introduction of structured format, it was mentioned in 
16.50%. 
Patient name was mentioned in 86.89% of urban manual prescriptions while it was 
mentioned in all 100% of the structured formats. 
Age was mentioned in only 25.50% of the urban manual prescriptions whereas it showed 
improvement to 74.76% of the prescriptions in structured format. 
 Gender details were mentioned in only 17.30% of the prescriptions in the urban manual 
category while they were mentioned in 74.27% of the prescriptions in the structured format. 
Weight of the patients was mentioned in only 11.29% of the urban handwritten 
prescriptions while it was mentioned in 30.10% of the prescriptions in structured format. 
Address was mentioned in only 9.29% of the manual prescriptions while in structured 
format there was a marked improvement to 81.07%. Contact number as such was not 
mentioned in urban manual prescriptions but was mentioned in 12.14% of the prescriptions 
in structured format. 
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Date of issue of the prescriptions on the urban manual prescriptions was mentioned in 
90.16% while it was mentioned in 99.03% of the structured format prescriptions. 
Table-7C: Comparative analysis of between prescription writing errors in urban 
manual prescriptions (n = 1854 prescribed items) and structured format 
prescriptions (n = 672 prescribed items) 
 
 Drug details 
No. = 1854 No. = 672 
Mentioned /Not mentioned Mentioned /Not mentioned 
Generic  
55 2.96% 1799 97.03% 7 1.04% 665 98.95% 
P value 0.000 
Brand 
1799 97.03% 55 2.96% 665 98.95% 7 1.04% 
P value 0.000 
Dosage form 
1434 77.34% 420 20.65% 545 81.10% 127 18.89% 
P value 0.000 
Route  
1449 78.15/% 405 21.84% 650 96.72% 22 3.27% 
P value 0.000 
Dose mention  
876 47.24% 978 52.75% 329 48.95% 343 51.04% 
P value 0.000  
Unit 
258 13.92% 1596 86.08% 117 17.41% 555 82.58% 
P value0.000  
Frequency of 
administration 1438 77.56% 416 22.24% 620 92.26% 52 7.73% 
P value 0.000 
Duration of 
treatment  1352 72.92% 502 27.08% 605 90.02% 67 9.97% 
P value 0.000 
Quantity to 
be dispensed 1335 72.00% 519 28.00% 552 82.14% 120 17.85% 
P value 0.000 
Signa  
1156 62.35% 698 37.65% 672 100% 0 0% 
P value 0.0000  
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The table above depicts that compared to the urban manual prescriptions, structured format 
prescriptions showed a marked improvement in the various parameters.  
Dosage form from 77.34% to 81.10%, route of the prescribed items from 78.15% to 
96.72%, dose from 47.24% to 48.95% of the prescribed items, frequency from 77.56% to 
92.26% in structured format prescriptions, duration of treatment from 72.92% to 90.02%, 
quantity of the prescribed items to be bought by the patients was mentioned in 72.00% of 
the drugs in the urban manual prescriptions, while in 82.14% prescriptions in the structured 
format prescriptions.  
Signa was mentioned in only 62.35% of the prescribed items for urban manual prescriptions 
while table shows improvement to 100% of the prescribed items in the structured format. 
However in certain areas, structured format prescriptions faired poorly e.g. in case of unit 
(mg, gm, ml) from 13.92% in manual prescribed items to 17.41% only in the structured 
format prescriptions. In 2.96% prescriptions in urban manual prescriptions the drugs were 
mentioned by generic names while in only 1.04% prescriptions in the structured format 
mentioned the drug items by the generic names. 
Table-7D: Comparative analysis between prescription writing errors in urban manual 
prescriptions (n = 549) and structured format prescriptions (n= 206) 
 
 
Others 
 
Prescription type 
Manual Format 
Count % Count % 
Allergy/Sensitivity 
p value 0.00* 
Mentioned 0 0% 106 51.46% 
Not mentioned 549 100% 100 48.54% 
Legibility Legible 415 75.59% 206 100% 
p value 0.00* Poorly legible 134 24.5% 0 0% 
Specific drug 
Communication 
p value 0.00* 
Mentioned 0 0.00% 17 8.25% 
Not mentioned 549 100% 189 91.75% 
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Others 
 
Prescription type 
Manual Format 
Count % Count % 
Status: 
RS/CVS/L/K 
p value 0.00* 
Mentioned 0 0.00% 106 51.46% 
Not mentioned 549 100.00% 100 48.54% 
Refill 
p value 0.00* 
Mentioned 0 0.00% 15 7.28% 
Not mentioned 549 100.0% 191 92.72% 
Follow up 
p value 0.00* 
Mentioned 42 7.65% 0 0.00% 
Not mentioned 507 92.34% 206 100% 
Dispense as written 
p value 0.00* 
Mentioned 0 0.00% 15 7.28% 
Not mentioned 549 100% 191 92.72% 
History of  other 
medicine 
p value 0.00* 
Mentioned 0 0.00% 51 24.75% 
Not mentioned 549 100.00% 155 75.24% 
 
*  Highly significant (p value less than 0.00). 
As depicted in the table with the introduction of the structured format in the urban 
practitioners there was improvement in mentioning the following parameters in the 
structured format category. Mention of the allergy or sensitivity status of patient from 0% to 
51.46 %, mention of specific drug communication from 0% to 8.25%, mention of status of 
Respiratory/cardiac/liver/kidney from 0% to 51.46%, dispense as written from 0% to 
7.28%, history of intake of other medicines from 0% to 24.39% of the prescriptions under 
structure format category.  However, there was poor improvement in mention of refill as 
well as follow up being mentioned in only 7.28% and 0.00% respectively. 
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Table-8A: Combined table of prescription writing errors in urban manual 
(n = 549), urban structured format (n = 206), urban computer generated 
prescriptions (n = 200) 
 
Doctors details 
Prescription Type 
Manual Format Computerized 
Count % Count % Count % 
Name 
Mentioned 549 100.00% 206 100.00% 200 100% 
Not mentioned 0 0% 0 0% 0 0% 
Qualifi- 
cation 
 
Mentioned 525 95.63% 206 100.00% 200 100% 
Not mentioned 24 4.37% 0 0.00% 0 0% 
Address  
 
Mentioned 544 99.09% 206 100.00% 200 100% 
Not mentioned 5 0.91% 0 0% 0 0% 
Reg. No 
 
Mentioned 94 17.12% 120 58.25% 200 100% 
Not mentioned 455 82.88% 86 48.75% 0 0% 
Esoteric 
symbol 
 
Mentioned 423 77.05% 206 100% 200 100% 
Not mentioned 126 22.95% 0 0.00% 0 0% 
 Signature 
Mentioned 361 65.76% 206 100% 164 82% 
Not mentioned 188 34.24% 0 0.00% 36 18% 
 
In the given table in each category i.e. urban manual, urban structured format and urban 
computer generated prescriptions, doctor’s details like name and qualification were 
mentioned 100% in the urban manual, structured format and computer generated 
prescriptions. Address of the doctor being mentioned 100% in both structured format and 
computerized prescriptions while in urban manual it was mentioned in 99.09%. Registration 
number was mentioned in all computerized prescriptions whereas it was mentioned in just 
over half of the structured format prescriptions but barely in 17.12% of the urban manual 
category. Esoteric symbol was mentioned in all the structured format and computerized 
prescriptions while in three quarters of the prescriptions in the urban manual category. 
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Doctor’s signature was there in 100% of the structured format prescriptions while in the 
computerized category had it in 82.00% of the prescriptions but the urban manual 
prescriptions fared badly even here at 65.76%.  
Table-8B: Combined table of prescription writing errors in urban manual (n=549),urban 
structured format (n=206), urban computer generated prescriptions (n=200) 
 
Patient details 
Prescription Type 
Computerized Manual Format 
Count % Count % 
OPD No. 
Mentioned 34 6.19% 34 16.50% 200 100.00% 
Not mentioned 515 93.81% 172 83.50% 0 0.00% 
Name  
Mentioned 477 86.89% 206 100.00% 200 100.00% 
Not mentioned 72 13.11% 0 0% 0 0.00% 
Age 
Mentioned 140 25.50% 154 74.76% 200 100.00% 
Not mentioned 409 74.50% 52 25.24% 0 0.00% 
Sex 
Mentioned 95 17.30% 153 74.27% 200 100.00% 
Not mentioned 454 82.70% 53 25.73% 0 0.00% 
Weight  
Mentioned 62 11.29% 62 30.10% 171 85.50% 
Not mentioned 487 88.71% 144 69.90% 29 14.50% 
Address 
Mentioned 51 9.29% 167 81.07% 0 0.00% 
Not mentioned 498 90.71% 39 18.94% 200 100.00% 
Contact No 
Mentioned 0 0% 25 12.14% 0 0.00% 
Not mentioned 549 100% 181 87.86% 200 100.00% 
Prescription 
date 
Mentioned 495 90.16% 204 99.03% 200 100.00% 
Not mentioned 54 9.84% 2 0.97% 0 0.00% 
 
The above table depicts that O.P.D. number mentioned in 6.19% of prescriptions in the 
urban prescriptions and in computerized category it was 100% while after introduction of 
structured format, there was improvement in 16.50%. 
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Patients name was mentioned in 86.89% of urban manual prescriptions while it was 
mentioned in 100% of the structured format in computerized prescriptions respectively. 
Age of the patient was mentioned in only 25.50% of the urban manual prescriptions 
whereas it shows improvement in mention of age in 74.76% of the prescriptions in 
structured format. In computerize prescriptions it was mention in all 100% of cases. 
Gender was mentioned in only 17.30% of the prescriptions in the urban manual category 
while it was mentioned in 74.27% of the prescriptions in the structured format. In 
computerize prescriptions it was mentioned in 100% prescriptions.  
Weight of the patients was mentioned in only 11.29% of the urban manual prescriptions 
while it was mentioned in 30.10% of the prescriptions in structured format and in the 
computerize prescriptions it was mentioned in 85.50% prescriptions. 
Address of the patient was mentioned in only 9.29% of the manual prescriptions while in 
structured format there was a positive response of mention of present address in about 
81.07% of the structured format prescription cases. In computerize prescriptions there is no 
mention of the address of the patients. Contact number was mentioned in only 12.14% of 
the structured format while in both the urban manual category and in the computerize 
category it was not mentioned.  
Particulars on mention of date of issue of the prescription on the urban manual prescriptions 
by the doctors were mentioned in 90.16% while it was mentioned in 99.03% of the 
structured format prescriptions and 100% in computerized prescriptions. 
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Table-8C: Comparison of prescription writing errors in urban manual drug items (n = 
1854), urban structured format drug items (n = 672), urban computerised 
prescriptions drug items (n = 595) 
Drug items  
 
N  = 1854  
(Urban manual) 
N  = 672  
(Urban structured format) 
N  = 595  
(Urban computerised) 
Mentioned Not mentioned Mentioned 
Not 
mentioned Mentioned 
Not 
mentioned 
Generic  
55 2.96% 1799 97.03% 7 1.04% 0 98.95% 3 0.50% 592 99.49%
p Value 0.000* 
Brand  
1799 97.03% 55 2.96% 665 98.95% 7 1.04% 592 99.49% 3 0.50% 
p Value 0.000* 
Dosage form  
1434 77.34% 420 20.65% 545 81.10% 127 18.89% 435 73.10% 160 26.89%
p value0.000 * 
Route  
1449 78.15% 405 21.84% 650 96.72% 22 3.27% 435 73.10% 160 26.89%
p value 0.000* 
Dose mention  
876 47.24% 978 52.75% 329 48.95% 343 51.04% 519 87.22% 76 12.77%
p value0.000 * 
Unit 
258 13.92% 1596 86.08% 117 17.41% 555 82.58% 434 72.94% 161 27.05%
p value0.000*  
Frequency of 
administration 1438 77.56% 416 22.24% 620 92.26% 52 7.73% 567 95.29% 28 4.70% 
p value 0.000* 
Duration of 
treatment  1352 72.92% 502 27.08% 605 90.02% 67 9.97% 567 95.29% 28 4.70% 
p value 0.000* 
Quantity to be 
dispensed 1335 72.0% 519 28.00% 552 82.14% 120 17.85% 569 95.63% 26 4.36% 
p value 0.000* 
Signa  
1156 62.35% 698 37.65% 672 100% 0 0% 567 95.29% 28 4.70% 
p Value0.000 * 
 
*  Highly significant (p value less than 0.000) 
 
 
Here in the table generic names were hardly used in 2.96%, 1.04%, 0.50% prescriptions in 
the urban manual, urban structured format and urban computerized category respectively. 
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Dosage form of the drugs was mentioned in 77.34% in urban manual, in 81.10% in 
structured format, while in 73.10% in computerized prescriptions. So structured format 
intervention showed a significant improvement in writing the dosage form of the drugs. 
Similarly, route was mentioned in 78.15% in urban manual, in 96.72% in structured format, 
while 73.10% in computerized prescriptions. 
Dose was mentioned in 47.24% in urban manual, 48.95% in the structured format category, 
87.22% in the computerized category.  
Unit was mentioned in barely 13.92% in urban manual, 17.41% in structured format while 
in 72.94% in the computerized category.  
Frequency was mentioned in 77.56% in the urban manual category, 92.26% in the 
structured format while 95.29% in the computerized category. The introduction of the 
structured format has shown improvement in writing the frequency. 
Duration of treatment was mentioned in 72.92% in the urban manual category, 90.02% in 
the structure format while 95.29 % in the computerized category.  
Quantity was mentioned in 72.00% in the urban manual category, 82.14% in the structure 
format while 95.63% in the computerized category.  
There was a significant improvement in the signa in structured format i.e. 100% as 
compared to 62.35% in the urban manual category and in 95.29% in the computerized 
category. 
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Table-8D: Combined table of prescription writing errors in urban manual 
(n = 549), urban structured format (n = 206), urban computer generated 
prescriptions (n = 200)  
 
Others 
Prescription type 
Urban manual Structure format Computerized 
Count % Count % Count % 
Allergy/ 
sensitivity 
Mentioned 0 0.00% 106 51.46% 0 0.00% 
Not mentioned 549 100.00% 100 48.54% 200 100.00% 
Legibility 
Legible 415 75.59% 206 100.00% 200 100.00% 
Poor legible 134 24.41% 0 0.00% 0 0.00% 
Specific drug 
communi-
cation 
Mentioned 0 0.00% 17 8.25% 6 3.00% 
Not mentioned 549 100.00% 189 91.75% 194 97.00% 
RS/CVS/H/R 
Mentioned 0 0.00% 106 51.46% 0 0.00% 
Not mentioned 549 100.00% 100 48.54% 200 100.00% 
Refill 
Mentioned 0 0.00% 15 7.28% 0 0.00% 
Not mentioned 549 100% 191 92.72% 200 100.00% 
Follow up 
Mentioned 42 7.65% 0 0.00% 186 93.00% 
Not mentioned 507 92.35% 206 100.00% 14 7.00% 
Dispense as 
written  
Mentioned 0 0.00% 15 7.28% 33 16.50% 
Not mentioned 549 100.00% 191 92.72% 167 83.50% 
History of 
intake of other 
medicine 
Mentioned 0 0.00% 51 24.75% 0 0.00% 
Not mentioned 549 100.00% 155 75.24% 200 100.00% 
 
As depicted in the given table - Allergy or sensitivity was not mentioned in urban manual as 
well as computerized prescriptions while in 51.46% of the structured format it was 
mentioned. 
Except in 24.41% poor legible of the urban prescriptions others were legible 75.59%, all the 
prescriptions were in the typed format in the computerized category so there was no 
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question of illegibility or poor legibility, while in structured format also all prescriptions 
were 100% legible.  
Specific drug communication was mentioned in only 8.25% and 3.00% of the prescriptions 
in the structure format category and computer generated prescriptions respectively while it 
was not mentioned at all in urban manual prescriptions i.e. 0%. 
Status of respiratory/cardiac/hepatic/renal systems in the prescriptions was only mentioned 
in structured format intervention in 51.46% of the prescriptions while it was not mentioned 
in the urban manual and in the computer generated prescription category. 
Refill was not mentioned in urban manual as well as in computerized prescriptions, 
however, in only 7.28% of the structured format it was mentioned. 
Follow up was mention in computer generated prescriptions i.e. in 93.00% while in the 
urban manual it was mentioned in 7.65% only and not mentioned in structured format.  
Dispense as written was mentioned in 7.28% and 16.50% prescriptions in structure format 
and computerized prescriptions while not mentioned in urban manual 0%. 
History of intake of other medicines was mentioned in 24.75% 0f structured format as 
compared to urban manual and computerized wherein it was not at all mentioned. 
75.59% prescriptions were legible in the urban manual prescriptions while all prescriptions 
were legible in the structured format as well as computerised prescriptions.  
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Table-9A: Comparison of prescription writing error rates in urban manual (n = 549), 
urban structured format (n = 206) and rural manual (n = 191)  
 
Doctors details 
 
Prescription type 
Urban manual Format Rural manual 
Count % Count % Count % 
Name 
Mentioned 549 100% 206 100% 191 100% 
Not mentioned 0 0% 0 0% 0 0% 
Qualification 
Mentioned 525 95.63% 206 100% 191 100% 
Not mentioned 24 4.37% 0 0.00% 0 0% 
Address 
Mentioned 544 99.09% 206 100% 191 100% 
Not mentioned 5 0.91% 0 0% 0 0% 
Reg. No 
Mentioned 94 17.12% 120 58.25% 27 14.10% 
Not mentioned 455 82.88% 86 48.75% 164 85.90% 
Esoteric 
symbol 
Mentioned 423 77.05% 206 100% 121 63.00% 
Not mentioned 126 22.95% 0 0.00% 70 37.00% 
 Signature 
Mentioned 361 65.76% 206 100% 92 48.17% 
Not mentioned 188 34.24% 0 0.00% 99 51.83% 
 
As depicted in the table above, doctor’s details were mentioned in all 100% of the 
prescriptions in the urban manual, urban format prescriptions and rural manual 
prescriptions.  
Qualification of the doctors was mentioned in 95.63% of the urban manual prescriptions 
while it was mentioned in 100% prescriptions of structured format as well as in rural 
manual prescriptions. 
 Address of the doctor was mentioned in 99.09% of the urban manual prescriptions while it 
was mentioned in all 100% structured format and the rural manual prescriptions. 
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There was a mention of the registration number in only 17.12% prescriptions in the urban 
manual category while 58.25% doctors mentioned their Registration number in the 
structured format while it was mentioned in 14.10% of prescriptions in rural manual 
category.  
The esoteric symbol was present in 77.05% of prescriptions in the urban manual 
prescriptions and in 63% of the rural manual but was mentioned in 100% of the structured 
format prescriptions. Prescriber’s sign was present in less than half of the rural manual 
prescriptions and in 65.76% of the overall prescriptions but improved to 100% in the 
structured format prescriptions. 
Table-9B: Table of comparison of prescription writing error rates in urban manual 
(n=549), urban format (n=206) and rural manual (n=191) – patient’s details 
 
Patient details 
 
Prescription type 
Urban manual Format Rural manual 
Count % Count % Count % 
OPD No. 
Mentioned 34 6.19% 34 16.50% 11 5.80% 
Not 
mentioned 515 93.81% 172 83.50% 180 94.20% 
Name 
Mentioned 477 86.89% 206 100.00% 191 100.00% 
Not 
mentioned 72 13.11% 0 0% 0 0.00% 
Age 
Mentioned 140 25.50% 154 74.76% 77 40.30% 
Not 
mentioned 409 74.50% 52 25.24% 114 59.70% 
Sex 
Mentioned 95 17.30% 153 74.27% 17 8.90% 
Not 
mentioned 454 82.70% 53 25.73% 174 91.10% 
Weights 
Mentioned 62 11.29% 62 30.10% 0 0.00% 
Not 
mentioned 487 88.71% 144 69.90% 191 100.00% 
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Patient details 
 
Prescription type 
Urban manual Format Rural manual 
Count % Count % Count % 
Address 
Mentioned 51 9.29% 167 81.07% 66 34.60% 
Not 
mentioned 498 90.71% 39 18.94% 125 65.40% 
Contact no.  
Mentioned 0 0% 25 12.14% 0 0.00% 
Not 
mentioned 549 100% 181 87.86% 191 100% 
Date of 
prescription 
Mentioned 495 90.16% 204 99.03% 191 100% 
Not 
mentioned 54 9.84% 2 0.97% 0 0.00% 
 
Herein o.p.d. number was mentioned in 5.80% rural manual prescriptions, 6.19% of the 
urban manual prescriptions while after introduction of structured format, it was mentioned 
in 16.50%. 
Patient’s name was mentioned in 86.89% of urban manual prescriptions while it was 
mentioned in all of the structured format and rural manual prescriptions. 
Age was mentioned in only 25.50% of the urban manual prescriptions whereas it fared 
better at 40.30% in the rural manual prescriptions. It showed improvement to 74.76% of the 
prescriptions in structured format.  
 Gender details were mentioned in only 8.90% prescriptions in rural manual category, 
17.30% of the prescriptions in the urban manual category but in 74.27% of the prescriptions 
in the structured format which clearly was a huge improvement. 
 While weight of the patients was mentioned in none of the rural manual prescriptions and 
only 11.29% of the urban handwritten prescriptions, it was mentioned in 30.10% of the 
prescriptions in structured format.  
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Address was mentioned in only 9.29% of the urban manual prescriptions while in rural 
manual prescriptions it was a mention in 34.60% but 81.07% of the structured format 
prescriptions mentioned it.  
The mention of date of prescription threw a pleasant surprise in that while it was mentioned 
in 90.16% urban manual prescriptions and in 99.03% of the structured format prescriptions, 
in the rural manual category it was mentioned in all prescriptions. 
Contact no. of patients was mentioned in neither urban manual prescriptions nor the rural 
manual prescriptions and just in 12.14% structured formats. 
Date of issue of prescription was mentioned in 90.16% of the prescriptions in the urban 
manual prescriptions, in 99.03% prescriptions in rural category while in 100% prescriptions 
in structured format. 
Table-9C: Comparison of prescription writing errors in urban manual drug items (n = 
1854), urban structured format drug items (n=672), rural manual (n= 420) 
 
Drug 
items  
No. = 1854  
(Urban manual) 
No. = 672  
(Urban structure format) 
No. =420  
(Rural manual) 
Mentioned Not  mentioned Mentioned 
Not 
mentioned Mentioned 
Not 
mentioned 
Generic 
55 2.96% 1799 97.03% 7 1.04% 0 98.95% 1 0.24% 419 (99.76%) p Value 
0.000* 
Brand 
1799 97.03% 55 2.96% 665 98.95% 7 1.04% 419 99.76% 1 (0.24%) p Value 
0.000* 
Dosage 
form  
1434 77.34% 420 20.65% 545 81.10% 127 18.89% 293 69.76% 127 (30.24%) p value 
0.000 * 
Route 
1449 78.15% 405 21.84% 650 96.72 22 3.27% 256 60.95% 164 (39.05%) p value 
0.000* 
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Drug 
items  
No. = 1854  
(Urban manual)
No. = 672  
(Urban structure format)
No. =420  
(Rural manual)
Mentioned Not  mentioned Mentioned 
Not 
mentioned Mentioned 
Not 
mentioned 
Dose 
mention 
876 47.24% 978 52.75% 329 48.95% 343 51.04% 118 28.09% 302 (71.90%) p value 
0.000 * 
Unit 
258 13.92% 1596 86.08% 117 17.41% 555 82.58% 12 2.86% 408 (97.14%) p value 
0.000 * 
Frequency 
of admini-
stration 1438 77.56% 416 22.24% 620 92.26% 52 7.73% 309 73.57% 111 (26.43%) 
p value 
0.000* 
Duration 
of 
treatment 1352 72.92% 502 27.08% 605 90.02% 67 9.97% 325 77.38% 95    (22.62%) 
p value 
0.000* 
Quantity 
to be 
dispensed 1335 72.0% 519 28.00% 552 82.14% 120 17.85% 300 71.42% 120         (28.57%) 
p value 
0.000* 
Signa  
1156 62.35% 698 37.65% 672 100% 0 0% 208 49.52% 212  (50.48%) p Value 
0.000*  
 
*  Highly significant (p value less than 0.000). 
 
The given table depicts that only in 0.24% rural manual prescriptions, 2.96 % of the urban 
manual and only 1.04% prescriptions in the structured format category, drugs were 
mentioned by generic names. 
Dosage form of the prescribed items was mentioned in 77.34% of the prescriptions of the 
urban manual category, 81.10% in structured format prescriptions and just 69.76% of the 
rural prescriptions. 
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Route of administration was mentioned in 96.72% of the prescribed items in structured 
format prescriptions in comparison to 78.15% in the urban manual prescriptions and only 
60.95% in rural manual prescriptions.  
Dose or strength of the prescribed drug items was marginally improved in structured format 
prescriptions to 48.95% in comparison to 47.24% in the urban manual prescriptions 
although they were both much better than the 28.09% in rural manual group of 
prescriptions. 
Unit e.g. mg, gm, ml was mentioned only for 13.92% prescribed items in urban manual 
prescriptions and improved to just 17.41% in structured format prescriptions. Even here 
rural manual prescriptions fared much worse at 2.86%.  
Frequency was mentioned in 77.56% of the prescribed items in urban prescriptions while it 
was mentioned in 92.26% of the prescribed items in structured format prescriptions and in 
73.57% of the rural manual prescriptions. 
Duration of treatment was mentioned in 72.92% of urban manual prescribed items and 
77.38% of the rural manual prescriptions but improved to 90.02% of the prescribed items in 
the structured format prescriptions.  
Quantity of the prescribed items was comparable at 72.00% of the drugs in the urban 
manual prescriptions to 71.42% of the rural manual prescriptions, while it improved to 
82.14% in the structured format group. Signa was mentioned in more than half of the 
prescribed items i.e. in 62.35% of urban manual prescriptions while it showed improvement 
to 100% in the structured format group. In rural category just half of the prescriptions 
mentioned signa. 
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Table-9D: Comparison of urban manual (n = 549), urban structured format 
(n = 206), rural manual (n = 191) 
 
Others  
 
Prescription type 
Urban manual Structured format Rural manual 
Count % Count % Count % 
Allergy or 
sensitivity 
Mentioned 0 0.00% 106 51.46% 0 0.00% 
Not mentioned 549 100% 100 48.54% 191 100% 
Legibility 
Legible 415 75.59% 206 100% 125 65.45% 
Poor legible 134 24.41% 0 0.00% 66 34.55% 
Specific drug 
communication 
Mentioned 0 0.00% 17 8.25% 0 0.00% 
Not mentioned 549 100% 189 91.75% 191 100% 
Status 
RS/CVS/ H/R 
Mentioned 0 0.00% 106 51.46% 0 0.00% 
Not mentioned 549 100% 100 48.54% 191 100% 
Refill 
Mentioned 0 0.00% 15 7.28% 0 0.00% 
Not mentioned 549 100% 191 92.72% 191 100% 
Follow up 
Mentioned 42 7.65% 0 0.00% 0 0.00% 
Not mentioned 507 92.35% 206 100% 191 100% 
Dispense as 
written 
Mentioned 0 0.00% 15 7.28% 0 0.00% 
Not mentioned 549 100% 191 92.72% 191 100% 
History of 
intake of other 
medicine 
Mentioned 0 0.00% 51 24.75% 0 0.00% 
Not mentioned 549 100% 155 75.24% 191 100% 
 
As depicted in the table, comparison between the urban manual and structured format 
prescriptions shows that there was improvement in mention of the following parameters like 
allergy or sensitivity in patients from 0% to 51.46% of the prescriptions, mention of status 
of respiratory/cardiac/hepatic/renal from 0% to 51.46%, but a poor improvement in mention 
of specific drug communication from 0% to 8.25%, refill from 0.00% to only 7.28% and no 
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improvement in mention of follow up which was mentioned in 7.65% of the urban manual 
prescriptions while not at all in the formatted prescription form.  
 While dispense as written improved only marginally from 0% to 7.28%, history of intake of 
other medicines was improved modestly from 0% to 24.75%.  Similarly, if we compare 
rural manual prescriptions and the structured format, the results appear to be almost the 
same except that follow up was not mentioned at all in the rural manual prescriptions as 
compared to a few in urban manual prescriptions. Prescriptions in urban manual category 
were 75.59% prescriptions legible while 24.41% were poorly legible, while in structured 
format prescriptions all prescriptions were legible. In rural manual category the ratio of 
legibility verses poor legibility was 65.45%:34.55%.  
 
CHAPTER – V 
 
DISCUSSION 
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CHAPTER - V 
DISCUSSION 
Prescription errors account for 70% of medication errors that could potentially result in 
adverse effects3. In our study a total of 740 handwritten prescriptions were collected from 
urban as well as from rural sector. They were screened for the essential elements of 
prescription writing6. Our observations showed various types of lacunae in prescription 
writings as discussed below. 
Doctor’s details: Name of the doctor was mentioned in all the prescriptions in our study i.e. 
100% while their qualifications were mentioned in 97.54%. Our findings are some what 
similar to findings of study conducted by Sibailly et al. 147 which stated that the prescriber’s 
name was mentioned in 99.2% of the prescriptions, and qualifications mentioned in 98.8% 
of the prescriptions. While in a study conducted by Irshaid et al.2 in hospitals of Saudi 
Arabia it was found that as many as 17% prescriptions did not bear the name of the 
prescriber. Similarly Balbaid and Al-Dawood148 reported that prescriptions from ministry of 
health hospitals in Jeddah city were deficient in patient’s name in 14% of the cases. This is 
similar to a study carried out by Ansari M149 wherein prescribers name was mentioned in 
85.4% of the prescriptions. Such type of deficiencies can pose a major difficulty for 
dispensing pharmacist to contact the prescriber in case of any clarification. Apart from this 
it becomes and illegal document if it does not bear the name of the doctor. In a study 
conducted by Wilson et al.150 on legal issues in prescription writing in two health 
institutions in Nigeria stated that for teaching hospital prescribers name was mentioned in 
80% of the prescriptions. In the similar study, it was mentioned in 100% prescriptions in 
health centre in Nigeria, which is similar to the situation in Anand district where all 
prescriptions carried the prescriber’s name.  
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In our study doctor’s contact address was mentioned in 100.00% of the overall 
prescriptions. Thus all prescriptions had the doctor’s hospital address in line with the study 
done by Sibailly et al.147 where clinician’s address was mentioned in 100% of the 
prescriptions. On the contrary, study conducted by Irshaid et al. 2 revealed that only 9.6% of 
the prescriptions had prescriber’s address which is an important element to be included in 
the prescription.  
In all 78.24% prescriptions mentioned the contact numbers either in the form of landline 
number or mobile numbers on the prescriptions in our study while in contrast the study 
done by Irshaid et al. 2, shows that, none of their prescriptions contained the telephone 
number of the prescriber. This parameter has a lot of significance as an error of omission or 
commission if detected by a pharmacist can be avoided or an instruction not clearly 
understood by the patient can be clarified if the prescriber is just a phone call away.  On the 
other hand clinicians were not very comfortable about giving their personal phone numbers 
as they find it invading their privacy at times, as discussed with the clinicians in our study. 
In our study doctor’s registration number was mentioned in only 36.87% of the overall 
manual prescriptions. On the contrary it was mentioned in 98.8% of the prescriber’s 
prescriptions in study by Sibailly et al. 147 and in 99.06% prescriptions in a study done by 
Ansari et al.149 in Nepal while it was mentioned in 89% of the prescriptions in study 
conducted by Meyer TA7. In one of the study conducted by Kuann Mun Ni et al.151 hardly 
0.5% of the prescribers mentioned their registration number on the prescription letter pads 
In the same context out of the 397 prescriptions screened in a single day, 96.7% had one or 
more legal or procedural requirement missing. The medicolegal significance of mentioning 
registration number of the qualified medical practitioner cannot be overemphasized besides 
being a legal requirement to be fulfilled by doctors as well as registered medical 
practitioners by the director General of health.  This again indicated a need for pharmacy 
and medical educators to further emphasize the importance of writing complete 
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prescriptions and also calls for implementation of educational and monitoring programmes 
to bring more awareness to all concerned so as to reduce the rate of non compliance in 
prescription writing and hence minimizing chances of prescription errors. Moreover 
according to information regarding medical council registration number, doctors are 
required to quote their registration number on all medical prescriptions, reports and all other 
documentation and records, whether in paper or electronic format relating to their medical 
practice thus prescribing doctor should put his rubber stamp bearing his full name, 
qualification and registration number. This requirement arises from section number 43 (8) 
of the Medical Practitioner Act 2007 and comes in with the annual certificate of registration 
by the Medical Council of India152. 
The esoteric symbol was mentioned in 79.97% of the prescriptions in our study, which is 
somewhat similar to study done by Ansari et al. 149 wherein in 66.8% of the prescriptions 
treatment symbol was missing while in a study conducted by Al Khaja et al.153 showed that 
96.1% of the prescriptions bore this symbol. . The esoteric symbol “Rx” separates the 
superscription from the inscription sections, which means “take thou” or a prayer to the God 
of healing, Zeus or Jupiter (i.e. the Gods whose protection may have been sought in medical 
contexts). This perhaps suggests that a vast majority of our clinicians do believe in the age- 
old adage ‘I treat, He cures’ as they write a prescription beginning with “Rx ”, depicting 
that he or she is completing the command.  
Doctor’s signature was present in 67.00% of the prescriptions in our study as compared to 
study by Sibailly et al.147 in which 99.8% bore doctor’s signature and 96% prescriptions 
bore doctors signature in Professor Wilson150 study. On contrary study by Ansari et al.149   
had doctors signature in only 15.7% prescriptions. As in our study 67.00% prescriptions 
bore   doctors signature, which would imply that a large number of prescriptions in our 
study would be invalid for execution by the pharmacist, but were being honoured 
nevertheless, thereby raising major legal issues. In another study conducted by Balbaid and 
  204
Al-Dawood et al.148 prescriber signatures were deficient in 16.3% of the cases and in a 
study conducted by Irshaid et al.2, the same was deficient in 18.1% of the cases. Thus the 
clinicians in our study fared much worse on this front with almost 33% prescriptions being 
without signatures.  
Patients details: Date of issue of prescription was mentioned in 94.48% of the prescriptions 
in our study which is similar to 94.2% in study conducted by Sibailly et al.147. 
The date of issue of prescription to the patient was not mentioned in 5.52% of the 
prescriptions in our study, which is similar to the study of Balbaid and Al Dawood 
(8.7%)148 and Fancois et al. (4.5%)154. The mention of date signifies the fact that a medical 
consultation was sought and action was taken by the clinician for the ailment. Since 
treatment protocols follow set algorithms, the mention of date is essential to show that the 
treatment followed the dynamics of patient response to treatment instituted. This can have 
serious implications in medicolegal cases since the prescription is a legal document and not 
mentioning date can be construed to be negligence even in nonmedico-legal cases. 
OPD number was mentioned in only 29.00% prescriptions, clearly illustrating a lack of 
serial case recording for future easy access to old case records if required. This shows the 
glaring lacuna in the Indian medical reporting. Despite great medical acumen and skills of 
Indian doctors acclaimed all over the world, this poor record keeping reduces the credibility 
of Indian medical research.  
Patient’s name was not mentioned in 7.36% of overall prescriptions (only 34.01% had the 
full name, while partial name in 58.63%). In a populous country like ours, there can be 
numerous persons with the same name so it is imperative to reduce erroneous medication by 
mentioning the full name. Patient’s age was not mentioned in 53.43% prescriptions. This 
can be an important factor in various prescriptions and can lead to very serious implications, 
besides being an important factor in identification also. Patient’s sex was not mentioned in 
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64.15%.In comparison with our findings that prescriptions were deficient in mentioning 
name, age and sex, the study by Irshaid et al.2 had deficiency in the same to the extent of 
5.4%, 22.7% and 48.7% of prescriptions, respectively. 
Patient’s weight was mentioned in just 23.79% of the overall prescriptions which is an 
important part of prescription order writing (superscription). According to WHO6 the 
inclusion of weight is recommended and should be included in the prescription especially at 
the extremes of ages6,155 because of its implications on the pharmacokinetics and  
pharmacodynamics. Lack of information on weight of child in the prescriptions could lead 
to medication errors during dispensing. Only 54% of the paediatric prescriptions in our 
study which were computer generated were having information on weight of child but in all 
fairness it must be pointed out here that a majority had this data mentioned in the 
accompanying case file and thus it perhaps now needs to be understood that this should be 
considered an extension of the prescription itself.  
The address of patient is among the elements that should be added in the prescription 
according to WHO guidelines for better prescribing6. Patient address was mentioned in only 
11.95% of the overall prescriptions while contact number of the patient was not mentioned 
in any of the prescriptions Also there was lacunae in mention of address in a study 
conducted by Wilson et al.150 i.e. patients address was mentioned in only 1.8% of 
prescriptions respectively. This too shows the lack of will to remind patient for follow-ups 
and at times even to make corrections if errors of omission or commission are noticed by 
the clinicians before an unwanted event occurs. Omission of patient’s address from 
prescriptions is a serious deficiency as when the problems in prescriptions are discovered 
and the patient needs to be contacted urgently to correct the problem. Relative lack of 
information about the patient reported in this study was similar to the one reported by 
Mallet et al.156. 
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Drug details: Low generic prescribing ranging from 0.24% - 2.96% of the drugs was one of 
the most glaring features of prescription writing as seen our data. In our study, generic 
names were mentioned in just 2.02% prescriptions compared to 97.97% brand names in all. 
This perhaps shows that clinicians have either more faith in a particular brand or that they 
do not wish the pharmacist to have the liberty to decide the brand. Besides, a majority of 
patients on chronic lifestyle disease management, like to remember their drugs by brand 
names which are much easy to recall as opposed to generic names. Nevertheless, there 
could be more ulterior motives in over prescribing particular brands, but that is outside the 
purview of our study and best left under wraps. This finding is similar to study conducted 
by Kumari et al.157 wherein there is low generic prescribing (1.1%) at the tertiary health 
care level. As seen in our data various studies done in India i.e. Bapna et al.158, Hazra et 
al.159 in this regard had similar findings perhaps due to a dominating influence of the 
pharmaceutical companies and medical representatives. On the contrary generic prescribing 
may vary in several studies carried out in other countries like the one carried by Blatt et 
al.160 which reports that 16% of outpatient prescriptions contained brand names in hospital 
in Cameroon, study by Biswas et al 161 done in outpatient reported the percentage of drugs 
being prescribed by generic names was 35%. One of the study conducted by Thawani et 
al.162 states that generic prescribing of drugs was prevalent in 69.93% of prescriptions.   
In our study the dosage form was mentioned in 75.94% but the doses in only 51.01%. In our 
practice “dose” i.e. the quantity of drug to be taken, is mentioned as “frequency of tablets to 
be taken” that is a common practice. Apparently it seems that deciding on the dose to be 
dispensed to the recipient is left for the pharmacist to decide upon. On the contrary, one of 
the studies conducted by Bawazir163 reports that dose of the drug was missing in only 4% of 
the prescriptions which is a good practice. It is important for the clinicians to bear in the 
mind that the dose or strength of the medicines prescribed, is particularly needed when the 
pharmaceutical product exists in more than one strength. In our study unit was mentioned in 
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only 23.70% of the collected prescriptions. In all fairness to the prescribers, many of the 
drugs were fixed dose combinations/single dose and therefore do not need to be specified as 
well it is difficult to memorise each dose. The frequency of administration was mentioned in 
80.02% of the prescriptions. The quantity was mentioned in 85.95% prescriptions and 
duration of medication was mentioned in 31.50% of the prescriptions. This would imply 
that a very large number of prescriptions would leave it to the discretion of the pharmicist or 
the patients themselves to decide on their own, a perfect recipe for disaster.  However as 
compared to these findings in our sample, a study conducted by Balbaid and Al Dawood148 
reported that the dose, frequency, and duration of medication were there in 92.4%, 93.1%, 
89.8% of the prescriptions.  
Signa/direction for drug use was mentioned in 63.83% of the overall prescriptions. Study 
conducted by Irshaid et al.2 reported that prescriptions were seriously deficient in 
instructions for patient use and the majority of the (90.7%) prescriptions contained only 
partial instructions while in only 2.3% of the prescriptions there were full instructions for 
patient use. Again contrary to this, Bawazir163 reported that instructions/directions for drug 
use were missing in only 4% of the prescriptions, a finding that certainly will affect the 
adequacy of therapy. Numerous studies have demonstrated patients difficulty in recalling or 
understanding basic directions for taking the medicines. If the medication is to be taken at a 
specific time of the day, if a particular dosage interval is desired or if there are any 
additional directions for use, these should be noted on the prescription and precisely 
explained to the patient in simple terms. The presence of this information is of help to 
prevent dispensing errors.  
Others: Details like allergy, mention of medical condition like status of respiratory/hepatic/ 
renal/cardiac functioning as well as, history of intake of other medicines was not mentioned 
in any of the prescriptions but it is worth mentioning here that though the prescription itself 
did not contain this data, it was mentioned in the accompanying case files in quite a few 
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cases which is a part of data base prescribing system complex to detect problems to warn 
the patients31,35 thereby forcing us to reconsider the case file to be an integral extension of 
the prescription. By acquiring this complete information one can study the prescribing faults 
and the rationality status of the prescriptions. Mention of refill was not there in any of the 
prescriptions. This is an interesting observation and perhaps partially explained by the fact 
that most clinicians are either uncomfortable with the patient taking medicines for long 
periods of time without regular follow up checks as doses and drugs may need to be altered 
with changing patient physiology, prognosis and additional factors or perhaps have financial 
considerations not to mention refills. Study done by Al Khawaja et al.152 also states that 
there was no mention of the refill element in the prescriptions. In fact mentioning the 
number of refills on each original prescription order irrespective of whether it is for 
controlled substance helps to control the overuse and the abuse of prescription medications, 
however follow up was mentioned in 5.67% of prescriptions only in our study. 
Specific drug communication or drug information was mentioned in barely 0.61% of the 
prescriptions in our study, as compared to study done by Irshad et al. 2 which reported that 
specific drug information was mentioned in 85% of the out patients. Parameters like 
’Dispense as written’ or ‘do not substitute’ was not written. Poor handwriting was noted in 
20.42% of the prescriptions in our study while in the study by Irshaid et al.2 poor 
handwriting was recorded in a large number of prescriptions (65.3%), in another study by 
Balbaid et al.148 illegible handwriting in 7.2% of the prescriptions was reported. Similar 
study conducted by Meyer et al.7 found that 15% of the prescriptions had illegible 
handwriting. Furthermore, Makonnen et al. 164 also reports in the study done in tertiary care 
pharmacy that illegible prescriptions accounted for 15% of the cases. Poor handwriting is a 
serious problem and is a matter of concern for pharmacist, patient, further referral etc. When 
the pharmacists are in doubt they may call the doctor otherwise it might lead to pharmacist 
dispensing wrong medication, to the patient with serious or even fatal results. 
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On a comparative analysis it was clearly evident in our study, that computer generated 
prescriptions were much more error free than hand written ones. In fact as seen in our study, 
half of the pediatricians were using computer-generated prescriptions. Almost all the 
computer generated prescriptions contained 100% information on clinician details like 
name, qualification, address, registration number, esoteric symbol and the patient details 
like OPD number, name, age, sex of the patient. Similarly, in the drug item related 
prescriptions errors there was a marked reduction in the errors in areas like dose, unit, 
frequency of drug administration, duration of treatment, quantity, signa and legibility of 
prescriptions. On similar lines were the findings in a study done by Bates et al.165 which 
reports reduction in prescription errors in computer generated prescriptions. Also the 
problem of legibility would not be there as computer generated prescription would be 
printed. In our study there were some lacunae in computerised prescriptions in a few areas 
like in the doctors signature 82%, use of generic names barely in 0.50% prescriptions, no 
mention of refill, and mention of dispense as written in only 16.50% of the prescriptions. 
Investing in information technology may not always be feasible, at least not in those health 
care settings with the economic constraints. On discussing with our clinicians, it became 
evident that not all were very keen about using software for prescription writing. They were 
of the opinion that the use of computer software for prescription writing was a very tedious 
job. Most of the practitioners possessed or had purchased the software for the same but did 
not want to use it. They felt that they needed a separate skilled person for the same since 
they felt dissociated from the patient while entering data themselves and even the 
prescription did not bear their personal touch. This conveys the message that although 
technologies have helped in reducing errors in certain ways but they have their own 
shortcomings. 
In our study modified prescription format significantly reduced the errors in prescription 
writing as compared to standard handwritten prescriptions with improvement in most of the 
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parameters such as mention of clinicians details, patient details, drug details as well as in 
others. Similar to these are findings as documented in study by Gommans J. et al.166. This 
study showed an improvement in the quality of prescribing by improvising the alternative 
interventions like modification of medication charts, which showed progressive 
improvement in legibility (97%), patient identification (100%), documentation of date 
(98%), mention of drug dose (99%) and route (97%) but the identification of prescribers 
still remained suboptimal. Modified prescription forms significantly reduced clinically 
important prescribing problems as compared to standard forms. Based on the legal 
requirements of prescription, modified forms do decrease omission errors as compared to 
standard forms which is also stated in a study done by Kennedy A.G.167 which reports that 
after introduction of modified prescription format, problems remained with only 2.3% of the 
prescriptions.   
Limitations: 
• In our study we could not study the prescription for “prescribing faults” due to a 
paucity of details necessary to make this assessment as listed below in the list of 
prescribing error definition by Dean et al.12. It is our contention that the patient file 
should be considered an extension of the prescription so that important data (a lot of 
this data was found available in the respective files which were issued to patients by 
the clinicians in our study as shown in Annexure-III) becomes available for a better 
assessment of prescribing errors. Interventions aimed at improving prescribing and 
reducing errors are a vital component in improving patient safety. The patient files 
are containing the full detailed medication history as well as patient particulars in 
detail, which is a very important aspect for the determination of the prescribing 
faults (errors of commission). Our study is an effort to highlight one of the aspect of 
error i.e. prescription errors in the act of writing a prescription rather than 
prescribing faults which emphasizes mainly on the rationality aspects of 
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prescriptions like overprescribing, underprescribing, inappropriate prescribing and 
irrational prescribing   for which education regarding clinical pharmacology and 
therapeutics is needed. Broadly the rational drug therapy means correct use of 
correct drug/s when indicated. Not only the disease, but the patient, the family and 
the environment (socioeconomic and educational levels) should also be selected 
while selecting the drugs. To study this aspect of prescribing errors there should be 
full medication history, which is missing in OPD prescriptions. Rational therapeutic 
decisions are based on the criteria like examination of patient for the evidence of 
drug effects and drug actions, planning appropriate therapy and dosage regimens by 
calculations based on age, body weight and gender of patient, the clinical condition 
of the patient. At the same time education on drug therapy to patients is a must to 
improve compliance. There has been considerable variations in the study designs, 
methods, and error definitions and error rates of medication errors and its types. Till 
consistent definitions and methods are used we struggle to understand the types of 
errors and their occurrence in this part. 
Agreement on a standard definition is urgently required, as demonstrated by the wide range 
of definitions used in the studies we reviewed. Thirty-five separate criteria were noted from 
studies, which used varying combination of these. A strong contender for the ‘ideal’ 
definition is Dean’s Delphi derived definition3,12 which represents the result of an expert 
consensus (doctors, pharmacists and nurses), this definition has the benefit of describing 
both elements of prescription writing and of decision making, but where all elements are a 
possible danger to patients. Two directions for future research are suggested that will 
provide the information needed. First, future research in prescribing error rates should be 
well constructed and generalised using standard definitions and methodology. A well- 
conducted study of prescribing errors by junior doctors is urgently needed. Second, further 
in depth research into the reasons for errors using human error theory is required, building 
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on the work done by Dean et al.16 although attention should continue to be focused on 
systems, factors, individual factors should not be discounted. Future research should 
concentrate on providing the theoretical foundations prior to developing and validating 
actual interventions. Listed below is the list of prescribing error as defined by Dean et al.12  
• Prescribing a drug for a patient for whom, as a result of a co-existing clinical 
condition, that drug is contraindicated, prescription of a drug to which the patient 
has a documented clinically significant allergy, not taking into account a potentially 
significant drug interaction, prescribing a drug in a dose that, according to National 
Formulary or data sheet recommendations, is inappropriate for the patient’s renal 
function, prescription of a drug in doses below that recommended for the patient’s 
clinical condition, prescribing a drug with a narrow therapeutic index  in a dose that 
is  predicted to give serum levels significantly above the desired therapeutic range,  
and not altering the dose following steady stage serum levels significantly outside 
the therapeutic range, continuing a drug in the event of a clinically significant 
adverse drug reaction, prescribing two drugs for the same indication when only one 
of the drugs is necessary, prescribing a drug to be given by intravenous infusion in a 
dilutent that is incompatible with the drug prescribed, prescribing a drug to be 
infused via an intravenous peripheral line, in a concentration greater than that 
recommended for peripheral administration, writing illegibly, writing a drug’s name 
using abbreviations or other nonstandard nomenclature, writing an ambiguous 
medication order prescribing ‘one tablet’ of a drug that is available in more than one 
strength of tablet, omission of the route of administration for a drug that can be 
given by more than one route, prescribing a drug to be given by intermittent 
intravenous infusion, without specifying the duration over which it is to be infused, 
omission of the prescriber’s signature, on admission to hospital, unintentionally not 
prescribing a drug that the patient was taking prior to their admission continuing a 
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general practitioner’s prescribing error when writing a patient’s drug chart on 
admission to hospital, transcribing a medication order incorrectly writing 
‘milligrams’ when ‘micrograms’ was intended, writing a prescription for discharge 
medication that unintentionally deviates from the medication prescribed on the 
inpatient drug chart, on admission to hospital, writing a medication order that 
unintentionally deviates from the patient’s pre-admission prescription, prescribing a 
drug in a dose above the maximum dose recommended in the  National Formulary 
or data sheet, misspelling a drug name, prescribing a drug in a dose that cannot 
readily be administered using the dosage forms available, prescribing a dose regime 
(dose/frequency) that is not  recommended for the formulation prescribed, 
continuing a prescription for a longer duration than necessary, prescribing a drug 
that should be given at specific times in relation to meals without specifying this 
information on the prescription, unintentionally not prescribing a drug for a clinical 
condition for which medication is indicated. 
 
 
CHAPTER – VI 
 
CONCLUSION 
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CHAPTER - VI 
CONCLUSION 
In the present study after assessing the prescriptions and then comparing with the 
predetermined standards of good quality prescribing, it is evident that out patient 
prescription errors are abundant and often occult. The handwritten prescriptions be it from 
urban or rural areas, are associated with relatively higher error rates associated with 
prescription writing in the Anand district in all areas like doctors details, patient details and 
drug details and even on other aspects like allergies, major illnesses and specific 
communication about the drug. The computerized prescriptions on the contrary had the 
lowest frequency of prescription writing errors. 
Although there is an increasing awareness regarding the use of computers for the generation 
of prescription orders in some practice settings. In developing countries handwritten 
prescriptions will most probably continue to be the main tools for communicating 
therapeutic intent for a long time. Computer Physician order entry systems have advantages 
of clear legibility, accurate information on drugs, patient specific information such as 
warnings on overdoses, drug interactions and alerts on drug allergies, but they are expensive 
to introduce, measures must also be taken to encourage doctors to write prescriptions 
legibly. In conclusion this study is an effort to assess the quality of handwritten 
prescriptions in Anand district and interventions thereof designed to address the identified 
deficiencies in prescription writing i.e. especially in the area of omission errors. Prescribers 
could be helped by designing systems to reduce the risk of these errors like that of a 
compromise between error prone manual method and indifferent (in human) approach of 
computerised prescription. The approach sorted, could be a prescription form printed with 
proper layout i.e. a structured format. While the prescriptions continued to be manually 
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written, the printed spaces in the prescription, became reminders to the clinicians and 
therefore the error rates in various parameters fell dramatically. Various educational 
interventions like face to face education and group seminars can also help to bring about 
modest changes in prescription errors. 
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Annexure-I 
 
 
INFORMED CONSENT FORM 
 
STUDY TITLE:  PRESCRIPTION DRUG ERRORS IN ANAND DISTRICT 
 
DOCTOR’S NAME: _______________________________________________ 
 
I have been explained regarding the research project ‘PRESCRIPTION DRUG ERRORS IN 
ANAND DISTRICT’ to be conducted by Dr. Anuradha Joshi. I understand that my participation 
in the study is voluntary and that I am free to withdraw at any time, without giving any reason. 
I understand that my identity will not be revealed in any information released to third parties or 
published. 
I agree to take part in the above study. 
 
Signature of the Doctor:  
Date: 
Signatory’s Name: 
Signature of the Investigator: 
Date: 
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 F ig . 4(Table ‐4A): Analys is  of ov e rall pre s c ription
writing  e rrors  (n  =  979)
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F ig .5 (Table‐4B ):  Analys is  of overall 
pres c ription
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F ig . 6 (Table‐4C ‐i):  Analys is  of overall pres c ribed  
items  (n  = 3069)
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13.68%
19.38%
6 51%.
Urban Rural
F ig .8  (T able‐4D):  others  analys is  of overall 
pres c ription
writing  errors   (n  =  979)
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F ig . 7 (T able ‐4C ‐ii): Analys is  of overall pres cription 
writing
in drug  details  (n =  3069)
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Fig.9 (Table-5A): Comparative analysis of prescription 
writing errors between urban manual (n = 549) 
and rural manual prescriptions (n = 191) Clinician details
 Mentioned Overall (740)  Mentioned Urban (549)
 Mentioned Rural (191) Not Mentioned Overall (740)
Not Mentioned Urban (549) Not Mentioned Rural (191)
        
 Mentioned Overall (740)  Mentioned Urban (549)
 Mentioned Rural (191) Not Mentioned Overall (740)
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F ig 10 (Table‐5C ‐i): Analys is of pres c ription.          
writing  errors  of urban  manual pres c riptions  :  
drug  details  (urban) 
total drug items (n = 1854)         
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F ig .12 (Table‐5D ‐v):  F ollow up
O ll U b R l
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F i 11 (T bl 5C ii A l i f i ti itig .   a e ‐ ‐ :  na ys s  o  pres cr p on wr ng  
errors  of rural manual pres criptions  ‐ drug  details  
(rural) total drug  items  (n =  420)
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F ig .13 (Table‐5D ‐viii):  R efill mentioned  
Overall Urban Rural
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Fig.15 (Table-6B):  Analysis of prescription writing errors in urban 
t t d i ti ( 200)
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F ig .14 (Table‐6A): Analys is of pres c ription writing           
errors  in  urban  computer g enerated  
pres c riptions  (n=200)
Mentioned Not Mentioned
100% 100% 82% 100% 100% 100% 82.00%
 
0.00% 0.00% 18% 0.00% 0.00% 0.00% 18%
m
e
 
c
a
t
i
n
o
.
s
s
 
.
 
N
o
e
r
i
c
b
o
l
t
u
r
e
 
N
a
 
Q
u
a
l
i
f
i
c
o
n
C
o
n
t
a
c
t
 
 
A
d
d
r
e
 
R
e
g
.
E
s
o
t
e
s
y
m
S
i
g
n
a
t
F ig .17 (Table‐6D):  Analys is  of pres c ription  writing  
i t i d i ti ( 200)errors   n  c ompu er s e  pres c r p ons   n  = 
Mentioned Not Mentioned
93.00%
100% 97.00% 100% 100%
83.50%
100%
16.50%
7 00%
0.00% 3.00% 0.00% 0.00% 0.00%
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Specif ic
communicat ion of
Drug : Status:
RS/CVS/L/K
Ref ill Follow up Dispense as
Writ ten 
History of intake
of other medicine 
drugs
Fig.16 (Table-6C): Analysis of prescription writing errors of 
prescribed items of  computer generated prescriptions 
200 (595 ib d it )
Mentioned Not Mentioned
n=   prescr e  ems
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F ig .‐18 (Table‐7A):  C omparative analys is  of differenc e 
between  pres c ription  writing  errors  in  urban  manual 
pres c riptions  (n  = 549) and  s truc tured  format 
pres c riptions  (n  = 206)
100 00% 99 09% 100% 100 00%100 00% 100 00% 100 00%
Manual  Mentioned Manual Not Mentioned Format  Mentioned Format Not Mentioned
. .
17.12%
77.05% 65.76%
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82.88%
22.95% 34.24%
58.25%
.
0% 0.00% 0%
48.75%
0.00% 0.00%
95.63%
. . .
Name Qualification Addres s   Reg. No E soteric
s ymbol
 S ignature
Fig .19  (Table‐8B): Combined table  of pres c ription writing  
errors  in  urban manual (n =  549), urban s truc tured format (n 
=  206),  urban c omputer generated pres c riptions  (n =  200)
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Fig.20 (Table‐8C):  Comparison of prescription writing errors in urban manual drug 
items (n = 1854), urban structured format drug items (n = 672),  urban computerized 
prescriptions drug items (n = 595)
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